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SUMMARY
It has been assumed that the factors which control 
antibody biosynthesis in the chicken, and their mode of operation, 
are subsequently reflected in the characteristics of the antibody 
response. These characteristics were taken to include the kinetics 
of antibody biosynthesis, as well as the quantity, the quality 
(i.e. the affinity, avidity and heterogeneity) and the class of the 
antibody molecules themselves. This assumption is particularly 
justifiable in the chicken, where the relative short half life 
values of immunoglobulins ensure that the characteristics of the 
antibody response reflect preceding events in the induction and 
control of biosynthesis fairly rapidly and with reasonable accuracy.
One of the most important factors which exert control 
on the biosynthesis of antibodies is the immunogenicity of the 
antigen and the influence of immunogenicity on the processes of cell 
selection and induction of biosynthesis of antibodies in chickens 
was examined. For example, the effect of antigen structure upon 
the production of specific antibody in chickens was studied - 
this involved investigation of the proficiency of different carriers 
and the effect of epitope density upon the antibody response to the 
DNP hapten. Another consideration is the presentation of the 
antigen, and this entailed examination of the effect of carrier 
pre“immunisâtion upon the response to a hapten coupled to that 
carrier and also investigation into the action of adjuvants. Although 
birds of all ages produced detectable amounts of antibody when 
immunised with a protein antigen such as HSA, and the kinetics of the
response and the avidity of the antibodies could be readily 
determined, the age of chickens did appear to have a considerable 
bearing upon their ability to produce anti-DNP antibodies. The 
kinetics of the anti-DNP response were very similar to the pattern 
observed for production of anti-HSA antibodies; however, the 
affinity of chicken anti-DNP antibodies, as measured by equilibrium 
dialysis, was found to be very low and not affected significantly by 
the dose of antigen.
The effect of adjuvants upon biosynthesis of antibodies 
in chickens was also investigated. From the characteristic kinetics 
of antibody biosynthesis following immunisation with antigen in 
Freund’s complete adjuvant, as well as from the pattern of antibody 
avidity, the distribution of antibody classes and the effect of 
adjuvant on homeostasis of the antibody response in chickens, certain 
conclusions concerning the mode of action of adjuvants were reached; 
their influence either on the selection process or on the regulation 
of biosynthesis was discussed.
Efficient regulation of antibody production in chickens 
was readily inferred from the kinetics of biosynthesis. This homeostatic 
mechanism was studied by analogy with the effects of passive antibody 
upon the production of specific antibodies, and the possibility that 
regulation of biosynthesis was achieved by antibody-mediated feedback 
inhibition was discussed.
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SUMMARY
It has heen assumed that the factors which control 
antibody biosynthesis in the chicken, and their mode of operation, 
are subsequently reflected in the characteristics of the antibody 
response. These characteristics were taken to include the kinetics 
of antibody biosynthesis, as well as the quantity, the quality 
(i.e. the affinity, avidity and heterogeneity) and the class of the 
antibody molecules themselves. This assumption is particularly 
justifiable in the chicken, where the relative short half life 
values of immunoglobulins ensure that the characteristics of the 
antibody response reflect preceding events in the induction and 
control of biosynthesis fairly rapidly and with reasonable accuracy.
One of the most important factors which exert control 
on the biosynthesis of antibodies is the immunogenicity of the 
antigen and the influence of immunogenicity on the processes of cell 
selection and induction of biosynthesis of antibodies in chickens 
was examined. For example, the effect of antigen structure upon 
the production of specific antibody in chickens was studied - 
this involved investigation of the proficiency of different carriers 
and the effect of epitope density upon the antibody response to the 
DNP hapten. Another consideration is the presentation of the 
antigen, and this entailed examination of the effect of carrier 
pre-immunisation upon the response to a hapten coupled to that 
carrier and also investigation' into the action of adjuvants. Although 
birds of all ages produced detectable amounts of antibody when 
immunised with a protein antigen such as HSA, and the kinetics of the
XIV
response and the avidity of the antibodies could be readily 
determined, the age of chickens did appear to have a considerable 
bearing upon their ability to produce anti-DNP antibodies. The 
kinetics of the anti-DNP response were very similar to the pattern 
observed for production of anti-HSA antibodies; however, the 
affinity of chicken anti-DNP antibodies, as measured by equilibrium 
dialysis, was found to be very low and not affected significantly by 
the dose of antigen.
The effect of adjuvants upon biosynthesis of antibodies 
in chickens was also investigated. From the characteristic kinetics 
of antibody biosynthesis following immunisation with antigen in 
Freund's complete adjuvant, as well as from the pattern of antibody 
avidity, the distribution of antibody classes and the effect of 
adjuvant on homeostasis of the antibody response in chickens, certain 
conclusions concerning the mode of action of adjuvants were reached; 
their influence either on the selection process or on the regulation 
of biosynthesis was discussed.
Efficient regulation of antibody production in chickens 
was readily inferred from the kinetics of biosynthesis. This homeostatic 
mechanism was studied by analogy with the effects of passive antibody 
upon the production of specific antibodies, and'the possibility that 
regulation of biosynthesis was achieved by antibody-mediated feedback 
inhibition was discussed.
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ABBREVIATIONS AND SYMBOLS
a index of heterogeneity of antibody affinity, identical to. the
parameter c used by Sips (1948).
ABCgQ antigen-binding capacity; a primary measure of the amount of 
antibody in an antiserum in terms of the serum dilution at 
which 30^ of added antigen at a specified total concentration 
is bound by antibody; from this the amount of antigen which 
would bind to 1 ml of undiluted antiserum is calculated.
Ab antibody,
Ab total concentration of antibody combining sites, measured as
V *■
the total antigen-binding capacity of a unit volume of 
antiserum at high concentrations of free antigen.
AFC antibody-forming cell.
AFPC antibody-forming precursor cell.
Ag antigen.
B cell bursa-derived lymphocyte or its functional equivalent in mammals.
BGG bovine gamma globulin.
BSA bovine serum albumin.
Cg constant region of the immunoglobulin heavy chain.
Cg constant region of the immunoglobulin light chain.
cm centimetre.
cpm counts per minute.
CSA chicken serum albumin.
DEAE diethylaminoethyl.
DNA deoxyribonucleic acid.
DNFB 2 ,4-dinitrofluorobenzene.
DNP dinitrophenyl.
xyi.
DHP^
EACA
2^80
E 1%'280
'280
EDTA
e.g.
et al. 
etc. 
et seq. 
F(ab>).
Fc
FCA
FIA
Sl
S
H
conjugated dinitrophenyl groups; x = number of 
substituent groups per carrier molecule, 
e-amino-n-caproic acid.
spectrophotometric extinction or absorbance
(= logj_Q lo/l, where lo is the incident intensity and
I is the transmitted intensity) of a solution at
wavelength denoted by subscript in nm.
spectrophotometric extinction or absorbance of a 1%
“1 \solution (10 mg ml ) at wavelength denoted by subscript 
in nm.
spectrophotometric absorbance of a 1 molar solution at 
wavelength denoted by subscript (i.e. molar extinction 
coefficient; mol 1. cm ). 
ethylenediaminetetra-acetic acid.. 
exempli gratia (for example). 
et alii (and others). 
et cetera (and the rest). 
et sequentia (and what follows).
divalent fragment (containing two antibody combining sites) 
obtained by digestion of immuno^obulin with pepsin, 
crystallizable fragment obtained by digestion of 
immunoglobulin with papain.
Freund's complete adjuvant.
Freund's incomplete adjuvant.
acceleration due to gravity at the earth's surface 
(= 9-81 m s ^) ; centrifugal force is expressed as a 
multiple of this value, 
gram. /
hapten molecule(s).
xyii
3H tritium.
HBC„_ hapten-binding capacity: a primary measure of the amount of
jv
antibody in an antiserum in terms of the serum dilution at 
which 30^ of added hapten at a specified total concentration 
is bound by antibody; from this the amount of hapten which 
would bind to 1 ml of undiluted antiserum is calculated.
HCN haemocyanin.
HGG human gamma globulin.
]^A human serum albumin.
HuRBC human red blood cells,
i.e. id est (that is).
IgA immunoglobulin A.
IgG immunoglobulin G.
IgM immunoglobulin M.
im intramuscular.
ip intraperitoneal.
iv intravenous.
*I radioactive iodine (i.e. or
heal kilocalorie.
kg kilogram.
average affinity or mean intrinsic association constant of 
anti-hapten antibodies (litres mole ). 
average avidity or relative association constant of 
antibodies.
K kappa light chain of an immunoglobulin molecule.
1. litre.
IPS lipopolysaccharide.
xyiii
X lambda light chain of an immunoglobulin molecule.
Xmax wavelength of maximum spectrophotometric absorbance
of a solution (in nm).
""1
M molarity (moles litre ).
mA milliampère.
mCi millicurie.
mg milligram,
ml millilitre,
mol mole.
MW molecular weight (daltons).
yg microgram,
yl microlitre,
ym micrometre.
ng nanogram,
nm nanometre,
nmol nanomole.
oz ounce.
OVA ovalbumin.
P probability of the difference between two means of two
samples occurring as a result of random sampling errors.
PBS phosphate (H^PO^ /HPO^^ , O.OIM, pH 7.2) buffered saline
(0.15M NaCl).
PGA passive cutaneous anaphylaxis.
PPG plaque-forming cell.
average radius of centrifuge rotor,‘measured from the rotor
centre to half-way down the sample tube.
rpm revolutions per minute.
“13S Svedberg unit (= 10 seconds) for expressing sedimentation
constants.
XIX
SE standard error.
SRBC sheep red blood cells.
E operator denoting summation over all experimental points.
Tj half-life time.
T cell thymus-derived lymphocyte.
TCA trichloroacetic acid.
V volt.
Vg variable region of the immunoglobulin heavy chain.
variable region of the immunoglobulin light chain, 
v/v proportion, volume/volume, expressed as a percentage or
as a ratio.
v/v proportion, weight/volume, expressed as a percentage.
PHYSICO-CHEMICAL CONSTANTS
The following values for physico-chemical constants were used in this 
thesis ;
Molecular weight (daltons) Spectrophotometry
1%
Human serum albumin 69,000 ®280 ” 5*8
Ovalbumin 46,000 ^280 ” 7*35
Immunoglobulin G 150,000 ®280 " ^3.0
e-DNP-lysine 312 = 17,400
-  -1 _ -1mol 1. cm
s-DNP-aminocaproic acid 297 = 17,800
-1 -1mol 1. cm
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DEFINITION OF CERTAIN IMMUNOCHEMICAL TERMS USED IN THIS THESIS
Because of the necessity for accurate statements in 
describing immunochemical concepts, the following terms, which will be 
used frequently in this thesis, have been interpreted thus :
AFFINITY is a thermodynamic expression of the strength of 
binding between the antibody combining site and an antigenic determinant 
and thus of the stereochemical compatibility between them, i.e. it is 
a measure of complementarity whereby the antibody combining site and an 
antigenic determinant can come into sufficient proximity to maximise the 
effects of chemical bonding. As such, affinity may be measured by the 
equilibrium or association constant (K litres mole for the antigen- 
antibody interaction, but since there is most usually heterogeneity of 
affinities within a population of antibody molecules of defined 
specificity, it is at the best an average value referred to as the 
"geometric mean intrinsic association constant," (K^ litres mole ^). 
Affinity is most accurately applied to interactions involving simple, 
uniform determinants, e.g. haptens, thus obviating the difficulty of 
having to consider heterogeneous determinants on the same molecule.
AVIDITY is an expression used to describe the strength of 
binding between antibody and a complex antigen. Because the antigenic 
entity has a number of heterogeneous determinants, avidity is a composite 
description of the overall antibody-antigen interaction; it is 
however somewhat more complicated than a simple summation of affinities 
for individual determinants, and because of the effective multivalency 
of the antigen there is often a co-operative "bonus" effect.
Various definitions of avidity have Ibeen and are used, and 
to a large extent these definitions, as well as the quantitation of 
avidity, can only he expressed in terms of the particular technique 
(e.g. binding of radio-labelled antigen, inhibition of plaque formation, 
inhibition of phage neutralisation) used to measure avidity and usually 
require that a number of fundamental assumptions are made.
For example, in this thesis avidity has been measured as K^, the 
geometric mean association constant obtained from the Sipsian version 
of the equilibrium equation for an antigen antibody interaction - 
assuming that each antigen molecule of a homogeneous population interacts 
with only one antibody combining site.
I N T R O D U C T I O N
Immunity is the ability of an individual to recognise as 
foreign any material or substance which has penetrated the physical 
barriers of the body and which does not belong to the native 
constitution of that individual; the term refers especially to the 
variety of responses {nsually specific but including non-specific 
mechanisms) by which the body subsequently attempts to eliminate the 
invading entity. A specific immune response consists of the production 
of antibody immunoglobulins and/or specifically reactive cells, both 
of which are circulated in the body and interact physically with the 
antigen; this interaction will potentially result in the inactivation, 
death or phagocytosis of the invading material. These two types of 
immune response are respectively that of humoral immunity and that of 
cell-mediated immunity. The experimental work in this thesis deals
explicitly with humoral immunity in chickens and the factors controlling 
this response.
Antibody molecules are the executives of the humoral immune 
defences and in fulfilling this role they constitute a highly 
discriminating molecular recognition system. When an animal is 
subjected to an infection or is inoculated with antigen artificially, 
the ensuing immune reaction has two fundamental properties. First of 
all there is the actual responsiveness of the individual to consider: 
thus in most cases, but not all, antigenic stimulation provokes some 
sort of antibody response and the animal incurs some memory of this 
stimulation. The second feature of antibody biosynthesis is its 
potential diversity such that the antibody response to any one antigen 
involves exclusive production of molecules of that specificity and even 
within a given specificity there is usually considerable heterogeneity 
of antibody affinities.
The formation of antibodies is governed by several control 
mechanisms. This much is apparent from observation of the antibody 
responses induced in laboratory animals : not only are the amount and
duration of antibody production (i.e. the responsiveness) subject to 
finite limits, but the antibody molecules themselves are restricted to 
a single specificity complementary to the antigen involved - indicative 
of the potentially enormous diversity of antibody formation. Obviously, 
elucidation of the control of antibody production both in terms of its 
indue ib il it y and its diversity is important in our understanding of 
immunity against infection and tumour antigens, as well as in the 
management of allergies, auto-immune disease and in tissue transplantation,
It was the object of this thesis to obtain information about the 
mechanisms which control antibody biosynthesis in the domestic fowl; the 
experimental approach was to study the characteristics of the antibody 
response (i.e. the concentration, kinetics, affinity, heterogeneity and 
specificity of antibodies) and to discover the way in which these 
properties were influenced by the nature of antigenic stimulation (the 
type, dose, presentation and schedule of administration of antigen), 
as well as by the presence of passive antibody and by the operation of 
negative feed-back homeostasis.
THE SCOPE OF CONTROL MECHANISMS AFFECTING ANTIBODY BIOSYNTHESIS 
The Induction of Antibody Biosynthesis
In the preceding short description of how humoral immunity is 
controlled, it was stated that there are two fundamental properties of 
the antibody response which are subject to control; the first point to 
be considered was the induction of antibody biosynthesis. This refers 
to whether or not a certain antigen is recognised by the individual as 
being foreign, and then whether it either induces active production of 
antibodies, or stimulates cell-mediated immunity, or both. When an 
antigen is encountered by the immune defences of an individual, there 
are at least four recognised effects which can occur. Firstly, 
lymphocytes may be triggered to differentiate and proliferate to become 
either antibody-forming cells or the specialised cells which participate 
in cell-mediated immunity. The second possibility is the induction of 
complete or partial unresponsiveness to the antigen in the form of 
specific immunological tolerance. A third alternative is that neither 
induction of biosynthesis nor induction of tolerance take place, for 
example if there is insufficient antigen or else the antigen structure 
is non-immunogenic. In addition there is often the establishment of 
immunological memory, whereby the specificity of an antigen encountered 
for the first time is remembered by the immune system and a second 
encounter with the same antigen results in enhanced responsiveness (or 
unresponsiveness). These effects are by no means all mutually 
exclusive and they can probably occur concurrently in a variety of 
combinations.
The inducihility of an antibody response (i.e. the 
particular combination of the above effects which is ultimately 
observed) depends on a number of factors, both intrinsic and extrinsic. 
The intrinsic factors (which have not been investigated but which must 
be mentioned) may include for example, the genetic control exerted by 
the histocompatibility-linked immune response (ir) genes, positive and 
negative feed-back mechanisms mediated by specific antibody, the 
synergism of different cell populations, and the rate of catabolism of 
the antigen. The extrinsic factors which control the induction of 
antibody biosynthesis depend on the nature of the antigenic stimulus ; 
thus the quantity, complexity, chemical structure, route and rate of 
administration of antigen as well as the use of adjuvants all contribute 
to determine the eventual characteristics of an immune response. These 
variable aspects of antigenic stimulation were considered to be 
particularly relevant for studying control processes governing the 
induction of antibody biosynthesis.
The Diversity of Antibody Biosynthesis
The other property of humoral immunity is the diversity of 
antibody production; i.e. each individual is capable of producing an 
enormous number of different specificities of antibody and within the 
confines of a given specificity there is very often considerable 
heterogeneity of the antibody population. In more precise terms the 
diversity of the antibody combining sites is likely to be particularly 
informative because it is probably a strict reflection of the immuno­
globulin receptors selected by antigen during the induction of the 
immune response.
Iminunoglobulin molecules have a genetically determined 
primary sequence of amino acids, which in turn determines the secondary 
and tertiary structures and hence the steric configuration of the 
antibody combining site. Direct evidence for this comes from 
experiments on the reversible dénaturation of antibodies, where 
specificity is lost upon denaturing the molecule but is faithfully 
restored by renaturation (Freedman and Sela, I966).
It seems logical that differences in specificity are a result 
of variations in the primary amino acid sequence and the physical 
participation of the variable regions of both heavy (V ) and light (V ) 
chains in providing contact amino acids within the combining site has 
been confirmed by the results of affinity labelling experiments whereby 
a suitably identifiable hapten was inserted into the combining site and 
then remained in association with the amino acids involved following 
digestion of the immunoglobulin. Such experiments (e.g. Singer and 
Doolittle, 1966) have shown that three main segments in the light chain 
and possibly four segments in the heavy chain contribute contact amino 
acids within the active site and it was found that these segments 
correlated well with the hypervariable regions identified by statistical 
analyses of immunoglobulin primary sequences (Koshland, I966). They 
also appeared in relatively similar positions in the variable parts of 
both heavy and light chains , indicating a symmetrical arrangement of the 
two chains around the active site. The structure of immunoglobulin 
molecules is therefore genetically pre-determined by the genome of the 
individual and is not subject to extrinsic controlling influences.
Although the structure of each imimmoglohulin molecule
resides ultimately in the cellular DNA, the process by which a certain
configuration (or set of configurations) of the antibody combining
site may be multiplied and proliferated is controlled by certain
extrinsic factors. A selective theory, whereby the antigen selects
the complementary specificity from a pre-existing range rather than
giving instructions for a completely innovatory structure to be
synthesised was first proposed by Ehrlich (19OO) and later reiterated
and elaborated (Jerne, 1955; Burnet, 1959; Lederberg, 1959; Siskind.
and Benacerraf, I969) as a working model for antibody biosynthesis.
The clonal selection theory formulated by Burnet (1959) has now
become one of the central principles of immunology and briefly this
hypothesis proposes that at some time in ontogeny, and independently
of antigen, an individual either inherits or acquires the potential
to respond uniquely to any one of an enormous range of antigens.
Therefore the operation of clonal selection would require that the
individual possessed a complete repertoire of genetic information
(a body of germ line V genes probably provides the requisite diversity
of antibody molecules; somatic mutation could augment this variation
further, but there is as yet no firm evidence for this), such that
there was the potential capacity to produce specific antibodies
capable of counteracting each and every antigenic contingency. It
is envisaged that this state of preparation takes the form of clones
of pre-committed antigen-reactive precursor cells, i.e. each
lymphocyte becomes committed to the expression of one V and one V
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gene which combine with the C region genes to provide a template for 
antibody of given specificity, class and type. Given that these
clones are produced, the selection process can only be achieved if 
there is some means of trapping, localising or effectively 
concentrating the antigen at the surface of receptive precursor 
cells. This is followed by antigen-driven selection of the 
appropriate antibody specificity; each precursor lymphocyte (or 
clone) is responsive to one, or at the most a restricted number of 
similar antigenic determinants. This commitment is mediated by 
antigen-specific receptors on the cell surface, and these receptors 
will have antigen-binding characteristics similar to those of the 
eventual antibodies secreted. Then, once the precursor cells of 
the appropriate specificity have been selected, biosynthesis moves 
into the inductive phase. It is now widely accepted that the 
register of genetic information relating to different antibody 
specificities is effectively indexed by antibody representatives on 
the surface of precursor antibody-forming cells. Indeed, it is 
difficult to visualise how the selection process could function 
without some kind of specific receptors. In this way, an antigen 
is both recognised as being foreign and will subsequently provoke 
an immune reaction, by virtue of the fact that there are already 
some complementary structures in existence within the individual.
It is proposed that the antigen associates preferentially with 
those precursor cells bearing receptors whose stereochemical 
configuration most suitably accommodates the determinant antigenic 
structure (i.e. of highest affinity for the antigen). This 
concept of complementarity is clearly not an all or nothing idea 
and the average affinity and the range of affinities for a response 
would be expected to depend, amongst other things, upon antigen
concentration. This point is illustrated in Figure 1; at low 
antigen concentrations only those receptors of most exact 
complementarity (i.e. where the free energy of association between 
receptor and antigen is greatest), will be selected. Higher 
antigen concentrations will involve, in addition, less perfect but 
nonetheless satisfactory combinations.
The control of specificity is therefore apparent at both 
the molecular and cellular levels. Refined genetic control 
determines the stereochemical configuration of individual molecules; 
thereafter, those cells bearing receptors having the highest affinity 
for the antigen are preferentially stimulated to proliferate and to 
differentiate (or become tolerised). Accordingly, the requirement 
of clonal selection for (l) Precursor cells of predetermined 
specificity, was manifested by the demonstration that non-immune 
animals possessed small numbers of lymphoid cells which could 
interact specifically (presumably by means of membrane receptors) with 
antigen, e.g. haemocyanin (Byrt and Ada, I969), BSA (Naor and 
Sulitzeanu, I967) or DNF (Davie and Paul, 1971) and that these 
apparently pre-committed cells could be removed by affinity 
chromatography (Wigzell and Andersson, 1969a) or by "killing" with 
lethally radioactive antigen (Ada and Byrt, I969). (2) Receptors on
the.se precursor cells of which the specificity (Wigzell and Andersson,
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1969a; 1969b; Makela, Cross and Ruoslahti, I969; Ada and Byrt, 1969), 
the avidity (Andersson, 1972; Davie and Paul, 1970; 1972a; Julius 
and Herzenberg, 197^), and the type of heavy chain (Walters and 
Wigzell, 1970) were identical to those of the eventual secreted
Number of lymphocytes bearing 
receptors of a given affinity.
LOW HIGH
Affinity of receptors on individual lymphocytes.
Lymphocytes stimulated at high antigen concentrations
Lymphocytes stimulated at low antigen concentrations.
FIG. 1. Hypothetical distribution of lymphocytes with respect 
to the affinity of their receptors for a given antigen — to illu s­
trate how the affinity of antibody formed may be expected to 
depend on antigen dose.
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antibody molecules, has also been shown experimentally. The 
prediction of cell selection that a single plasma cell subsequently 
produces one type of molecule exclusively has been convincingly 
confirmed by experimental evidence: e.g. single antibody-producing
cells in microdroplets caused immobilisation of organisms belonging 
to one or other Salmonella serotype, but not both (Nossal and 
Lederberg, 1958); also, immunofluorescence has been used to 
demonstrate that plasma cells from rabbits immunised with two 
different antigens could be stained for antibody to one or other of 
the antigens, but not both (White, 1958), or that cells from an 
animal immunised with a hapten on a protein carrier could be stained 
either for hapten or for carrier specificity but not both (Green, 
Vassalli, Nussenzweig and Benacerraf, 1967). In addition, immuno- 
enzymological techniques have similarly shown monospecific cells in 
animals immunised with alkaline phosphatase and peroxidase (Avrameas, 
Taudou and Ternynck, 1971). In the heterozygous rabbit double 
immunofluorescent staining for two allotypes controlled by allelic genes 
has shown the existence of two plasma cell populations - one 
population containing one allotype and the other the alternative one 
(Pernis, Ghiappino, Kelus and Cell, 1965); finally, there is good 
evidence that a plasma cell tumour will only produce one unique type 
of myeloma protein molecule (Awdeh, Williamson and Askonas, 1970).
MANIFESTATIONS OF CONTROL MECHANISMS IN OPERATION
A productive phase of specific antibody biosynthesis may be 
characterised according to the following criteria, and these may be 
regarded as a reflection of the control of both the inducihility and
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the diversity of the response,
1. The absolute quantity of antibody produced or in the circulation 
at a given time after immunisation.
2. The quality of antibody, in terms of its primary binding 
properties (i.e. affinity or avidity).
3. The heterogeneity of antibodies within a population: both 
idiotypic variation manifested in the distribution of binding 
affinities and also the proportional representation by different 
isotypes.
The Quantity of Antibody
The quantity of antibody produced by chickens following 
immunisation is dependent upon the type, dose and presentation of the 
antigen, and also upon the genetic constitution of individual and 
different strains of birds. After immunisation with a single injection 
of soluble protein, specific antibody has rarely been shown in the 
circulation before four days, but thereafter the levels of antibody 
have been found to rise - reaching peak values at approximately the 
seventh day (Benedict, Brown and Hersh, 1963; White, French and 
Stark, 1970). Subsequently there was an exponential decline in the 
antigen-binding capacity of the serum (White, 1973). A similar 
pattern has been observed in haemagglutinin and splenic plaque assays 
of antibody production in response to immunisation with SRBC, although 
the earliest detection and attainment of peak levels of specific 
antibody were fractionally advanced in time (White, 1973). The 
primary response of the chicken to antigens like HSA or SRBC is
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characteristic ally different from that found in mammals, especially 
in the later phases of IgG* antibody production. Mammalian 
production of IgG antibody may be described in two phases ; an 
early phase in which the IgG antibody shows an initial rapid rise 
to reach a maximum level after about 8 days. The second phase 
comprises a very gradual rise in IgG antibody titres for 2 - 3  
weeks, to reach a plateau which may be maintained for several weeks 
or even months (e.g. Uhr, Finkelstein and Bainaann, I962). In 
contrast, the chicken shows a steady decline in serum antibody levels 
after the peak titre has been reached at about seven days after 
immunisation. That this decline phase of the avian response reflects 
a total cessation rather than a gradual diminution of antibody 
biosynthesis was inferred from the fact that the rate of regression 
of the antigen-binding capacity of serum antibody was virtually 
identical to the rate of catabolism of chicken IgG in the body (White, 
1973); i.e. the decline of antibody levels in the serum had the same 
half-life as passively injected radiolabellçd chicken IgG. (There 
have in fact been conflicting values reported for the half-life times 
of chicken antibodies; White (1973) has given a value of 1.93 days, 
whereas Wostman and Olson (1969) have found a value of days for the 
half-life time, rising to 8 days in germ-free chickens).
^Chicken 72 immunoglobulin is sometimes called "IgY" because of its 
lack of identity with gammaglobulins from other vertebrates (Mehta, 
Reichlin and Tomasi, 1972). However, it will be referred to 
forthwith as IgG, in keeping with common practice.
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Although the production of anti-hapten antibodies by the 
chicken has been described (Gold and Benedict, 1962; Orlans,
Saunders and Rose, I968 ; Orlans , I966 ; Gallagher and Voss, I969;
tt ti
Voss and Eisen, 1972; Sarvas, Makela, Toivanen and Toivanen, 197^; 
Yamaga and Benedict, 1975a*} and the antibodies have been character­
ised (Orlans, I968; Gallagher and Voss, I969; Voss and Eisen, 1972; 
Yamaga and Benedict, 1975a; 1975b), several authors have noted how 
surprisingly difficult it is to elicit biosynthesis of large amounts 
of anti-hapten antibodies in chickens either by attention to the 
mode of immunisation (Orlans, launders and Rose, 1969) or to the 
primary dose and the frequency of immunisation (Yamaga and Benedict, 
1975a)' Certainly there has been a lack of systematic examination 
of the kinetics of anti-hapten antibody production in chickens.
The Quality of Antibody
The quality of antibody is governed primarily by the fact 
that during the processes of antigen recognition, antigen (or at 
least a determinant part of it) will associate preferentially with 
those immunocompetent cells which carry surface receptors of 
sufficient affinity to bind the antigen (in this respect therefore, 
affinity is a marker of the V region of the immunoglobulin molecule 
and hence of the genes coding for it). This means that those 
membrane receptors of high affinity for the antigen will compete with 
more success for the antigen than cells bearing low affinity receptors, 
Hence only cells with the higher affinity receptors will be stimulated 
as antigen becomes increasingly scarce by virtue of catabolism or 
removal by antibody. As a means of defence it is in the best
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interests of the individual to have circulating antibodies of the 
highest possible affinity, and indeed the direct relationship 
between antibody affinity and its biological activity has been 
shown; e.g. Siskind and Eisen (1965) found that the amount of 
purified anti-DNP antibody required to give a positive PGA reaction 
in rabbits became less as the association constant of the antibody 
increased; also, Fauci, Frank and Johnson (1970) demonstrated that 
complement fixation by antigen-antibody complexes increased as the 
affinity of IgG antibody for its antigenic determinant became 
greater. On the other hand, Soothill and Steward (1971 ) have 
shown that variations in the antibody affinity of individuals may be 
of pathological significance in that mice prone to nephritis 
(following neonatal infection with lymphocytic choriomeningitis 
virus) produced antibody of lower affinity to certain soluble protein 
antigens compared with nephritis-resistant mice. Antibody affinity 
would appear to be subject to indigenous genetic control, since it 
has been found that affinity varies between different strains of rat 
(Lamelin and Paul, 1971) or mouse (Petty, Steward and Soothill, 1972; 
Steward and Petty, 1976) or for different rabbit allotypes (Werblin, 
Kim, Mage, Benacerraf and Siskind, 1973).
On the basis of a cell selection theory Eisen (I966), and 
Siskind and Benacerraf (I969) have reasoned that the average affinity 
of antibodies will increase with time following immunisation.
Indeed, both the avidity (Jerne, 1951; Talmage and Maurer, 1953;
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Farr, 1958; Sarvas and Makela, 1970) and antibody affinity (Eisen 
and Siskind, 1964; Fujio and Karush, I966; Klinman, Rockey,
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Frauenberger and Karush, I966; Little and Eisen, I966; Zimmering, 
Lieberman and Erlanger, 19^7; Parker, Godt and Johnson, 1967; Goidl, 
Paul, Siskind and Benacerraf, I968 ; Siskind, Dunn and Walker, I968; 
Andersson, 1970; Barel, Ben-Efraim and Liacopoulos, 1970; Lamelin 
and Paul, 1971) have been found to increase with time by a variety 
of experimental approaches; this "maturation" pattern was also 
apparent in respect of the average receptor affinity for radio-labelled 
antigen of a population of lymph node cells from immune guinea pigs 
(Davie and Paul, 1972a). Further experiments by Davie and Paul 
(1972b) have shown that the maturation of antibody affinity reflected 
the maintainance of high affinity antibody-producing cells accompanied 
by a gradual loss of the low affinity producers rather than a 
sequential appearance of progressively higher affinity clones. In 
contrast it has recently been reported by Yamaga and Benedict (1975a) 
that there was no appreciable rise in the average affinity of chicken 
anti-DNP antibodies (either 72 or macroglobulin) following immunisation 
with a single or with repeated injections of antigen. However, in 
experiments with mammals where the maturation of antibody affinity has 
been well documented, it was found that the rate of maturation of 
antibody affinity, at least above a minimal level of antigenic 
stimulation, was inversely related to the original dose of antigen.
Thus the rate of maturation of antibody affinity was slower when larger 
doses of antigen were used (Eisen and Siskind, 1964); in other words 
the continued recruitment of low affinity antibody-producing cells was 
less with lower concentrations of antigen. In the same way it was 
found that the maturation of anti-DNP affinity was inversely related in 
a non-linear fashion to the number of DNP groups on the carrier molecule
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(i.e. the DNP:carrier molar ratio) used for immunisation (Larralde 
and Janof, 1972; Klaus and Cross, 1974; Quijada, Kim, Siskind 
and Ovary, 1974). Further evidence has been provided by the 
demonstration that memory cells were eliminated by passage down an 
affinity chromatography column less efficiently if they were taken 
at an early stage rather than later on during the course of the 
antibody response (Wigzell and Andersson, 1969a).
It has been suggested that as the affinity of an antibody 
for a certain determinant increases, then its affinity for similar 
determinants also rises - until the point is reached where that 
antibody becomes cross-reactive. In support of this idea Little 
and Eisen (1969) found that as the affinity of anti-DNP antibody 
increased, so the affinity of that antibody for the picryl group 
(TNP) rose. The tendency for an antiserum to become more cross- 
reactive (to "degenerate") with time after immunisation led Gershon 
and Kondo (1972) to suggest that the antiserum was in fact becoming 
more avid.
The observed rise in antibody affinity with time could be 
rationalised in two ways: firstly, that the relatively large amounts
of antigen which are present directly after immunisation interact 
preferentially with circulating antibody of high affinity - resulting 
in its selective removal in the early stages of a response. Secondly, 
it may be true that there is a time-dependent shift in cell populations, 
from one synthesising antibody of low average affinity towards a 
population producing antibody of high average affinity. The latter 
alternative has been found to hold, at least in vitro; thus, in an
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antigen-free cell culture system the affinity of antibody produced 
during a brief incubation period was directly related to the prior 
duration of the antibody response in the animals from which the 
cells for culture were obtained (Steiner and Eisen, I96T).
More recently it has been suggested that high and low 
affinity antibodies may alternate during the course of biosynthesis 
(Macario and De Macario, 1973) or that variations in antibody
affinity may parallel the changes in antibody titres (Urbain, Van
Acker, De Vos-Cloetens and Urbain-Vansanten, 1972). It has also 
been found that the mean association constant tended to decrease 
towards the end of an antibody response (Doria, Schiaffini , Garavini 
and Maneini, 1972; Urbain et al., 1972) and that low affinity 
antibody was still present during the decline phase of the response 
(Macario and De Macario, 1974). In addition, there is good
evidence that antibodies of low affinity do in fact persist for a
considerable length of time, concurrent with a rise in the proportion 
of high affinity antibodies (Werblin and Siskind, 1972a; 1972b) and 
that such persistent low affinity antibody could be re-activated by
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a second stimulation with the antigen (Moller, Bullock and Makela, 
1973). One possible explanation for this is that these persistent 
low affinity antibodies were in some way connected with the process 
of memory (Macario and De Macario, 1974). The variable patterns for 
the maturation of antibody affinity described above could be explained 
by a fluctuating predominance of antibody-forming cell clones; thus 
when a dominant clone declined to a low level of antibody biosynthesis, 
another clone could then be stimulated and subsequently take over the
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task of producing antibody (Williamson and Askonas, 19T2; Askonas 
and Williamson, 1972). Moreover, if serum antibodies were sampled 
at any time during these periods of clonal flux they would be 
considerably heterogeneous (and therefore probably of variable 
average affinity), being a mixture of products from cell clones in 
either their ascendancy or their decline. It would seem then that 
the consecutive changes in antibody affinity which have been observed 
are not as simple as was first believed, and that the pattern perhaps 
reflects more complex processes than the straightforward selection of 
cells by antigen. Although the effect of clonal selection upon 
antibody affinity is very relevant, it probably constitutes a 
contributory rather than an exclusive influence in determining the 
dynamics of clonal replacement and the effect this has on the affinity 
of antibodies.
The investigations into antibody affinity described above 
usually dealt with entire antibody populations and therefore 
predominantly with IgG antibodies. Early work on the binding 
properties of IgM antibodies showed no significant maturation of IgM
II II
affinity with increasing time after immunisation (Sarvas and Makela, 
1970; Baker, Prescott, Stashak and Amsbaugh, 1971; Huchet and 
Feldmann, 1973) and that they were always of low affinity anyway
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relative to IgG antibodies (Makela, Ruoslahti and Seppala, 1970). 
However, recent advances in techniques for detecting antibody secretion 
at the cellular level and for studying antibody binding at the cell 
population level, have furnished contrary evidence. For example, by 
studying the relative binding characteristics of IgM plaque-forming
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cells secreting anti-hapten antibodies using the plaque inhibition 
technique, it was found that the concentration of free hapten 
required to give 50% reduction in IgM PFC numbers decreased with 
time after immunisation - indicating that an increase in average 
binding affinity of PFC antibodies had occurred (Wu and Cinader,
1972; Claflin, Merchant and Inman, 1973). Antibodies of the IgM 
class specific for the Forssman antigen on sheep erythrocytes became 
increasingly avid (assessed by the ease with which antibody could 
be dissociated from sheep erythrocytes) with time after immunisation 
(Linscott, 1969). In the chicken however, Yamaga and Benedict 
(1975a) have reported that anti-DNP macroglobulin antibody, elicited 
by intravenous administration of antigen, was of a low affinity 
which did not increase either with the passage of time or with 
repeated immunisation.
Whether or not the affinity of IgM antibodies shows 
maturation characteristics comparable to those of IgG antibodies, it 
is generally true to say that IgG antibodies predominate within the 
high affinity antibody population, and that in most cases the affinity 
of IgM antibody is low relative to that of IgG. Such a situation may 
be explicable in terms of a controlled switching from IgM to IgG 
production. On the assumption that IgM receptors are pentameric, 
cells carrying these receptors would bind antigen at multiple sites 
on the cell surface (e.g. possibly 10 combining sites per receptor), 
thereby allowing IgM cells of relatively low affinity to be triggered, 
whereas from the IgG cells only those of higher affinity could be 
stimulated. This would be directly due to the valency of IgM,
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meaning that the "functional affinity" of the whole IgM molecule 
represented a total amplification of the mean intrinsic association
g
constant for each combining site by a factor as high as 10 (Hornick
ft I
and Karush, 1972). It has been argued by Makela, Kostiainen,
Koponen and Ruoslahti (1967) on this basis that intact antigens may 
stimulate a considerable number of IgM-producing cells and some 
IgG-producing cells; then, as the antigen is degraded and catabolised, 
there is no longer such advantage in having multivalent receptors 
and the antigen fragments will associate more and more with IgG 
receptors of higher affinity. This argument is favoured by the 
empirical finding that large antigens of uniformly repeating structure 
characteristically induced biosynthesis predominantly of IgM
II If
antibodies (Moller, 1965; Britton and Moller, 1968); the hypothesis 
is further supported by the demonstration that a densely haptenated 
carrier elicited proportionately more IgM production than its lightly
II II
haptenated counterpart (Kontiainen, 1971; Sarvas and Makela, 1974). 
This sort of hypothesis for an antigen-driven switch, which proposes 
a shift in cell populations from those producing IgM antibodies to 
cells producing IgG antibody of increasing affinity, is challenged by 
arguments that such a switch is genetically controlled, and it has 
been postulated that this may begin within the non-specific environment 
in which stem cells are induced to become B lymphocytes, before any 
clonal selection is accomplished by antigens (Cooper, Lawton and 
Kincade, 1972).
It is clear then that a process of clonal selection based 
purely on receptor affinity is an over-simplification, since it takes
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no account of the differences between cells producing IgM and those 
producing IgG antibodies, nor does it consider the switching of cells 
from IgM to IgG production, or the importance of the anatomy of 
lymphoid systems for concentrating foreign materials around the cells 
which can respond to them. Other mechanisms which may also influence 
the quantity and affinity of antibody are possible interactions among 
different cell populations, the best studied example being the co­
operation between B and T lymphocytes. The presence of two distinct 
populations of lymphocytes (B cells derived from the bursa of Fabricius 
in chickens and probably from the bone marrow in mammals, T cells 
derived from the thymus in both cases)and their collaboration in 
bringing about antibody biosynthesis was first shown by Claman,
Chaperon and Triplett (1966) who noted the lack of antibody production 
when pure populations of either thymocytes or bone marrow lymphocytes 
were transferred into different irradiated host animals and challenged, 
and contrasted this with the successful biosynthesis of antibody when 
a mixed population of lymphocytes was similarly tested. The cells 
responsible for secretion of antibodies were shown in chickens to be 
bursa-derived (Cooper, Peterson, South and Good, 1966) and in mammals 
to be B lymphocytes (Mitchell and Miller, I968). The role of T ' 
lymphocytes as "helper cells" in an anti-hapten antibody response was 
demonstrated by Mitchison (1969) and Rajewsky (1971) who both found 
that primed B cells made a secondary antibody response to a hapten 
bound to carrier only when T cells primed to the carrier were present. 
In other words the T cells recognise and respond to carrier 
determinants and in so doing they somehow promote the development 
of certain B lymphocytes into cells producing antibody to the hapten.
A variety of mechanisms have been proposed to explain co-operation,
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and these include; (l) The antigen is presented in a multivalent 
form following congregation of antigen molecules as an ordered 
array on the carrier-specific T cell (for instance promoting low 
affinity B cell receptors to form multiple cross-links of high total 
affinity). (2) A chemical factor (i.e. a T lymphokine) is secreted 
which acts as a second signal on B cells independently of antigen; 
e.g. co-operation has been demonstrated between T and B cells when 
the two populations were separated on either side of a porous 
membrane (Feldmann and Basten, 1972). (3) There exists some form of
amplification mechanism whereby T cells specific for the antigen 
secrete cytophilic receptors which can then endow other cells, 
including possibly macrophages, with the same specificity and the 
same ability to co-operate with B cells; e.g. Feldmann (l972a) has 
shown that macrophages are required before an in vitro response to a 
thymus-dependent antigen could be evoked. Although the precise 
mechanism of co-operation is not yet clear, the importance of the 
phenomenon in the induction of antibody biosynthesis has been 
demonstrated convincingly; e.g. (l) Cells synthesising anti-hapten 
antibody of high affinity were shown to derive from the co-operative 
effects between B cells and helper anti-carrier T cells (Schirrmacher, 
1971). (2) Thymectomy of mice caused a decrease in the amount of
anti-hapten antibodies which the animals could subsequently produce 
(Taylor, 1971). (3) In the absence of T cells, anti-hapten antibody
affinity was reduced (Gershon and Paul, 1971). (4) Thymus-independent
antigens have been found to favour the production of macroglobulin 
antibodies (Ada, Nossal,' Pye and Abbot, 1963).
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The Heterogeneity of Antibody
The heterogeneity of antibodies provides another source of 
information about control mechanisms affecting antibody production; 
in this respect, heterogeneity includes the differences between 
isotypes as well as the heterogeneity of idiotypes within a given 
antibody class.
Considering first of all the relative proportions of 
different antibody classes in an immune response, the chicken has 
been found to produce demonstrable amounts of IgM antibodies during 
the early phase of a primary response to both soluble and particulate 
antigens (Benedict, Brown and Hersh, 1963). This early production 
of IgM antibodies rapidly gave way to biosynthesis of IgG, which 
predominated at later stages. Recent work by Yamaga and Benedict 
(19T5&) implied that intravenous immunisation of chickens with 
repeated doses of DNP-BGG led to biosynthesis of both 78 and macro­
globulin anti-hapten antibodies but that both classes were produced 
only in small amounts.
It has been proposed that cells which start out as producers 
of IgM are subsequently switched to producing IgG antibodies; Nossal, 
Szenberg, Ada and Austin (1964) reached this conclusion from the 
observation that the number of cells producing mereaptoethanol-sensitive 
antibodies declined during the course of an immune response. In the 
chicken, treatment with anti-IgM of embryos which were subsequently 
bursectomised at hatching caused total suppression of IgM production 
as well as partial suppression of IgG production, suggesting that
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inhibition of IgM biosynthesis hindered the development of IgG- 
producing cells (Kincade, Lawton, Bookman and Cooper, 1970). In 
addition, it was found by Pernis, Forni and Amante (1971) that a 
small proportion of rabbit peripheral blood lymphocytes which were 
actively synthesising IgG nonetheless carried an IgM marker on their 
surface membranes, implying that a transition from IgM to IgG 
production had occurred. Kincade and Cooper (1971) provided further 
evidence that this transition took place in individual cells rather 
than reflecting a gross shift in antibody-producing cell populations j 
thus, by using different fluorescent antibodies to chicken y or y 
chains to detect the appearance of antibody classes in single cell 
suspensions, a high proportion of single bursal cells containing heavy 
chains of both IgM and IgG were demonstrated. The presence of 
immunoglobulin receptors in the surface membranes of a proportion of 
unstimulated B lymphocytes, either from the central lymphoid organs 
or from the peripheral circulation, has been confirmed using specific 
fluorescent antibodies (Rabellino, Colon, Grey and Unanue, 1971). 
Furthermore, there is good evidence, obtained by acrylamide gel 
electrophoresis of radiolabelled heavy and light chains of immuno­
globulins isolated from solubilised plasma membranes of splenic 
lymphocytes (Vitetta, Baur and Uhr, 1971i Marchalonis and Cone, 1973), 
that the receptor on lymphocyte membranes has the characteristics of 
a monomeric IgM molecule (often referred to as IgMs), even for those 
cells destined to produce IgG antibodies; it has been shown equally 
for those cells whose secretory product is pentameric IgM (Vitetta 
and Uhr, 1973). It must be pointed out that the finding of a
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ubiquitous monomeric IgM receptor for all antigen-sensitive cells 
is at variance with the supposition put forward on page 20 , where 
the occurrence of pentameric IgM receptors was postulated. It 
seems therefore quite possible that a lymphocyte or immunoblast with 
surface IgM receptors switches to the biosynthesis of IgG and at the 
same time is transformed into a cell with the morphological and 
ultrastructural features of a plasma cell. This would preclude any 
requirement for surface IgG receptors, although it has been found 
that receptors of the IgG class were present on the surface of 
antigen-stimulated mouse spleen cells in vitro (Pierce, Solliday and 
Asofsky, 1972). Further evidence for the switch from IgM to IgG is 
seen in the low proportions of IgM in the antibody response upon 
secondary stimulation. In mammals there is usually a lesser 
proportion of IgM in the total antibody content of a secondary response 
compared with the proportion of IgM antibody in a primary response 
(e.g. Bauer, Mathies and Stavitsky, I963); this could reflect a more 
rapid switch from IgM to IgG biosynthesis, or else the switch that 
has taken place during the primary response has been incorporated in 
the immunological memory. In chickens it has been reported that 
hyperimmune birds had no macroglobulin antibody in their serum (Dreesman 
and Benedict, I965), although there is also evidence suggesting that 
the proportion of IgM antibody in a secondary response to particulate 
antigens (e.g. virus or bacteriophage) was increased relative to the 
primary response (Szenberg, Lind and Clarke, I965).
The control of antibody biosynthesis is also reflected in 
idiotypic heterogeneity; i.e. the structural differences between
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individual immunoglobulin molecules of the same specificity and 
class, found in any one animal. Even within the same specificity 
the number of different idiotypes is enormous ; for example, Kreth 
and Williamson (1973) have estimated that the number of different 
molecules with antibody properties to a given hapten in immune 
inbred mice, was probably about 8000. A selective theory implies 
that for any given antigen, even if all its determinants are 
identical in structure, there will usually be a variety of receptors 
with different affinities for the determinants. This variety of 
individual antibody affinities will be reflected in the heterogeneity 
of the antiserum as a whole, and there is a considerable amount of 
evidence for such heterogeneity within antibody populations: e.g.
(l) From the analysis of primary binding data (Pauling, Pressman and 
Grossberg, 19^ +^ i Karush, 1956; Nisonoff and Pressman, 1958). (2)
From the iso-electric separability of various antibodies of the same 
specificity and class (Williamson and Askonas, 1972). (3) From the
chemical fractionation of an antibody population (Schlossman and 
Kabat, 1962; Gelzer and Rabat, 1964 ; Eisen and Siskind, 1964).
(4) From physical differences between individual combining sites 
(Warner and Schumaker, 1970; Carson and Metzger, 1974).
Information obtained from studying binding affinities was 
at first found to be consistent with the assumption of a continuous 
symmetrical distribution of antibody affinities (in terms of the free 
energy change), and this distribution could be adequately described in 
terms of either a Gaussian (Pauling, Pressman and Grossberg, 1944) or 
a Sipsian (Wisonoff and Pressman, 1958) distribution function. This
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sort of assumption was convenient and useful as a first approximation 
of the geometric mean association constant, hut more sophisticated 
analysis of antihody-hapten interactions has led to the belief that 
the distribution of affinities is by no means continuous and/or 
symmetrical in every case (.Roholt, Grossberg and Pressman, I968 ;
Roholt and Pressman, I968; Pressman, Roholt and Grossberg, 1970;
Werblin and Siskind, 1972a; Werblin, Kim, Quagliata and Siskind, 1973;
Kim and Siskind, 1974; Kim, Werblin and Siskind, 1974; Mukkur ,
Szewczuk and Schmidt, 1974). The development of a computational 
model involving an iterative approximation technique to account for 
any departures from the normal distribution (Werblin and Siskind, 1972a), 
has indicated that the distribution may in fact be skewed or even 
bimodal. Using this method to study the maturation of antibody 
affinity with time, the distribution of affinities was found to be 
symmetrical initially but subsequently became negatively skewed, i.e. 
with most of the antibody occurring towards the high affinity end of 
the distribution range (Werblin and Siskind* 1972a; Werblin, Kim, 
Quagliata and Siskind, 1973). As mentioned previously, there also 
appeared to be significant amounts of low affinity antibody which 
persisted throughout the course of biosynthesis (Werblin and Siskind, 
1972b; Werblin et al., 1973). The sort of advances in assessing 
heterogeneity which have just been referred to have helped considerably 
to elucidate some of the principles underlying idiotypic heterogeneity. 
Moreover, the concept of discontinuous distributions of affinity 
could possibly explain the conflicting accounts of heterogeneity which 
have appeared in the past; e.g. an overall rise in heterogeneity with 
time has been reported (Eisen and Siskind, 1964; Miller and Segre, 1972),
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or decreased heterogeneity, or indeed more complex patterns 
(Kitagawa, Grossberg, Yagi and Pressman, 19^7; Roholt, Seon and 
Pressman, 1970; Jaton, Waterfield, Margolies, Bloch and Haber,
1971 ; Kimball, 1972; Macario, De Macario, Franceschi and Celada,
1972; Macario, De Macario and Celada, 1973; Claflin, Merchant and 
Inman, 1973). The concept of antibody heterogeneity being 
symmetrical and continuous is contrasted in diagrammatic form in 
Figure 2 with the more recent idea that heterogeneity of antibody 
affinities may be represented more accurately by a non-symmetrical 
discontinuous distribution.
It was originally thought that the heterogeneity of 
antibodies within a population was a direct reflection of the 
heterogeneous nature of the antigen; according to this theory, the 
heterogeneity of anti-hapten antibodies produced in response to 
immunisation with a hapten-carrier conjugate was due to the different 
environments in which otherwise uniform haptenic groups were situated 
on the carrier (Singer, 1964; Parker, Godt and Johnson, I966). Control 
of antibody specificity solely by a process of selection would, on 
this basis, predict that a more homogeneous population of antibodies 
is produced in response to more homogeneous antigens. In concurrence 
with this hypothesis it has been found for example that a relatively 
well-defined DNP-polypeptide antigen of regularly repeating structure 
stimulated an antibody response of restricted heterogeneity (Richards 
and Haber, 1967; Haber, Richards, Spragg, Austen, Volloton and Page,
1967 ; Pappenheimer, Reed and Brown, I968 ; Richards , Pincus, Bloch, 
Barnes and Haber, I969). A similar result was found following
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FIG. 2. Two different models of the heterogeneity 
of antibody affinities.
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experimental immunisation either with a hapten coupled in a definite 
known position on a small carrier (Trump and Singer, 1970; Montgomery, 
Hockey and Williamson, 1972; Keck, Grossberg and Pressman, 1973) or 
with hapten conjugated to an autologous protein carrier (Escribano, 
197^). It has also been reported that if a carrier-attached hapten 
was variously expanded by adding on other chemical groups (e.g. DKP 
with either glycylglycylglycine or with p-amino-benzolyl glutamate), 
and these antigens were used to immunise rabbits, then the temporal 
variations in the binding affinities of antibodies for the original 
hapten decreased as the site-filling capacity of the antigenic 
determinant increased (Woehler, Cannon, Clark and Lovins, 197^ )** 
these authors suggested that this effect was due to the restriction of 
the number of ways in which the determinant could orientate itself, 
as its size increased,within the combining site of a receptor. 
Immunisation of responder guinea-pigs with a series of a-DWP- and 
e-DNP-oligolysines caused production of antibodies which "recognised" 
(as assessed by the maximum binding affinity) the exact chain length 
(± 1 lysine residue) of the oligolysine carrier molecule (Levin, Levine 
and Schlossman, 1971)* Evidence of this sort therefore lends support 
to the idea that the carrier provides suitably immunogenic environments 
for haptenic determinants, and that idiotypic heterogeneity reflects 
the structural variations between the different sites of hapten 
substitution on the carrier. On the other hand however, there is a 
considerable amount of experimental evidence which argues against such 
a local environment hypothesis as the basic cause of idiotypic 
heterogeneity. For instance, the carrier molecule has been shown to 
contribute per se only very slightly towards the total energy of
31
interaction between a hapten-carrier conjugate and specific 
anti-hapten antibody (.Eisen, 1964a; Schlossman, Ben-Efraim, Yaron 
and Sober, I966). Similarly, antibody produced either in guinea- 
pigs against e-29~ENP-insulin (Little and Counts, I969), or in 
rabbits against e-4l-mono-DNP-ribonuclease (Eisen, Simms, Little 
and Steiner, 1964), had no apparent restriction in its range of 
anti-DNP affinities. Also, the "carrier effect" was still evident 
and maintained its specificity even when a long spacer molecule was 
inserted between the carrier and the hapten (Mitchison, 196%;
Un gar -Waron, Gurari, Hurwitz and Sela, 1973). Even more confusing 
to the overall picture have been claims of limited heterogeneity or 
even complete homogeneity of anti-hapten antibodies elicited in 
response to immunisation with antigens of considerable heterogeneity, 
such as azo-p-benzoate-BGG (Nisonoff, Zappacosta and Jureziz, 1967; 
Roholt, Seon and Pressman, 1970)* The alternative to the local 
environment hypothesis is that each individual possesses a large set 
of variable region genes and this results in intrinsic heterogeneity 
of the receptor combining sites suitable for any one determinant; 
Montgomery and Williamson (1972) have pointed out that there are 
probably discrepancies in the expression of these V-region genes 
between individuals of the same species and strain. The 
distribution which is eventually observed may well constitute the 
dual influences of both mechanisms; i.e. the effect of the local 
environment of hapten groups on the heterogeneity of antibodies and 
the result of inherent genetic variability of receptor combining sites. 
Finally, it is worth remarking how these different hypotheses regarding 
the control of antibody heterogeneity have influenced thinking in
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devising experimental methods for producing antibodies of restricted 
heterogeneity: e.g. (l) Immunisation with a homogeneous antigen.
(2) The cloning of antibody-producing cells. (3) By selection of 
individuals producing myeloma protein with the properties of specific 
antibody. (4) The chemical and physical fractionation of hetero­
geneous antibody populations.
The Induction of Tolerance
So far the scope of control mechanisms controlling antibody 
biosynthesis has- included only the active production of specific 
antibodies, describing how the quantity, quality and heterogeneity of 
antibody is subject to control and how these parameters are affected. 
However it is equally a characteristic of the immune response that 
under certain circumstances a state of specific unresponsiveness is 
encountered, when an individual becomes tolerant to a certain antigen; 
this form of control may, for example, represent the way in which the 
distinction between self and non-self components is made.
Tolerance is a specific state of unresponsiveness resulting 
in partial or complete inability to respond to a certain immunogenic 
stimulus by virtue of prior (tolerising) contact with the antigen; 
it has been found applicable to particulate, soluble and haptenic 
antigens (Dixon and Maurer, 1955; Cinader and Dubert, 1956; Dresser, 
1961 ; Boyden and Sorkin, I962; Sercarz and Coons, I963). The first 
possibility in trying to explain tolerance is that immunocompetent 
cells are eliminated; it has been suggested that this results either 
from irreversible inactivation (Dresser and Mitchison, I968 ; Ivânyi
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and Salerno, 1972) or from terminal differentiation (Sterzl, I966).
It is attractive however to contrast this with a model whereby the 
tolerogen remains on the surface of the antigen-binding cell instead 
of that clone of cells being deleted; i.e. the tolerant cell does 
exist, but its receptors have been blockaded in a reversible fashion. 
Autoradiographic studies in mice which had been made either immune or 
tolerant to DEP were done by reacting radio-labelled anti-DNP antibody 
with splenic lymphocytes, and these investigations showed that cell 
receptors, maintained their specificity for DNP both in normal and 
tolerant animals; moreover, in tolerant animals it was concluded that 
tolerogen remains on the cell surface - whereas in immune animals the 
antigen does not (Aldo-Benson and Borel, 1974). By treating lymphoid 
cells with trypsin, either before or after being tolerised in vitro, 
Diener and Feldmann (1972) were able to prevent or abrogate respectively 
the state of specific unresponsiveness. It was also found that 
transfer of tolerised cells into irradiated recipients quickly restored
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the immunocompetence of the transferred cells (Sjoberg, 1972) - again
suggesting that the tolerisation was reversible. This sort of
reversible mechanism of receptor blockade would satisfy the requirements
for a selective process in either the induction of tolerance or immunity,
and could account for the events of acquired and self tolerance. In
what manner the state of tolerance is influenced by cell co-operation is
not fully understood, although claims for its origin in the population
of helper cells (Rajewsky, 1971), or in the hapten-specific cell
precursors (Feldmann, 1972b), or in both (Chiller, 1970) have been made.
Another suggestion has been that high dose paralysis incapacitated both
B and T cell function, whilst low dose paralysis affected the helper T
0 "
cells only (Andersson, Celada and Asjo, 1974).
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One route of investigation into the mechanisms of 
tolerance has been the study of antibody affinity in partially 
tolerant animals, or in those which have recovered from or have 
"broken" tolerance. If cells have to compete for antigen during the 
induction of tolerance, then the high affinity receptor-bearing cells 
would be the first target for the tolerogen; thus any cells still 
able to produce antibody would have receptors of low affinity and 
would therefore produce antibody of low affinity. Depression of 
antibody affinity under such conditions has been reported (Theis and 
Siskind, 1968; Harel, Ben-Efraim and Liacopoulos, 1970; Urbain 
et al., 1972; Davie, Paul, Katz and Benacerraf, 1972). Conversely, 
it has also been claimed that induction of tolerance had no effect 
on the affinity of small amounts of antibody which were produced 
(Mitchison, 1964).
A once tolerant animal has often been found to regain its 
immunological capabilities with the passage of time; in such cases 
the affinity or avidity of antibody produced has apparently increased 
as the animal "escaped" from the tolerant state, until these parameters 
attained similar values to those found in conventionally immune 
animals (Theis, Thorbecke and Siskind, 1968; Dowden and Sercarz, 1968), 
Such a loss of tolerance could be explained in two ways relative to 
the different hypotheses for tolerance outlined above: (l) It
represents a recruitment of virgin cells (Dresser and Mitchison, I968). 
(2) It reflects the spontaneous recovery of paralysed (blockaded) cells 
(Dowden and Sercarz, I968).
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Tolerance may be broken by immunising the tolerant animal 
with an antigen which is a cross-reacting or a modified form of the 
tolerogen (Weigle, I96I; Paul, Siskind and Benacerraf, I96Tj 
Ivânyi, 1972). However, antibody produced under these conditions 
most probably reflects the synthesis of a cross-reacting antibody of 
low affinity for the tolerogen. This has been confirmed to some 
extent by the finding that if the initial tolerising dose was 
sufficiently large to suppress even low affinity (and therefore 
potentially cross-reactive) antibody-producing cells, then it proved 
impossible to break tolerance (Paul, Thorbecke, Siskind and 
Benacerraf, I969)•
The exact mechanism of tolerance is still in doubt, although 
it obviously represents an aspect of control which affects the 
induction of antibody biosynthesis and which is highly antigen-specific.
FACTORS AFFECTING ANTIBODY BIOSYNTHESIS
So far, only the direct manifestations of the antibody 
response have been considered; i.e. the parameters such as antibody 
concentration, affinity, and heterogeneity which can be used to 
characterise the response. A study of these parameters alone cannot 
yield much information about control mechanisms unless we find out how 
they are influenced by various aspects of the immunisation procedure.
For example, the properties of the antigen, its dose and administration, 
the use of adjuvants and the use of passive antibody are all factors 
which may influence the characteristics of the antibody response.
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The Importance of Antigen Dose
The amount of antigen administered to an individual will 
have a definite affect upon the subsequent antibody response. Thus, 
the chicken has been found capable of producing measurable amounts of 
antibody following immunisation with as little as 40 ug of HSA 
(Steinberg, Munro, Fleming, French, Stark and White, 19T0). The 
maximum levels of antibody reached following immunisation with larger 
amounts of antigen, e.g. up to 50 mg of HSA, were progressively but 
not proportionately greater. It has already been mentioned on page li 
that a characteristic of the antibody response in chickens immunised 
by a single intravenous injection of antigen was the steady exponential 
decline in serum antibody levels which occurred from about 7 days 
after■immunisation. The half-life of the antigen-binding capacity 
during this exponential decay was found to be independent of the peak 
level of antibody in the serum, and by inference therefore, to bear no 
relation to the dose of antigen. With repeated injections of large 
doses , of antigen it has proved possible to render chickens tolerant to 
that antigen (French, Stark and White, 1970).
The effect of antigen dose upon the affinity of antibody 
produced, and upon the maturation of affinity, has already been 
referred to on page 15. Previous findings were generally compatible 
with a theory of cell selection, in that a negative correlation existed 
between the total number of specific receptors occupied and the 
average binding affinity of antibodies produced. In other words, 
high doses of antigen selected for stimulation of a greater total 
number of cells, including many of low affinity, whilst smaller doses
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Caused stimulation of fever cells because those of low affinity were 
effectively ignored. In chickens, Yamaga and Benedict (l9T5a) found 
that repeated immunisation, irrespective of the priming dose, the 
frequency of injections or the total number of injections, caused 
biosynthesis of uniformly low amounts of low affinity antibody.
The Mode of Administration of the Antigen
The presentation of antigen is another factor which may 
govern the eventual features of an antibody response. Variations in 
the route of injection (e.g. intravenous, intramuscular, intraperitoneal, 
sub-cutaneous, etc.) do not generally affect the quantity, quality or 
duration of a response significantly - and the injection site of 
preference will depend primarily upon the type and amount of antigen, 
whether adjuvant is included, and the animal being immunised.
However, it has been claimed that the route of injection of antigen is 
an important consideration when attempting to immunise chickens with 
haptens; for example, Orlans, Saunders and Rose (1968) reported that 
birds given one injection of DNP-BGG intravenously or subcutaneously 
with FCA, or multiple injections intramuscularly, responded neither to 
the hapten nor to the carrier moieties of the antigen. DNP-BGG 
injected directly into the spleen elicited production of anti-BGG 
only, whilst two subcutaneous injections of antigen in FCA produced 
high levels of anti-DNP.
The Use of Adjuvants
The inclusion of antigen in the aqueous phase of a water-in- 
oil emulsion (with or without mycobacteria) has been shown to stimulate
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characteristic patterns of antibody production in chickens (French,
Stark and White, 1970). As with a straightforward intramuscular or 
intravenous injection of antigen in saline, there was an initial 
burst of antibody biosynthesis starting with the appearance of 
detectable antibody in the serum about 4 days after immunisation, 
reaching a peak level between J and 12 days, and thereafter falling 
off at an exponential rate. However, when complete or incomplete 
adjuvant was used, there was an additional second phase of antibody 
production; this began approximately 21 days after immunisation and 
reached maximum levels about 3 weeks later (French, Stark and White,
1970). This biphasic pattern of antibody production was found when 
antigen was given either in Freund's complete or incomplete adjuvants; 
in both cases the first phase of antibody production was of similar 
magnitude to that observed for immunisation with antigen in saline.
For incomplete adjuvant the second phase gave comparable antibody 
levels to those in the initial phase, whereas the use of complete adjuvant 
provoked a second phase response in which serum antibody levels were 
usually significantly greater compared to those in the first phase. In 
addition, it was claimed that the avidity of anti-HSA produced during 
the second phase of antibody production following immunisation with 
HSA in either Freund's complete or incomplete adjuvant was greater than 
the avidity of antibody produced in the first phase (French, Stark and 
White, 1970). There has been recent evidence that a single intra­
muscular injection of DNP-BGG in Freund's complete adjuvant caused 
production of a restricted population of high affinity 7S antibodies 
(Yamaga and Benedict, 1975b). Generally however, there has been very 
little comparative work done to explore the effects of adjuvants on
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antibody affinity (in fact most experimentation on antibody affinity 
has been done by routine immunisation of animals with antigen in 
adjuvant by force of habit), although in mammals too it has been 
reported that the use of adjuvants was responsible for increased 
affinity of antibody (Soothill and Steward, 19T1; Kim, Greenbaum,
Davis, Fink, Werblin and Siskind, 1975); this has been attributed 
by Mond, Kim and Siskind (1974) to the fact that non-specific 
augmentation of the immune response (e.g. by injecting FCA or endotoxin 
with the antigen) favoured more efficient selection of high affinity 
antibody producing cells.
The Importance of the Carrier in Anti-Hapten Antibody Responses
In the study of anti-hapten antibody responses it has been 
found empirically that it was essential for the hapten to be coupled 
to an immunogenic macromolecular carrier before successful immunisation 
against the hapten could be achieved (Landsteiner and Simms, 1923; 
Schlossman, Yaron, Ben-Efraim and Sober, I965). Most commonly used 
carriers have been serum proteins (globulins and albumins), very large 
molecules such as haemocyanin, and particulat.e carriers such as 
erythrocytes; more exotic carriers have been tried, and these have 
included polyurethane sponge (Borek and Battisto, 1971) and Brucella 
organisms (hitman, Chartrand, Finstad and Good, 1973). In guinea pigs, 
carrier molecules have been graded in terms of their ability to promote 
production of anti-hapten antibodies of high affinity; i.e.
BGG > OVA > BSA > Gelatin > Guinea pig albumin, in terms of carrier 
effectiveness (Siskind, Paul and Benacerraf, I966). The actual
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density of substituents on the carrier has been shown to affect the 
amount and quality of antibody (Larralde and Janof, 1972) - possibly 
as a result of increased receptor affinity for multivalent ligands 
due to co-operative binding effects. It has already been mentioned 
on page 30 that the function of a carrier molecule could not be 
explained solely on the basis of the carrier providing a suitable 
environment for each haptenic determinant and thereby conferring 
immunogenicity. The specific role of the carrier in the induction 
process became evident in the secondary response; an animal immunised 
for the first time with a hapten-carrier conjugate generally 
produced an appreciable secondary response to that same hapten only 
if, for secondary stimulation, the hapten was coupled to the same 
(homologous) carrier as used in the first instance (Ovary and 
Benacerraf, 1963; Rajewsky, Schirrmacher, Nase and Jerne, 1968).
This phenomenon has been called the "carrier effect," and was still 
observed for example when the hapten and carrier were separated 
spatially by interposing a long molecular chain spacer between them 
(Mitchison, 1967; Ungar-Waron et al., 1973). There has latterly 
been a considerable amount of work done which supports the concept of 
a specific co-operative function of carrier determinants in the 
induction of the response to the hapten, e.g. (l) The induction of 
tolerance towards the carrier molecule gave rise to an associated 
depression of the corresponding anti-hapten antibody response upon 
subsequent challenge with hapten-carrier conjugate (Rajewsky,
II If
Rottlander, Peltre and Muller, 1967; Green, Paul and Benacerraf, I968) 
(2) Pre-sensitisation with free carrier has been found to enhance the
4l
subsequent anti-hapten response following immunisation with 
hapten-carrier conjugate (Rajewsky, Schirrmacker, Nase and Jerne,
1968; Katz, Paul, Goidl and Benacerraf, 1970; Paul, Katz, Goidl
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and Benacerraf, 1970; Hurme, Kontiainen, Seppala and Makela, 1973;
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Sarvas, Makela, Toivanen and Toivanen, 1974). This pre-sensitisation 
presumably served somehow to expand the carrier-specific helper T 
cell population (Katz, Paul and Benacerraf, 1973). In confirmation 
of these findings it has been possible to demonstrate that hapten- 
carrier co-operation was brought about by the interaction of hapten-
II
primed B cells with carrier-specific T cells (Niederhuber, Moller and
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Makela, 1972). (3) The susceptibility of specific T helper cells to
lethally radioactive carrier has been demonstrated (Roelants and 
Askonas, 1971). (4) Immunisation with hapten coupled to a T-
independent carrier (e.g. pneumococcal polysaccharide type III or 
bacterial levan) elicited a thymus-independent I ^  anti-hapten response 
(Klaus and Humphrey, 1974),
The Effect of Administration of Passive Antibody and its Possible 
Connection with Antibody-Mediated Negative Feedback Homeostasis
Specific antibody administered before, at the same time as 
or following active immunisation with the corresponding antigen, has 
the potential to suppress the production of antibodies by the animal 
to that antigen. This effect has been demonstrated for a wide range 
of antigens; e.g. proteins (Uhr and Baumann, 196I ; Dixon, Jacot- 
Guillarmod and McConahey, I967), flagella (Horibata and Uhr, 1967),' 
bacteriophage (Finkelstein and Uhr, 1964), erythrocytes (Rowley and
It
Fitch,1964 ; Moller and Wigzell, 1965; Wigzell, I966; Axelrad and
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Rowley, 1968), tumeur antigens (Moller, 19^3) and haptens (Brody,
Walker and Siskind, I967). It is reasonable to suppose that the 
antibody produced during a response may be as effective as passively 
administered antibody in controlling or limiting the response. It 
is clear that some mechanism for controlling the antibody response
I
must exist, and Uhr and Moller C1968) have suggested that the 
mechanism for this may well be antibody-mediated negative feedback.
In the elucidation of the mechanisms of antibody-mediated immuno­
suppression (and by implication, the mechanisms of negative feedback), 
the importance of the specificity, dosage, timing, antibody class, 
affinity and the presence of the Fc portion of passive antibody has 
been comprehensively studied by a great many workers.
The first important question concerns specificity - does 
antibody specific for a given determinant suppress the response to that
determinant alone or does it suppress the response to other
determinants on the antigen molecule? In support of the first 
suggestion, that immunosuppression occurs at the level of individual 
determinants, it has been shown that to satisfactorily suppress antibody 
production to key-hole limpet haemocyanin then sufficient passive 
antibody to cover all the determinant sites was required (Dixon et al.,
1967). Further experimental evidence came from the observation by 
Benacerraf and Gell (1959) that fixation of rabbit anti-BGG onto 
picrylated-BGG had no effect upon the antigenicity of the hapten; in 
contrast, immunisation by means of picrylated-BGG or picrylated-OVA 
with the picryl group blocked by specific antibody did not lead to
delayed reactivity to the picryl group. Similarly, passive antibody
specific for certain proteolytic fragments of human or guinea pig
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globulin did not suppress formation of antibody to all the globulin 
determinants, but only formation of those antibodies directed against 
the fragments concerned [Cerottini, McConahey and Dixon, 1969b;
Pincus and Nussenzweig, I969; Pincus, Lamm and Nussenzweig, 19Tl).
In the same way, passive antibody to a certain hapten suppressed 
antibody production to that hapten only - and not to a second hapten 
when an animal was immunised with both haptens coupled to the same 
carrier (Brody, Walker and Siskind, 1967). Likewise, the secondary 
response to a hapten-protein conjugate was suppressed only in the 
hapten-specific component by passive anti-hapten antibody (Hamaoka, 
Takatsu and Kitagawa, 1971). In contrast to these results, there is 
also a considerable amount of evidence indicating that immunosuppressive 
antibody acts on the complete antigen rather than on single 
determinants. Thus, passive antibody against the Forssman antigen was 
also immunosuppressive for the isophile antigen in animals immunised 
with SRBC (Greenbury and Moore, I968), In some cases it was possible 
to entirely inhibit the response to gammaglobulin molecules with 
passive antibody directed specifically against certain proteolytic 
fragments of the globulin (Henney and Ishizaka, I968). It has also 
been demonstrated that either carrier-specific or hapten-specific 
antibodies were separately capable of suppressing the antibody response 
to both moieties of a hapten-protein conjugate (Henney and Ishizaka, 
19T0).
The fact that passive antibody appeared to act sometimes on 
a single detenninant yet at other times suppressed the response to whole 
antigens may reflect the existence of two mechanisms of antibody-
kk
mediated immunosuppression; i.e. (l) A peripheral mechanism whereby 
passive antibody merely masks the antigenic determinants and
tt
deprives the antigen of its immunogenicity (Uhr and Moller, I968).
(2) A central mechanism in which the antibody in the circulation 
(probably in the form of antigen-antibody complexes) has a suppressive 
effect on the antibody-producing cells (Uhr and Baumann, I96I;
Feldmann and Diener, 1970)•
If both postulated mechanisms for antibody-mediated 
immunosuppression are operational, then the dose of passive antibody 
could be critical. A small dose of passive antibody would only be 
expected to act "centrally" (or not at all), being insufficient to have 
any significant masking effect. On the other hand, a very large dose 
of passive antibody would only act peripherally - as the immune 
complexes which it would form would have no free determinants to 
interact with antibody-producing cells, therefore excluding any 
central inhibition. It might be anticipated that doses of passive 
antibody somewhere between these two extremes would exert a dual 
immunosuppressive force and therefore be the most effective. It has 
been shown experimentally in fact that the degree of immunosuppression 
was directly related to the dose of passive antibody (Pierce, I969), but 
it has also been pointed out that there appeared to be a definite 
optimum amount of passive antibody, above and below which immuno­
suppression was less convincing (Feldmann and Diener, 1970; Diener 
and Feldmann, 1970). It must not be forgotten that passive antibody 
(especially IgM and small amounts of high affinity antibody) has, on 
occasion, augmented an immune response - this has been interpreted as a
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specific concentrating mechanism for antigen, for example in the 
spleen (Pearlman, 19^7; Walker and Siskind, I968; Dennert, I971).
Passive antibody has been found effective if administered 
prior to, together with, or after the antigen in suppressing antibody 
formation to that antigen; in the last instance however there was a 
definite time lag before any immunosuppressive effect was evident
It
(Moller and Wigzell, 19^5; Wigzell, I966) - the inference being 
that passive antibody has no inhibitory effect upon cells already 
committed to synthesising antibody. Moreover, if normal lymphoid 
cells were incubated with antibody in vitro (Moller, 1964) or spleen 
cells were taken from passively immunised donors (Ryder and Schwartz, 
1969)9 and in each case these cells were transferred into lethally 
irradiated recipients and challenged with antigen, then a conventional 
response in terms of antibody production was elicited. This 
implicated an absolute requirement for both antigen and antibody being 
present at the same time for immunosuppression to occur.
In correlating the concepts of negative feedback with the 
proposed switch from IgM to IgG antibody production, it might be 
expected that IgG antibody specifically inhibits IgM antibody 
biosynthesis. Experiments have in fact shown that 78 antibody was 
more efficient pro rata in this respect (Finkelstein and Uhr, 1964 ; 
Wigzell, 1966) and that 7S antibody specifically depressed 198 
antibody production in vivo (Sahiar and Schwartz,1964). In the same 
way it was found that 198 antibody production was more sensitive to 
suppression by passive antibody than the 78 response “ which in fact 
became more resistant with time (Wigzell, I967). It has also been
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claimed that in mice immunosuppressive function vas subject to 
sub-class restriction, I'gG^  being more effective than IgG^ (Mur git a 
and Tokuda, 1967; Murgita and Vas, 1972).
The amount of antibody in the circulation may therefore be 
related to the course of a natural infection. Initially, when there 
is little antigen available, the two positive feedback loops (T cell 
helper function and IgM concentrating mechanism) will be operative. 
Thereafter, no useful purpose is served by continued and unlimited 
escalation of antibody production, and at this point negative feedback 
homeostasis would come into action.
Passive antibody administered at doses large enough to act 
by the peripheral mechanism would be expected to compete with antigen- 
binding cells for free antigen, thereby preventing low affinity cells 
from being stimulated. In this way, any antibody which was produced 
would be of high affinity; observations of increased antibody affinity 
under such conditions have been reported (Siskind, Dunn and Walker, I968) 
On the other hand, if antibody acts centrally and in the presence of 
antigen, then a relative decrease in the affinity of any antibody 
formed might be expected. Such a decrease in antibody affinity has 
been demonstrated experimentally (Walker and Siskind, 1968). In terms 
of effectiveness, it has been found that an equivalent amount of high 
affinity antibody was more Inhibitory than low affinity antibody 
(Walker and Siskind, I968), and this could be connected with the 
finding that passive antibody from a late primary response was more 
immunosuppressive than material from the early phase.
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The proposed existence of two ways in which passive 
antibody might be immunosuppressive could be related to the 
functional structure of the antibody molecule itself. Straight­
forward masking of antigenic determinants would require no more than 
the FCabOg antibody fragment whereas inactivation at the cellular 
level might logically involve both recognition, FCab*]^» and 
effector, Fc, moieties of the antibody molecule. The apparent 
effectiveness of intact IgG antibody molecules has been contrasted 
to the limited immunosuppressive capabilities of F(ab' antibody 
fragments alone (Sinclair, Lees and Elliot, I968 ; Sinclair, 1969; 
Sinclair, Lees, Chan and Khan, 1970; Chan and Sinclair, 1971; Lees 
and Sinclair, 1973). Furthermore it has been demonstrated that 
F (ab')g fragments would compete with, and thereby diminish the 
immunosuppressive potency of intact IgG antibodies when the two were 
administered together (Chan and Sinclair, 1973). In chickens, 
selective removal of cytophilic antibody by adsorption with spleen 
cells considerably reduced the immunosuppressive qualities of the 
antiserum thereafter (ivânyi, 1970). Conflicting reports stating 
that the Fc portion of the antibody molecule was not required for 
immunosuppression have also been published (Tao and Uhr, I966; 
McConahey, Cerottini and Dixon, I968; Cerottini, McConahey and Dixon, 
1969a; Chang, Schneck, Brody, Deutsch and Siskind, I969; Feldmann 
and Diener, 1972).
To summarise, immunosuppression by passive antibody and 
probably by circulating antibody would appear to involve at least two 
processes: (l) The binding of passive (or circulating) antibody to
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antigenic determinants* effectively masking these. (2) The 
inhibition of the antigen-sensitive cells themselves, a central 
effect as proposed by Uhr and Baumann (1961) and Rowley and Fitch 
(1964) in which the number of immunocompetent cells capable of 
responding to antigenic stimulation is reduced. This second 
mechanism has been developed into a tripartite model by Chan and 
Sinclair (l97i), according to which, the binding of specific 
antibody to an antigenic determinant can inhibit an antigen-sensitive 
cell which attaches to a neighbouring determinant on the same 
antigen: this inhibition is perhaps effected by the Fc portion of
the attached antibody molecule. A scheme of this sort is 
supported by evidence that there are receptors on B lymphocytes 
specific for the Fc portion of immunoglobulin molecules (Basten, 
Warner and Mandel, 1972).
It is quite probable that the regulation of antibody 
biosynthesis in terms of homeostasis is effected by circulating 
antibody which may act in a similar fashion to antibody administered 
passively. Control of antibody production by antibody-mediated 
negative feedback would achieve the inhibition of prolonged and 
uneconomical antibody biosynthesis. In agreement with this, the 
removal of specific antibody from the circulation has been shown to 
cause temporary alleviation of such negative feedback (Graf and Uhr, 
1969; Bystryn, Graf and Uhr, 1970).
k9
The scope of this thesis was therefore to investigate 
certain aspects of the inducibility and specificity of antibody 
biosynthesis in the chicken. The evidence concerning control 
mechanisms was obtained from experimental measurements of antibody 
levels and of the affinity, avidity and heterogeneity of antibody. 
The influence of a number of factors on these variables, e.g. the 
effect of antigen, the type, dose and administration upon the 
subsequent biosynthesis of antibody in chickens was examined; so 
too were the effects of adjuvants and of passive antibody. The 
relationship between these factors governing biosynthesis and the 
characteristics of the antibody response are discussed in terms of 
a process of clonal selection by antigen followed by cellular 
differentiation and proliferation.
MATERIALS AND METHODS
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A. IMMUNISATION
1. PREPARATION OF MATERIALS FOR INJECTION
Human Serum. Albumin
The human serum albumin (HSA) used for experiments was 
obtained in a purified crystalline state from Behringwerke AO,
Marburg Lahn, Germany, For immunisation the required total amount 
of purified crystalline HSA was dissolved in saline (0.15 M NaCl).
Haptenated Proteins
Solutions of DNP-protein conjugates in PBS (phosphate 
buffered saline; 0.01 M phosphate buffer pH I.2, containing 0.15 M 
NaCl) were stored frozen at -20°. When required a DNP-protein conjugate 
was allowed to thaw at room temperature, clarified if necessary by 
centrifugation, and the concentrations of DNP and protein were 
confirmed by spectrophotometry (as described on page 56 ) immediately 
before injection.
Adjuvant Mixtures (water-in-oil emulsions)
(i) Freund's Incomplete Adjuvant (FIA) was prepared from the following 
reagents; antigen dissolved in saline; Drakeol 6VR, a mineral oil 
manufactured by The Pennsylvania Refining Company, Butler, Pennsylvania, 
U.S.A.; Arlacel A, an emulsifying agent manufactured by the Atlas 
Powder Co., Wilmington, Delaware, U.S.A. Three volumes of Drakeol 
6VR were mixed with one volume of Arlacel A in a screw-capped glass 
vessel (containing one glass bead, diameter 5 mm) and emulsified with
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one volume of antigen solution in saline as follows. One third of 
the antigen solution was taken up in a disposable hypodermic syringe 
and forcibly ejected into the oil mixture through a 0.5 mm needle.
The container was then capped and shaken vigorously before the next 
portion of antigen solution was added in the same way. After the 
third and final addition of antigen, the mixed emulsion was taken up 
into the syringe through a wide bore (l mm) needle and squirted out 
again through the fine bore (0.5 mm) needle. The container was then 
capped and shaken vigorously on a mechanical shaker for at least 30 
minutes to ensure that the aqueous phase was finely dispersed 
throughout the oil phase. The quality of the emulsion was tested 
by floating a few drops of adjuvant in a beaker of cold tap water; 
if the adjuvant mixture was a true water-in-oil emulsion then it 
remained as discrete drops on the surface of the water and showed no 
tendency to disperse. Adjuvant mixtures were always prepared on the 
same day as they were to be used.
(ii) Freund’s Complete Adjuvant (FCA) was'prepared in essentially 
the same way as the incomplete adjuvant, but with the addition of 
mycobacteria to the oil phase of the water-in-oil emulsion.
For immunising chickens, Mycobacterium avium Strain Dl+ER, 
equivalent to a dose of 5 mg per bird, was included in the oil phase 
of the adjuvant. For immunising rabbits, the adjuvant contained 
Mycobacterium tuberculosis human type Strain C equivalent to a dose of 
1.5 mg per animal. In both cases the mycobacteria were weighed out 
into a sterile glass container and finely ground with a glass bead 
(5 mm diameter) on a mechanical shaker for 10 minutes. The oil
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mixture was then added and shaking continued for a further 10 minutes 
to ensure an even distribution of mycobacteria throughout the oil 
mixture.
Both mycobacterial strains were obtained in a heat-killed, 
freeze-dried form from the Ministry of Agriculture, Fisheries and 
Food, Weybridge, Surrey, England.
2. EXPERIMENTAL ANIMALS AND IMMUNISATION PROCEDURES
Birds ; the experimental work to be reported was carried out in the 
domestic fowl. Callus domesticus. Both male and female birds were 
used, ranging in age from 6 to 20 weeks. White Leghorn (Thornber 808) 
and crossed White Leghorn/Rhode Island Red randomly bred strains were 
used.
During inoculation the birds were immobilised lying on their 
sides, either being held by an assistant or restrained by tying their 
legs together with string and at the same time tying the wings 
together with the head tucked back between them. Intravenous (iv) 
injection was by way of the basilic vein which is a tributary of the 
brachial vein in the wing of the bird. A hypodermic needle suitable 
for the size of the vein was selected and inserted in the direction of 
the blood flow. Intramuscular (im) injections were given into the 
breast muscle.
Rabbits ; New Zealand White rabbits, obtained from Kingford Conies, 
Great Tey, Colchester, England, were used to raise high titre antisera.
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For the production of antisera in rabbits, injections were 
made intramuscularly into both the left and right calf muscles, so 
that the maximum number of draining lymph nodes could be utilised. 
Assistance was required to hold the animal during injection, and for 
this purpose the rabbit was wrapped in a towel with either the left 
or right leg held free. The primary injections of antigen 
(approximately 1 mg in total) were given in Freund’s complete 
adjuvant. A second injection of antigen (l mg) in saline was given 
intramuscularly 6 weeks later and the animals were bled at T and 10 
days after the second injection; further booster injections were 
given at 6-week intervals.
Disposable needles and syringes: Sterile plastic disposable syringes,
sizes 1, 2, 10 and 20 ml were used during the course of experimental
work. They were obtained from Becton, Dickinson and Co. Ltd. , Dun 
Laoghaire, Co. Dublin, Republic of Ireland. Gillette Scimitar sterile 
disposable hypodermic needles were also used, the size depending on 
the size of the animals and the purpose for which they were intended; 
they were obtained from Gillette Surgical, Isleworth, Middlesex, 
England.
3. COLLECTION OF BLOOD SAMPLES, SEPARATION AND PRESERVATION OF SERA
Birds : (l) Heart Puncture. The bird was held firmly, by an
assistant, on its back on a flat surface. The size of the syringe 
and needle were governed by the size of the bird and the amount of 
blood to be taken, usually a 19 gauge needle and a 20 ml syringe were 
satisfactory. The syringe was held horizontally and the needle
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introduced in a posterior direction at the point of the "V" formed 
by the clavicle and then advanced into the heart.
(2) Brachial venipuncture. The bird was restrained on its side, as 
described before, and the feathers in the axillary region were 
plucked. At this point the brachial vein could be seen running from 
beneath the pectoral muscle to proceed subcutaneously along the 
ventral surface of the wing, parallel to the humerus. The initial 
percutaneous puncture was made into the vein in a direction contrary 
to that of the blood flow, and after the point of the needle was 
seen to enter the vein, blood was gently withdrawn.
Blood samples were allowed to clot and contract at 3T^ in 
a water bath (for between 1 and 4 hours) and then ringed with a 
flame-sterilised metal spatula to facilitate contraction of the clot. 
The clotted blood samples were centrifuged at 750 x g  for 10 minutes; 
the serum was removed by Pasteur pipette and stored at -20° in sealed 
containers.
Rabbits : Blood was taken from the marginal ear vein. The rabbits
were restrained by tightly wrapping them in a towel with only their 
heads protruding. The hair over the vein was carefully shaved and 
the ear lightly swabbed with xylene to cause vasodilatation. The 
vein was compressed at the base of the ear, a small 2-3 mm incision was 
made across the vein and the blood was allowed to drip into clean, 
sterile, glass Universal containers. Up to 50 ml of blood could be 
collected from each rabbit in this way. After collection, a cotton 
swab was pressed over the incision until bleeding from the vein had
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stopped; the ear was then carefully washed and cleaned.
Clotting of blood samples was carried out as described 
before. The sera were stored at -20°.
B. PREPARATION OF ANTIGENS M D  HAPTENS
U. PREPARATION OF DNP-PROTEIN CONJUGATES
DNP-protein conjugates were prepared either for the 
immunisation of chickens or for use in hapten-binding assays; the 
preparative procedure was adapted from the method of Eisen (1964b).
Protein solutions contained 200 mg of protein; e.g. human 
serum albumin (HSA), human gamma globulin (HGG; Blood Transfusion 
Service, Law Hospital, Lanarkshire, Scotland), ovalbumin (OVA; Sigma 
Chemical Co. Ltd., London, England), chicken serum albumin (CSA; 
prepared from chicken serum) and haemocyanin (HCN; prepared by 
differential centrifugation from the blood of Helix pomatia) were 
used as carrier proteins. These solutions’were made up to 10 ml in 
carbonate/bicarbonate buffer (0.5 M, pH 8.4). To the protein solution 
(approximately 20 mg ml ^) was added 0.1 ml of a 10^ (v/v) solution of 
2 ,4-dinitrofluorobenzene (DNFB; British Drug Houses Ltd., Poole, 
England) in 1 ,4-dioxan (British Drug Houses Ltd., Poole, England) and 
the mixture was allowed to react overnight at room temperature (to 
obtain less intensely substituted protein molecules the amount of 
DNFB and/or the reaction time were reduced accordingly).
The hapten-protein conjugate was subsequently separated 
from uncoupled hapten by gel filtration on a column (30 cm x 1 cm) of
56
Sephadex G25 (Pharmacia, Uppsala, Sweden) equilibrated with PBS.
The DNP-protein conjugate was eluted in the void volume, collected 
as a single fraction, and stored at -20° without preservatives.
5. DETERMINATION OF THE DNP AND PROTEIN CONCENTRATIONS OF CONJUGATES
Before using DNP-protein conjugates as antigens it was 
necessary to find the exact concentrations and the molar ratio of 
hapten and protein moieties. All spectrophotometric measurements 
were carried out using an SPI8OO Ultraviolet Spectrophotometer (Pye 
Unicam, Cambridge, England) incorporating an SPI806 Synchronised 
Wavelength Drive Unit and including the facility of a Unicam AR25 
Linear Recorder.
(a) DNP concentration: for practical purposes it has to be
assumed that all DNP groups attached to the protein are linked by way
of the e-amino group of lysine residues in the protein molecule. It
was also necessary to assume that the molar extinction coefficient of
conjugated DNP in a protein is the same as that of free e-DNP-lysine.
The DNP molar concentration in a solution of a DNP-protein conjugate
can therefore be determined spectrophotometricall.y - using the
information that the wavelength of maximum absorbance (X ) for
max
DNP-lysine is 360 nm and that the molar extinction coefficient at
this wavelength (^^60^ 17,400 mol ^1. cm ^ (Little and Donahue,
1968). In other words, the absorbance (measured through a 1 cm
thickness of solution) of DNP-lysine at a concentration of 1 mole 
—1
litre is greatest when measured at 36O nm and at this wavelength 
has a value of 17,400.
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The characteristic peak of absorbance at 36O nm for 
DNP-protein conjugates, due entirely to the presence of the DNP 
group, is shown in Figure 3 which is an ultraviolet absorption 
spectrum of DNP-HSA in solution.
(b) Protein concentration: both the DNP and protein components of
the conjugate absorb transmitted ultraviolet light at 280 nm (due to 
benzene rings in the DNP group and in the aromatic amino acids of the 
protein). It has already been mentioned that the absorbance of the 
conjugate at 360 nm is attributable solely to the DNP group and it 
has been found that the absorbance of e-DNP-lysine at 36O nm is 
directly proportional to its absorbance at 280 nm.
E
i.e. for DNP-lysine —--- = constant (c). Various values for this
360
constant have been reported, e.g. O.361 (Eisen, Kern, Newton and 
Helmreich, 1959) or O.385 (Iverson, 1973).
Our own calibration for the absorbance of DNP-lysine at 
both 280 nm and 36O nm is given in Table 1 and shown in Figure 4.
From this calibration, the following values were obtained:
E
= 16,800 mol'^ 1. cm"^, = 0.321.
G36O
If Eggg and E^^g are the values for the total absorbance of the 
conjugate at 280 nm and 36O nm respectively, then the value of E^g^ 
has two components; the contribution of DNP' at 280 nm can be 
calculated as described and is equal to E^^^ x c. Having found this, 
the contribution from the protein can be calculated and is equal to 
^280 ~ ^^360 ^ i.e. the component of the total absorbance at
280nm attributable to the protein alone = E^g^ - x c ). If the
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FIG. 3. Ultraviolet absorption spectrum of 
DNP-HSA.
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TABLE 1. Calibration of the Unicam SPI8OO Ultraviolet 
Spectrophotometer by measuring the absorbance 
of different concentrations of DNP-lysine in 
a 1 cm cuvette at 280 and 36O nm.
Concentration of 
DNP-lysine 
(pmoles litre )
^280 ^360
25 0.116 0.^25
50 0.258 0.860
75 0.386 1.250
100 0.5^6 1.620
ABSORBANCE 
( in a 1 cm cuvette )
60
1 . 5 - -
360
0 .5 * "
280
0 25 7550 100
CONCENTRATION OF DNP-LYSINE 
( micromoles litre )
FIG. 4. Calibration graph for the. absorbance of DNP- 
lysine at 280 and 360 nanometres.
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protein in question has a molar extinction coefficient = (p^otein),
then the molar concentration of protein in the conjugate =
^280 ~ ^ =)
^280 (protein)
(c) DNP to Protein Molar Ratio; this was calculated from the 
following equation, itself derived from the formulae describing the 
concentrations of DNP and protein in a conjugate.
B36O "280 (protein)
DNPiprotein (molar ratio) =  / .-- :-- r x
"360 (DMP-lysine) - (Egg^ x 0) ’
6. PREPARATION OF DINITROPHENYLATED ERYTHROCYTES
To assess the suitability of a particulate entity as a 
carrier for the DNP hapten, chickens were immunised with heterologous 
red blood cells to which the hapten had been conjugated. The method 
for coupling DNP to human erythrocytes was adapted from that recommended 
by Levine and Levytska (I967).
Human red blood cells were separated from heparinised venous 
blood by the addition of a J volume of 6% dextran in 0.9  ^sodium 
chloride (Dexbraven I5O; Fisons Ltd., Loughborough, England) and 
allowing the erythrocytes to sediment. The supernatant plasma was 
aspirated and the red blood cells remaining were washed three times 
with the coupling buffer (O.O5 M carbonate/bicarbonate, 0.15 M NaCl 
and 0.01 M EDTA, pH 8.O).
A 2 ml volume of packed human red blood cells was added to 
13 ml of coupling buffer containing 50 ]xl of a 10^ (v/v) solution of 
DNFB in acetone. The cells were agitated gently for 1 hour at room
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temperature. Thereafter the erythrocytes were washed 3 times in 
PBS and resuspended in a final volume of 10 ml. This procedure
O —
yielded suspensions containing approximately 2 x 10 BNP-HuEBC ml
7. PREPARATION OF DINITROPHENYLATED CELLULOSE
For investigating the effect of immunising chickens with 
the DNP hapten immobilised on a polysaccharide carrier, a batch of 
dinitrophenylated cellulose was prepared according to the method 
recommended by McKay (personal communication).
A 500 mg amount of chromatographic cellulose (DE 22; Whatman 
Biochemicals Ltd., Maidstone, Kent, England) was suspended in 10 ml 
of absolute ethanol. To this suspension was added 0.25 ml of 
undiluted DNFB. The coupling reaction was allowed to proceed 
overnight at room temperature. The product was then extensively 
washed consecutively in ethanol, water, dilute alkali and dilute acid 
until no further colour (indicating free dinitrophenol) appeared in 
the supernatant fluid.
8. PREPARATION OF DINITRQPHENYL HAPTENS
(a) DNP-s-aminocaproic acid (DNP-EACA).
DNP-EACA was used as the ligand in equilibrium dialysis 
studies of anti-DNP antibody affinity (and for this purpose was 
supplemented with small amounts of tritium-labelled DNP-EACA). Because 
chickens were usually immunised with DNP attached to a protein carrier 
and since for such conjugates the majority of DNP groups are assumed 
to be linked to the s-amino groups of lysine residues, DNP-EACA was 
selected as a suitable ligand because of its structural similarity to
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the dinitrophenyl determinant of DNP-protein conjugates (as 
compared in Figure 5)*
The method used for preparing DNP-EACA was similar to that 
employed by Werblin and Siskind (l9T2a) and was carried out as follows.
A solution containing 3 g of 6-aminocaproic acid (British 
Drug Houses Ltd., Poole, England) and 5 g of sodium carbonate was 
made up to 100 ml with distilled water ; 3 ml of a 10% solution (v/v)
of DNFB in 1,4-dioxan were added to the solution, which was then 
stirred for 1-2 hours at room temperature. . The product was 
precipitated with 2 M hydrochloric acid, sedimented by centrifugation 
and washed with 2 M hydrochloric acid. The DNP-EACA was then washed 
and finally recrystallised from 50% ethanol.
The dinitrophenyl group has a characteristic peak of
absorbance L^t approximately 360 nm. This peak of absorbance
is shown in Figure 6, which is an ultraviolet absorption spectrum of
DNP-EACA in distilled water; for this solution, X = 365 nm.max
(b) Tritiated DNP-e-aminocaproic acid, [ ^ h ]-DNP-EACA.
J ^ Hj-DNP-EACA was used as the radio-labelled ligand in an 
equilibrium dialysis system for assessing anti-DNP antibody affinity. 
The preparation was adapted from the methods employed by Katz, Paul, 
Goidl and Benacerraf (1970) and by Werblin and Siskind (1972a).
The radio-labelled ligand was prepared as a stock solution in 
the following way: 2 ,if-dinitro-l-fluoroJ3j5"^Hjbenzene (J^njDNFB) was
obtained from the Radiochemical Centre, Amersham, England, and was
6k
-N-(CH J.-C00H
NO
Representation of the DNP-EACA molecule.
COO
NH
N-HNO,
Representation of the DNP group attached to a protein 
molecule at the €-amino group of lysine.
FIG. 5. Comparison of the molecular structure of the 
ligand DNP-EACA with that of the DNP group when it is  
attached to the 6-amino group of lysine in a protein.
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FIG, 6. Ultraviolet absorption spectrum of DNP-8- 
aminocaproic acid ( DNP-EACA ).
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supplied as a 1 ml solution in benzene. The radioactivity was
“1 . . . .  . “1
1 mCi ml and the specific activity was 13 mCi ymol ; i.e. 1 ml
contained 1 mCi of radioactivity, which was equivalent to 0.0T7 
ymoles of
A 1 ml volume of [^h]~DNFB was taken to dryness by blowing 
a steady stream of dry nitrogen over its surface ; 0.1 ml of a
solution of 6-aminocaproic acid (MW 131.18) in 5^ Wa^CO^, representing 
a 100-fold molar excess (i.e. 7*7 ymoles or 1.012 mg in 0.1 ml, or 
10.12 mg ml was added to the dry j^ I^îj-DNFB and the mixture stirred 
for 2 hours. The reaction mixture was then applied to a thin layer silica 
gel chromatographic plate. Chromatograms were developed in n-butanol 
and the position of the |^Hj-DNP-EACA spot was located by correlation 
with a visible amount of non-radioactive DNP-EACA chromatographed 
simultaneously. The area of the gel containing the [^h ]-DNP-EACA was 
scraped from the glass plate, and the product was eluted from the 
scrapings of silica gel by thorough mixing with PBS.
The concentration of [ -DNP-EACA was determined as follows:
for DNP-EACA X = 365 nm and = 17,800 mol ^1. cm ^ (Little and
max 365
Donahue, 1968). For the [^h ]-DNP-EACA, prepared as described, E^^^ =
0.99* Therefore, the concentration of [^h]-DNP-EACA = 5.56 x 10  ^M,
—1
or 0.0556 ymoles ml , By diluting this 1:55.6, a stock solution of 
-DNP-EACA at a concentration of 1 nanomole ml ^ was obtained.
(c) Divalent DNP hapten. The divalent DNP hapten, 1 ,6-bis-(2,U- 
dinitrophenylamino)hexane, i.e. DNP-NH-(CH^)^ -NH-DNP, was used in 
experimental studies into the feedback inhibition of the anti-DNP
ABSORBANCE
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FIG. 7. Ultraviolet absorption spectrum  
of 1 ,6-bis-(2,4-dinitrophenylamino)hexane.
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antibody response in chickens. The preparation, based on the 
method described by Green, Wilder and Schumaker (1972), was as follows: 
60 millimoles (7.29 ml) of DNFB were made up to 120 ml with absolute 
ethanol. A solution containing 30 millimoles (3.U8 g) of 1,6- 
diaminohexane (British Drug Houses Ltd., Poole, England) dissolved 
in 90 ml of 1 M NaHCO was also prepared. The two solutions were 
then mixed and stirred for 2 hours at room temperature; the product 
precipitated spontaneously. The divalent hapten was washed 
alternately with ethanol and water three times and then dried.
An ultraviolet absorption spectrum of l,6-bis-(2,4-
dinitrophenylamino)hexane is shown in Figure 7; for the divalent hapten
\ = 362 nm.
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9. PREPARATION OF CHICKEN SERUM ALBUMIN (CSA)
Chicken serum albumin was required as a carrier for DNP in 
the Farr test to measure anti-DNP antibodies (as described on page 80 ). 
The method for preparing chicken serum albumin was as follows : a
200 ml volume of methanol containing 0,05 M trichloroacetic acid (TCA) 
was added to 20 ml of chicken serum. The resulting precipitate was 
deposited by centrifugation and discarded. Sodium hydroxide (2 M) 
was added dropwise to the supernatant until the pH (originally about 
pH 2) had reached 6.0. At this point a white flocculent precipitate 
was formed. This precipitate was sedimented by centrifugation and the 
supernatant fluid was discarded; the precipitate was then washed 
twice with methanol, twice with ether and then air-dried at room 
temperature.
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10. PREPARATION OF RADIO-LABELLED PROTEINS
(a) Radio-iodination of HSA.
HSA was trace-labelled with radioactive iodine (using 
131 125either I or I which were supplied as iodide, carrier free, in 
NaOH solution by the Radiochemical Centre, Amersham, England and 
were dispensed in millicurie amounts by the Isotope Dispensary,
Institute of Radiotherapeutics, Western Infirmary, Glasgow) for use 
in the measurement of the antigen-binding capacity and the determination 
of the avidity of chicken antisera. The radio-labelling was carried 
out using the direct oxidation procedure of Hunter and Greenwood (1962).
In aqueous solution chloramine T is a mild oxidising agent ; 
on addition to a solution of iodide and protein there is a rapid 
incorporation of iodine atoms into the protein molecules - almost 
exclusively by formation of mono-iodotyrosine.
The reactants were injected through the rubber seal on a 
phial containing the thiosulphate-free, radioactive sodium iodide.
The exact sequence of these additions, and the concentrations of 
reagents, are given in Figure 8 which is a "flow" diagram of the 
labelling procedure.
After sufficient time had been allowed for iodination to 
take place (3 minutes), sodium metabisulphite was added in slight 
excess to reduce the chloramine T and any excess iodine; carrier 
iodide was then added and the reaction mixture was loaded onto a 
30 cm X 1 cm column of Sephadex G25. The labelled protein was then
TO
1
I
1 01 1 O R  1 91
(a) I or I as carrier-free Iodide (e .g . Na I), 1 mCi
per mg of protein.
-1(b) 0.25 ml chloramine T (1 mg ml in PBS).
(c) 0.10 ml HSA (10 mg ml  ^ in PBS).
Shake and allow to react for 3 minutes
(d) 0.05 ml sodium metabisulphite (2.4 mg ml  ^ in PBS).
(e) 0.20 ml potassium iodide (10 mg ml  ^ in PBS).
Sephadex G25
1 ml fractionsRadioactivity- 
Protein------
N
Free I
I-HSA__<
Fraction number
FIG. 8. Procedures for radio- iodinating HSA and for separation 
of the labelled protein.
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separated from unattached radio-iodine by gel filtration; 1 ml 
fractions were eluted from the column, and the tubes containing the 
most radioactivity associated with radio-labelled protein were pooled 
together into a single aliquot. The radioactivity of this 3 ml 
aliquot was measured on a gamma counter and the HSA concentration was 
calculated from the spectrophotometric absorbance at 280 nm.
Under these conditions a radio-iodinated HSA solution of 
“1
200 to 300 yg ml and with a specific activity of 0.85 to O.9O mCi
*"1 •mg was usually obtained.
fb) Radio-iodination of DNP-Proteins.
DNP-proteins were trace-labelled with radioactive iodine for 
use in the measurement of the hapten-binding capacity of chicken 
anti-DNP antisera. The method was essentially the same as that used 
for radio-labelling HSA.
From experience it was found necessary to use a radio-labelled 
antigen with a low degree of DNP substitution, since heavily 
dinitrophenylated proteins were partially precipitable in hO% saturated 
ammonium sulphate. Both ovalbumin and chicken serum albumin were tried 
as carrier proteins in this system; however, CSA was used in preference 
to OVA because of the difficulty in attaching adequate amounts of 
radio-iodine to the inaccessible tyrosine residues of the latter.
0. PREPARATION AND SEPARATION OF IMMUNOGLOBULINS
11. PREPARATION OF IMMUNOGLOBULINS FROM CHICKEN SERUM BY SALT 
FRACTIONATION
For experiments involving the passive immunisation of chickens
72
with antibody, an antibody-containing globulin fraction was prepared.
Because of the high lipid content of chicken serum there is a
tendency for IgM and IgG to aggregate during salt precipitation and
for this reason a procedure using sodium sulphate precipitation,
comparable to that described by Orlans, Rose and Marrack (I96I), was
preferred to precipitation with kO% saturated ammonium sulphate.
The details of the method are as follows : to a known quantity of
chicken serum was added an equal volume of warm (30^) sodium sulphate
at a concentration of 0.36 g ml ^ (36%) - such that the resulting
solution contained O.I8 g ml ^ (l8%) of sodium sulphate. The
solution was allowed to stand at room temperature for 30 minutes,
after which the precipitate which had formed was sedimented by
centrifugation (M.S.E. Superspeed 50 TC) for 10 minutes at 30,000 x
The supernatant fluid was removed and discarded, and the precipitate
was dissolved to one half of the original serum volume in phosphate
buffer (O.l M, pH 8.0). The globulins were precipitated twice more -
each time by the slow addition of sodium sulphate to a final
—1concentration of 0.l4 g ml {lk%) and then centrifuged as before. 
Following the third and final precipitation and centrifugation, the 
globulin fraction was dissolved in PBS and dialysed against PBS for 
48 hours at 4^. After dialysis, the protein solution was cleared by 
centrifugation at 2,000 x ^  for 15 minutes and the concentration of 
protein determined by measuring the spectrophotometric absorbance at 
280 nm.
12. SEPARATION OF TS AND 19S CHICKEN ANTIBODIES BY ULTRACENTRIFUGATION 
For investigating the relative proportions of specific
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aixtitody belonging to either the ys or 19S class of immunoglobulin 
(i.e. the isotypic heterogeneity of antibodies) in an antiserum, a 
method for the complete separation of these two classes was required.
The separation was achieved by sucrose density gradient centrifugation 
using a procedure similar to that recommended by Stanworth and 
Turner (1973)»
Sucrose density gradients were prepared by layering 1 ml 
volumes respectively of 30%, 20% and 10% solutions of sucrose in
saline (w/v) on top of each other in g" x 2” plastic centrifuge tubes 
(Beckman - R.I.I.C. Ltd., Eastfield Industrial Estate, Glenrothes, 
Scotland). The gradients were equilibrated by leaving overnight at 
4^. Antiserum (a 1 ml volume of anti serum diluted 1:50) was carefully 
layered on top of the sucrose gradient, making a total volume of 5 ml 
in each tube. Separations were carried out in groups of three by 
centrifuging the samples in a swing-out SW65 rotor on a Beckman L2-65 
preparative ultracentrifuge at 40,000 r.p.m. (ll4,000 x g at = 6.4 cm) 
for 18 hours at 4°. Following centrifugation the tubes were 
punctured and 0.25 ml fractions were collected dropwise from the bottom 
of the tube, under positive pressure, using an automatic fraction 
collector and drop counter (Beaumaris Instrument Co. Ltd., Beaumaris, 
Angelsey, Wales).
Once the antibodies in the starting material had been 
separated according to sedimentation rate, specific antibody residing 
in each of the two immunoglobulin classes (ys and I98) was quantitated
TOT
by measuring the amount of radio-labelled antigen (e.g. I-HSA) which 
was bound by each 0.25 ml fraction. A 0.1 ml sample was taken from
T4
each separated fraction and was thoroughly mixed with 0.1 ml 10% 
normal chicken serum in PBS and with 0.1 ml radio-labelled antigen 
(e.g. at 2 pg ml The tubes were left to equilibrate
for 2 hours at room temperature, and then 0.2 ml of saturated 
ammonium sulphate* was added to each. The precipitates were 
deposited by centrifugation at 850 x g for 30 minutes, each washed 
with 0.5 ml 40% saturated ammonium sulphate and centrifuged as before. 
The final precipitate in each tube was suspended in 0.5 ml PBS and 
its radioactivity was measured using an automatic gamma counter.
(For measuring radioactivity in a large number of separate samples, 
an ICN Tracerlab Gamma Set 500, which had a maximum load of 500 
samples, was used).
Standard controls were obtained by mixing 0.1 ml 10%
131normal chicken serum, 0.1 ml PBS and 0.1 ml I-HSA in a tube with
either; (l) for the positive control, 0.3 ml of 10% trichloroacetic
acid (TCA) was added. This precipitated all the protein-bound
radioactivity and therefore indicated the radioactive counts which
would be obtained if 100% of the added antigen was bound by antibody
131(i.e. a possible maximum of 200 ng of I-HSA) in a 0.1 ml sample; 
or (2) for the negative control, 0.2 ml of saturated ammonium sulphate 
was added. This selectively precipitated the globulins present but
*Saturated ammonium sulphate solution: this was prepared by dissolving
550 g of ammonium sulphate (anhydrous) in 600 ml of distilled water. 
After filtration this solution was made up to 990 ml and the pH was 
adjusted to 6.5 by addition of concentrated aqueous ammonia. The 
final volume was made up to 1000 ml with distilled water.
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TABLE 2. Antigen-binding, spectrophotometric absorbance and
infflïunoelectrophoresis of fractions, from either chicken 
anti-HSA antiserum or from normal chicken serum, 
separated by sucrose density gradient centrifugation 
(1 ml diluted serum centrifuged for 18 hours at 
40,000 rpm and 4^).
Information from the fractionation of 
specific anti-HSA antiserum, diluted 
1:50
Information from the fractionation 
of normal chicken serum, diluted 
1:10
131
FRACTION  ^I-HSA ng HSA BOUND
NUMBER BOUND (cpm) PER FRACTION
E280 IMMUNOELECTROPHORESIS
IgG IgM
Bottom 
of tube
1 25,308 175.6 0.072 - ±
2 7,422 33.3 0.057 — -
3 5,248 16.1 0.051 - -
4 4,703 11.7 0.082 ± -
5 16,602 106.4 0.132 ± —
6 27,561 193.5 0.215 ++ —
7 40,791 298.8 0.317 +++ -
8 34,425 248.1 0.374 ++ -
9 10,453 57.5 0.427 + —
10 9,912 53.1 0.549 ± -
11 7,984 37.8 0.541 - -
12 8,124 38.9 0.345 - -
13 9,409 49.1 0.159 - -
l4 10,162 55.1 0.110 - -
15 10,944 61.4 0.118 - -
16 10,364 56.7 0.090 - -
17 5,279 16.3 0.053 - -
18 5,556 18.5 0.052 — -
19 4,521 10.3 0.044 - -
20 4,169 7.9 0.050 - -
Meniscus
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Nanograms of HSA bound 
per 0.25 ml fraction.
Detection and distinction 
of immunoglobulin classes  
by Immunoelectrophoresis
IgGIgM
100
5 15 2010
(bottom) Fraction number (top)
FIG. 9. Distribution of antigen-binding capacity in antiserum 
fractions separated by sucrose density gradient centrifugation.
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X3Xnot the I-HSA and therefore indicated the radioactive counts which 
wouXd be obtained if none of the added antigen was bound specificaXXy 
by antibody.
The radioactive count from each tube containing test sampXes 
was corrected for non-specific binding of antigen, precipitation of 
denatured antigen, and for background radiation by subtracting the 
mean vaXue for the ammonium suXphate controX tubes ; this corrected 
vaXue was then expressed as a percentage of the mean vaXue for the TCA 
controX tubes (similarXy corrected). This percentage was taken as 
representing the percentage of the antigen added to each tube which 
was bound by antibody, and from it was caXcuXated the amount of 
antigen bound by each 0.25 niX fraction of serum.
The cXass of immunogXobuXin in each fraction was identified 
by correXation with the immunoeXectrophoretic distribution of immuno­
gXobuXin cXasses obtained from a separate fractionation of normaX 
chicken serum (diXuted X/XO for this purpose) as given in TabXe 2.
Details of a typical separation of chicken anti-HSA antiserum 
into 7S and X9S antibodies and of the quantitation of each are given 
in TabXe 2 and shown graphicaXXy in Figure 9« From TabXe 2, antigen- 
binding activity in fractions X, 2 and 3 was attributed to IgM; 
antigen-binding in all subsequent fractions was attributed to 78 
immunoglobulin,
13. EXTRACTION OF IMMUHQGLQBULIH FROM ADJUVANT GRAHULOMA TISSUE
An immunoglobulin-containing extract was prepared from
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adjuvant granuloma tissue for the purpose of comparing the level of 
antibody in the tissue at the site of injection with the level of 
circulating antibody in the serum of chickens. Granuloma extract 
was also used for experimental passive immunisation of chickens.
The extract was prepared as follows ;
Chickens which had been immunised J weeks previously by 
a single intramuscular injection of antigen (5 mg HSA) in Freund's 
complete adjuvant were killed by an overdose of Nembutal (sodium 
pentobarbitone, 60 mg ml ^) - 50 mg per kg body weight injected 
intravenously. As much as possible of the adjuvant granuloma which 
had developed at the site of injection in the breast muscle was excised 
and the tissue was weighed. Each tissue specimen was then cut into 
small pieces and immersed in 50 ml saline before being homogenised 
(M.S.E. homogeniser) for 15 minutes. Fibrous remnants were removed 
from the homogenates which were then centrifuged at 5000 x g  for 15 
minutes to sediment debris. The supernatants were decanted and the 
total volume of each was made up to 50 ml with saline. To each 
50 ml extract was added 34 ml of saturated ammonium sulphate (to give 
a solution 40.5% saturated in ammonium sulphate); the solutions were 
stirred mechanically for 30 minutes at room temperature. The 
precipitated globulins were sedimented by centrifugation (750 x g  for 
30.minutes) and washed twice with 25 ml of 40% saturated ammonium 
sulphate each time. After the final precipitation and centrifugation 
the precipitates were dissolved in 30 ml PBS - and dialysed against PBS 
for 48 hours at 4^  ^; the extracts were then finally cleared of any 
precipitated material by centrifugation.
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The antigen-binding capacity of each soluble extract of 
granuloma tissue was measured by the Farr test. Results were 
expressed as the ABC^^ per 100 mg of tissue.
D. DETECTION AND MEASUREMENT OF ANTIBODY
l4. DETERMINATION OF THE ANTIGEN-BINDING CAPACITY OF CHICKEN 
ANTIBODIES
(a) Anti-HSA: the level of anti-HSA antibodies in the serum of
immune birds was determined by an ammonium sulphate precipitation 
method which provided a value for the antigen-binding capacity of the 
antiserum. The procedure was a modified version of the technique 
described by Farr (1958) and was carried out as follows.
The antigen used in the system was HSA, trace-labelled with
131 125 **1either I or I, and used at a concentration of 1 yg ml and at
a specific activity of 0.85 to O.9O mCi per mg HSA,
One tube contained undiluted test serum and a further seven 
tubes (soda glass, 2" x @") contained the test serum diluted serially 
X 2 (i.e. each antiserum was diluted from neat in the first tube, to 
1/128 in the eighth and final tube in the series) in 10% normal chicken 
serum (in PBS), The final volume in each tube was 0.1 ml. Radio­
labelled HSA (0.2 ml at 1 yg ml was added to each tube and the 
contents were mixed thoroughly (vortex mixer-; A. Gallenkamp and Co. 
Ltd., Stockton-on-Tees, England). All the tubes were then left 
overnight at 4° to allow complete equilibration. On the next day,
0.2 ml of saturated ammonium sulphate was added to each tube - this 
caused precipitation of the globulin fraction, including any radio-
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labelled antigen bound to antibody; antigen not attached to 
antibody remained in solution. Precipitates were deposited by 
centrifugation at 85O x (for 30 minutes) and the supernatants 
were carefully removed; the precipitates were then washed by 
addition and mixing with 0.5 ml of kO% saturated ammonium sulphate 
and centrifuged as before. After removal of supernatant fluid from 
the final precipitates, each was suspended in 0.5 ml PBS; the 
radioactivity in each tube was then measured using an automatic gamma 
counter.
Standard controls were obtained, in duplicate, by mixing
0.1 ml 10% normal chicken serum with 0.2 ml radio-iodinated HSA (l yg 
ml in a tube and then adding either: (l) for the positive control,
0,3 ml of 10% TCA was added. This precipitated all the protein-bound 
radioactivity and therefore indicated the radioactive counts which 
would be obtained if 100% of the added antigen was bound by antibody; 
or, (2) for the negative control, 0.2 ml of saturated ammonium sulphate 
was added. This selectively precipitated the globulins present but 
not the *I-HSA and therefore indicated the radioactive counts which 
would be obtained if none of the added antigen was specifically bound 
by antibody, and at the same time allowed for non-specific binding, 
precipitation of denatured antigen and background radioactivity to be 
corrected for in the test samples.
(b) Anti-DNP: the quantitation of anti-DNP antibodies in the serum
of immune birds was effected in exactly the same way as the measurement 
of anti-HSA antibodies described in the previous section, by using a 
modified Farr test. However, in this case the antigen used was
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radio-iodinated DNP-CSA (DNP-*I-C8A); for each test it was used
-1at a DÏÏP concentration of 100 ng ml (measured as DNP-lysine, 
calculated from the spectrophotometric absorbance of DNP-*I-CSA at 
360 nm).
Calculation of Antigen-Binding Capacity
The radioactive count in each tube was corrected by 
subtracting the mean count obtained from the ammonium sulphate control 
tubes. This subtraction is intended as a correction for non-specific 
binding of antigen, precipitation of denatured antigen, incomplete 
washing of precipitates and background radiation. The corrected 
count for each test sample is then divided by the similarly corrected 
TCA control count, to give the proportion of antigen bound. An 
estimate of antigen-binding capacity, ABC^^, was obtained from each of 
the eight tubes representing any one antiserum using the formula
ABC^q = - 1.89 CD log^o (l-B) (McKay, 19Tl),
where C = antigen concentration, D = dilution factor of test serum and 
B = proportion of antigen bound. The final stage in the calculation 
was to obtain a mean of the eight estimates for each serum. It was 
necessary to use a weighted mean, since the graph of bound antigen 
concentration against log^^D (dilution factor) has a sigmoid shape, 
which means that where a very high or very low proportion of antigen 
is bound, any experimental errors can have a very large effect. The 
formula for calculating a weighted mean is, by definition,
Mean (ABC) = — ..I ^  ’ where W is the weighting factor.
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The weighting factors used were calculated from.the formula
^  = UOO ( j[^ + 84 + 40 (McKay, unpublished),
which was a compromise between a formula derived from statistical 
arguments and an empirical formula which gives an imitation of the 
results obtained by the graphical interpolation method used by Farr.
All the above calculations were carried out using a 
programmable calculator (.Hewlett Packard, plOO B).
15. DETERMINATION OF THE AVIDITY OF CHICKEN ANTI-HSA ANTIBODIES
The measurement of avidity by an ammonium sulphate 
precipitation method enabled the effect of control mechanisms upon 
the avidity of circulating antibodies in the chicken to be investigated< 
The technique employed was based upon that recommended by Steward 
and Petty (1972).
Theory
The reaction between plurivalent antigen and antibody can be 
very complex, in that many molecular species of different structures 
and sizes may be formed. In order to obtain a quantitative 
measurement of avidity it was therefore necessary to apply certain 
simplifying assumptions and conditions :
(a) The antigen is a homogeneous population of molecules.
(b) The sites for combination on both the antigen and the antibody 
act independently of all other sites on the same molecule.
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(c) Under the conditions of our measurements, the antigen is 
always present in excess, so that most of it remains free, 
some is hound to antibody at a single determinant, and the 
amount bound to antibody by two or more determinants can be 
neglected.
(d) It must also be assumed in the first instance that all the 
antibody combining sites have the same affinity for the 
antigen.
Under these conditions it is possible to represent the antigen- 
antibody reaction by the equation
Ab^ + Ag Ab^Ag
where the symbol Ab^ is used to represent one antibody combining site,
Ag is used to represent a whole antigen molecule,
and Ab^Ag is used to represent a complex formed by one
antigen molecule and one antibody combining site. This complex will, 
of course, be covalently attached to at least one other Ab^ or Ab^Ag 
unit, but this does not invalidate the argument. Under the four 
conditions imposed above, the law of mass action can be applied to 
the reaction as written, and the association constant K can be 
expressed in terms of the equilibrium concentrations of the reactants 
and product as follows :
[Ab^Ag]
K =   (equation l).
[AbJ [Ag]
It should be borne in mind that the association constant defined in
this way does not depend solely on the structures of the antigenic
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determinant and antibody combining site, but will increase with 
increasing numbers of similar determinants on the antigen molecule.
Let us now introduce the symbols [c] for the molar 
concentration of free antigen and [b] for the molar concentration of
bound antigen, and for the total molar concentration
antibody combining sites (i.'e. bound plus free).
Since [=] [Ag] ,
and [b] [AbgAg] ,
and = [Ab^] + [Ab^Ag].
We can write [Ab^l - [b] .
and rewrite equation 1 in the new notation;
K = MC[A1d^ ] -[b]) [c]
Multiplying each side by [Abj] [b]
[b] [AbJK
1 - - L .  = ___1______
[^ ] [A\] [A\] K[c] .
i.e. 1 _ 1 1 1—  +
gives
[b] [Ab^jK • [c] [Ab^ ] •
This is now in the form of the equation for a straight line,
y = mx + c. Thus if we plot l/[b] against l/[c] we should obtain a
straight line with gradient l/[Ab^]K and intercept l/[AbJ on the
l/[b] axis. If the gradient and intercept are determined for a set
of data points it should be possible to calculate [Ab^ ] and K.
In practice, there is usually a deviation from the expected 
straight line by virtue of the heterogeneity of antibody avidities. 
However, this deviation may be accounted for by assuming that the
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heterogeneity of avidity can he described hy a Sipsian distribution 
function (Sips, 1948; Klotz, 1953). Thus, for binding by a large 
variety of sites, the mass action equation can be replaced by the 
Freundlich isotherm as modified by Sips (1948). Sips's equation 
(number 10) becomes in our notation :
I )"
1 )
where = the geometric mean association constant, commonly called 
the relative avidity since in practice in immunology its 
measurement is usually not absolute, and is useful only 
for comparing different sera.
0 = the proportion (mole fraction) of antibody combining 
sites occupied at equilibrium.
a - Sips's index of heterogeneity.
It would, strictly, be valid to use this equation only for univalent 
haptens, or only where conditions (a), (b) and (c) listed previously 
&PPiy' Steward and Petty (1972) however have applied it to reactions 
involving multivaient antigens, and have used it in preference to the 
Langmuir adsorption isotherm.
Thus, when half the total antibody combining sites are
2
occupied, i.e. 8 =
then  ^ 2(K^[c])^ - 1 + (K^[c])®'
i.e. (K^[c])^ = 1
. therefore [c] = 1
I.e.
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Thus the avidity is equal to the reciprocal of the free antigen 
concentration, l/[c], under those conditions where half of the total 
antibody combining sites are bound to antigen. This equation was 
used to calculate all the values reported in this thesis.
Experimental procedure
Sets of six tubes were used for each antiserum being tested, 
each tube containing 50 yl of the undiluted test serum. To each of 
the set of six tubes the required amount of antigen was added, always 
in a volume of 50 yl. Six different concentrations of antigen were 
used, made from stock solutions of HSA containing 250, 500, 1000, 1500, 
2000 and 2500 yg of unlabelled HSA per ml, and each of these stock 
solutions contained the same small amount of radio-iodinated HSA (the 
slight alteration in antigen concentration by addition of radio-iodinated 
HSA was taken into consideration when analysing the experimental results).
After mixing and overnight equilibration of the test samples,
0.2 ml of 60% saturated ammonium sulphate was added to each tube.
Globulin precipitates were spun down by centrifugation at 850 x g_ for 
30 minutes, washed in 0.5 ml kO% saturated ammoniuip sulphate and 
centrifuged as before. The final precipitates were each suspended in
0.5 ml PBS and their radioactivity was measured on an automatic gamma 
counter.
Standard controls were obtained in the following way;
(l) The positive controls consisted of 50 yl samples of undiluted 
normal chicken serum mixed together with 50 yl of antigen at each of
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the different concentrations and with 0.1 ml unlahelled HSA 
(l mg ml “ this last addition was found to he necessary if all 
the protein-hound radioactivity in antigen solutions of low 
concentration was to be precipitated. To each positive control was 
added 0.2 ml 10% TCA and the resulting precipitates were centrifuged, 
washed in 10% TCA and finally suspended in 0.5 ml PBS. These positive 
controls indicated the radioactive counts which would be obtained if 100% 
of the added antigen ' was bound by antibody.
(2) The negative controls consisted of 50 yl samples of undiluted 
normal chicken serum mixed together with 50 yl of antigen at each of 
the different concentrations. Globulin fractions were precipitated 
in each negative control tube by the addition of 0.2 ml of 60% saturated 
ammonium sulphate (as for the test samples). These negative controls 
enabled any non-specific binding and/or precipitation of protein-bound 
radioactivity to be accounted for, and indicated the radioactive counts 
which would be obtained if none of the antigen was bound specifically 
by antibody.
All the above controls were performed in duplicate as a 
precaution against experimental errors.
Calculation
The first step in the calculation of avidity was to 
determine the concentrations of bound, [b] , and free, [c] , antigen 
from the radioactive counts measured for each test.
Let P = mean radioactivity for the two positive control tubes at
a given antigen concentration, i.e. cpm equivalent to 100%
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binding of added antigen by antibody.
N « mean radioactivity for the two negative control tubes at
a given antigen concentration, i.e. cpm equivalent to none
of the added antigen being bound specifically by antibody.
T = radioactivity in the final precipitate of each test sample.
[Ag^ ] = total concentration of antigen in each 0.1 ml antigen-
antiserum reaction mixture.
[b] = bound antigen concentration.
[c] = free antigen concentration.
Therefore, the radioactivity corresponding to specific binding of 
antigen by antibody in a test sample (i.e. corrected for non-specific 
binding, precipitation of denatured antigen etc.) is equal to T - N; 
the radioactivity equivalent to 100% binding of antigen by antibody 
(represented by the positive controls) is equal to P - N. Thus the 
proportion of antigen added to each tube which is bound by antibody is:- 
T - N
p"_ . Therefore, at a given concentration of antigen, [Ag^ ] , the
actual concentration of antigen added to each tube which is bound by 
antibody is given by [b] = ( ^ ) x [Ag^ ] . Similarly, the
concentration of free antigen in each tube after equilibration can be 
calculated; [c] = ( ^ x [Ag^ ] ) - [b].
The second step in the calculation of avidity was to make use 
of the values of [b] and [c] (six sets for each antiserum tested) in 
order to calculate [Ab^] and Kp.
1 1 • 1 1 .
From the equation • r“"i + rTT"-, it can be seen that[b] [Ab.j.]K [o] [Ab^ ]
[Ab ] may be determined by plotting l/[b]against l/[c] and measuring
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the intercept, 1/jAh^] on the iy[h]axis. The value of Kp was then 
determined using the relationship Kp = l/[c] when half of the total 
antibody combining sites are occupied by antigen; i.e. by noting 
from the graph the value of l/[c] at the point where [b] = [Ab^]/2.
Having once determined [Ab^], the next logical step would 
be to draw a smooth curve through the points on the 1/ [b] against 
l/[c] graph and find the point on the curve at which l/[b] = 2/[Ab^]. 
The abscissa l/[c] of this point is equal to Kp. However, a study 
of all of the graphs drawn for determining avidities revealed no 
systematic tendency for them to be concave down (as would be the 
case when applying the Sips equation to data obtained from the binding 
of antigen to a heterogeneous population of antibodies). If anything 
the reverse was true, they sometimes appeared to be linear or were 
very frequently concave upwards, and this latter situation particularly 
can be attributed only to experimental errors. It was therefore 
thought best to treat all the graphs as linear, and this meant that 
Kp could be calculated from the intercept 1/[Ab^] and the gradient,
i.e. Kp = intercept / 'gradient.
On the first occasion when avidities were determined, 
experimental data was processed in two ways ;
(l) Using the Hewlett-Packard 9100B programmable calculator; this 
was programmed to determine the equation of the straight line of best 
fit for each set of data points. The best fit was determined by 
minimising the sum of the squares of the deviations of the data points
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FIG. 10. Graphical print out from program BMD^SR showing the 
1 1K[c] ’ optimised by the method of least
squares to fit 12 experimental values of
equation
and p-=i
[c]
from this
graph the values for jAb  ^and K for a single serum were obtained.
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from the line, the deviations being measured in the 1/[b] direction, 
From the best fitting straight line the values of the gradient, m, 
and of the intercept on the 1/[b] axis, l/[AbJ , were calculated.
n
Z (X. - X)(y. - Ÿ)
. . .  i=lI.e. gradient, m =
^ , - 2
Z (X. “ X)"'
i=l ^
The intercept on the 1/[b] axis = 1/ [Ab_^ ] = Y - mX.
The correlation coefficient, r, was also calculated - and this 
reflected how good the straight line "fit" was ( O ^ r ^ l ) .
(2) Using the IBM 350/155 Computer (Edinburgh Regional Computing 
Centre). The treatment of results was essentially the same, but the 
best straight line fit was obtained using a programme for polynomial 
regression (program BMD05R, cited by Dixon, 1971). This method, 
although the final results were virtually identical to those determined 
using the programmable calculator, had the advantage that a graph 
print-out showing both observed and predicted values for all the data 
points was obtained for each antiserum tested; a typical example is 
shown in Figure 10.
Once it had been shown that accurate results (compared with 
those calculated on the computer) could be obtained using the 
programmable calculator, subsequent determinations of avidity values 
were carried out solely on the Hewlett-Packard calculator.
16. DETERMINATION OF THE AFFINITY OF CHICKEN ANTI-DNP ANTIBODIES 
USING EQUILIBRIUM DIALYSIS
Equilibrium dialysis was used to measure the affinity of
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chicken anti-DNP antibodies for the dialysable ligand DNP-&- 
aminocaproic acid; the technique employed was adapted from the 
methods of Kabat and Mayer C1961), Eisen (1964c) and Pinckard and 
Weir (19T3).
Theory
The technique of equilibrium dialysis makes use of the 
facility with which low molecular weight hapten molecules are able to 
pass freely from one side of a dialysis membrane to the other side, 
whilst larger molecules (MW > 1000 daltons, e.g. antibody molecules) 
cannot do so and are therefore confined to one side of the dialysis 
membrane. The principle of the method is illustrated in Figures 11 
and 12.
The dialysis system is set up in such a way that solutions 
of the antibody (either whole antiserum, a crude globulin fraction or 
else a purified antibody preparation) and the hapten are effectively 
in two different compartments separated by à dialysis membrane 
(Figure 11). Usually the antibody is sealed inside a small dialysis 
sac which in turn is placed inside a sealed bottle containing a large 
volume of hapten solution. The hapten is then able to pass freely 
across the dialysis membrane and at equilibrium the concentration of 
free hapten on either side of the membrane (e.g. inside and outside 
the dialysis sac) will be the same; in addition, some hapten molecules 
which have crossed the dialysis membrane will be bound specifically by 
antibody (Figure 11(2) and Figure 12(2)) and will therefore play no 
part in establishing the equilibrium of free hapten across the membrane.
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(1). Antibody is  contained within a 
sealed dialysis compartment which 
in turn is immersed in a large 
volume of hapten solution at a given 
concentration.
O Free hapten molecule
* Hapten molecule bound to antibody 
Y  Antibody molecule
 Dialysis membrane
♦ EQUILIBRATION
(2). After equilibration, free  
hapten is present in equal concen­
trations on both sides of the 
dialysis membrane; in addition, 
some hapten is  specifically bound 
to antibody inside the dialysis 
compartment over and above the 
equilibrium concentration of free 
hapten and this is  directly related 
to the affinity of the antibody for 
the hapten.
FIG. 11. Representation of equilibrium dialysis in 
diagrammatic form.
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(1). Attainment of equilibrium in a system containing no antibody
( e .g . negative control with non-immune serum ), represented 
by the respective total concentrations of hapten outside ( large
volume, ---------) and inside ( small v o lu m e , ) the dialysis
compartment.
Is
os
os
Hours
(2). Attainment of equilibrium in a system containing antibody 
represented by the respective total concentrations of hapten
outside ( large volume, --------) and inside ( small volume,
 ) the dialysis compartment. / \ = the concentration of
hapten specifically bound to antibody.
FIG, 12. Graphical representation of equilibrium dialysis.
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The interaction of one antibody combining site (represented 
as Ab) with one hapten molecule (represented as H) may be described 
in the form of a stoichiometric equation:
Ab + H f:- -=ÿ AbH.
By determining the total and free hapten concentrations in 
the reaction mixture (the latter being inferred from the hapten 
concentration outside the dialysis sac) the concentration of bound 
hapten can be found by subtraction. Thus there is only one other 
quantity, namely the free antibody concentration, which has to be 
measured in order to find K, the association constant for the reaction 
described previously. When the reaction mixture has reached 
equilibrium
y _ [AT3H1 
- [Ab] [H]
where [Ab] = concentration of free antibody combining sites.
[H] = concentration of free hapten.
[AbH] = concentration of bound hapten.
= concentration of hapten-occupied combining sites.
If we introduce the symbol [Ab^jto represent the total concentration
of antibody combining sites, i.e. [Ab] + [AbH], then we can rewrite
the formula for K in the form of the Langmuir adsorption isotherm:
1 _ 1 1 1
T
[AbH] K[Ab^] • [H] [Ab^ ] •
Thus a plot of 1/[AbH] against 1/[H] should give a straight line with 
gradient l/K[Ab^]and intercept l7[Ab^]on the 1/[AbH] axis. The values 
of K and [Ab^jcan therefore be found from the gradient and intercept.
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Nisonoff and Pressman (1958) have found that in practice 
such a graph is seldom linear, probably owing to heterogeneity of 
the antibody population, and have therefore proposed that Sips's 
isotherm (Sips, 1948) be used instead. Sips's equation (Equation 
10; Sips, 1948), when written in a form analogous to the Langmuir 
isotherm above, is
1 _ 1 1 . 1 
[AM] ■ [Ab^]K^^ • [H]% [Ab^ ]
Thus if 1/[AbH]is plotted against 1/[h ]^, using a constant amount 
of antiserum and various amounts of hapten, this should give a 
straight line with gradient 1/[Ab^ ] and intercept l/[Ab^]. The 
value of a must be found by trial and error, choosing that value 
which gives the straightest line possible, and [Ab_^ ] may then
be calculated from the gradient and intercept.
An alternative method, which was used in this thesis for 
deriving and a from experimental data, is shown below. It does 
not involve determination of a by trial and error, and it has the 
advantage that a very wide range of hapten concentrations can be 
used for the one experiment without causing clustering of points at 
one end of the graph. Sips's equation may be rearranged thus:
[Ab^ ] + (K^ [II]) j. [AbH].
If this equation is now applied to two (hypothetical) extremes of 
hapten concentration .... namely [h ] is either very high or else very 
low, then.
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(1) At very high values of [H] : (K^[H] ) ^ 1, therefore
[A\] = [AbH].
(2) At very low values of [h ] : (K [H] ) ^ ^  1, therefore
[Ab^] 2  (K^[H])'f [AbH] , or [AbH] = [AbJ . [H]%
Taking log of each side gives,
log [AbH] = log C[Ab^]K^®') + a log [h ] .
Using the notation [AbH] " [b] = bound hapten concentration and
[h ] = [c] = free hapten concentration, the previous equation becomes
log [b] = log (,[Ab^]K^^) + a log [c] ,
These equations predict (l) that a graph of log [b] against log [c] 
will plateau at large values of [c] , the height of the plateau 
giving [Ab^ ] .
(2) the same graph at low values of [c] will 
be a straight line with gradient a and intercept equal to log([Ab^] ,
from which may be found.
Experimental procedure
Equilibrium dialysis of chicken anti-DNP antisera was 
carried out at seven different concentrations of the hapten DNP-e- 
aminocaproic acid, each hapten solution contaifiing a proportion of 
tritium-labelled hapten, [ ^ h]-DNP-EAGA. The first six concentrations 
of hapten solution were made up to a volume of 200 ml with PBS such
that there was a range of hapten solutions varying in concentration
”3 . . -8from 10 M by 10-fold dilutions to 10 M, and to each hapten
solution 0.5 ml of [ h^]-DNP-EACA (at a concentration of 1 nmol ml
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was added; the seventh and lowest concentration of hapten was made 
up by adding 0.5 ml of [^h]-DNP-EACA to 200 ml of PBS. The 
constitution and final molar concentrations of the hapten solutions 
for dialysis are tabulated below:
Concentration of 
200 ml un-labelled 
hapten solutions
Volume of tritiated 
hapten added 
(l nmol ml“^)
Final concentration 
of hapten solutions 
for dialysis
(correct to 3 significant 
figures)
10~3 M 0.5 ml 10"3 M
-k 
10 ^ M 0.5 ml lO”^ M
10“  ^M 0.5 ml 10"5 M
-6 10 M 0.5 ml
-6 10 M
lO"^ M 0.5 ml 1.02 X lO"? M
—0 
10 ° M 0.5 ml 1.25 X lO"® M
no hapten; 
200 ml PBS 0.5 ml 2.50 X 10"9 M
The hapten solutions were finally transferred to plastic bottles ready 
for dialysis. Antibody was included in the dialysis system either as 
undiluted antiserum or as an ammonium sulphate precipitated globulin 
fraction. In either case, the antibody was dialysed against PBS before 
use. A measured volume of antibody (a constant amount for each test) 
between 0.5 and 1 ml was placed in a rigid dialysis chamber; each 
dialysis chamber consisted of a 1 ml auto analyser cup (Sterilin Ltd., 
Richmond, Surrey, England) with a dialysis membrane (made from Visking 
dialysis tubing, flat width 10 mm and thickness 0,32 mm, obtained from
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A. Gallenkamp and Co. Ltd., Stockton-on-Tees, England) over the top 
secured by a polythene ring sealing the membrane over the cup.
Samples of each antiserum, together with separate controls 
for normal serum and PBS, were then dialysed against each of the 
different hapten concentrations. Polythene bottles (300 ml capacity, 
wide mouth with polypropylene screw caps; obtained from Macfarlane 
Robson Ltd., Glasgow, Scotland) containing the dialysis chambers 
immersed in hapten solution were rotated end over end and the 
solutions were allowed to eequilibrate in this way for at least 48 
hours at »
The dialysis chambers were then removed from the polythene 
bottles and a 0.2 ml sample of dialysate was extracted from each 
chamber; this aliquot was made up to 0.5 ml with PBS and then mixed 
with 5 ml of scintillation fluid in a screw-capped scintillation 
vial. The scintillation fluid used was prepared by dissolving 5 g 
of 2,5-diphenyloxazole and 0,3 g of l,4-di-2(5"phenyloxazolyl)benzene 
(PPO and POPOP respectively, both obtained from Nuclear Enterprises, 
Sighthill, Edinburgh, Scotland) in 1000 ml toluene at 50° and adding 
500 ml of Triton X-lOO (British Drug Houses, Poole, England). The 
samples were counted for 10 minutes each in a Packard Model 3320 
Tri-Carb Scintillation Spectrometer. The radioactive counts for 
each sample were subsequently corrected for quenching by the channels 
ratio method.
Calculation
The first step in calculating the affinity constant for an
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antiserum was to determine the hound, [h], and free, [c] , hapten 
concentrations from the equilibrium dialysis data.
3Let T = H cpm for test serum after dialysis, corrected for
quenching and background.
N = H cpm for normal serum after dialysis, corrected for
quenching and background.
3P = H cpm for PBS control after dialysis, corrected for
quenching and background.
S = H cpm for a hapten solution before dialysis, corrected for
quenching and background.
[HJ = molar concentration of hapten before dialysis.
T — N
Then, the molar concentration of bound hapten, [b] = — g—  x [H^ ]
P
and the molar concentration of free hapten, [c] = —  x [HJ 
(Table 3 shows typical equilibrium dialysis data used for calculating 
[b] and [c] ).
The equation log[b] = log ([Ab^]K^^) + a log[c] predicts
a linear relationship between log[b] and log[c] at low hapten 
concentrations. At high concentrations of hapten (i.e. where hapten 
is saturating the combining sites on all antibody molecules), then the 
relationship log[b] = log[Ab^] is applicable. Thus, from the value 
of log [b] corresponding to the plateau of the graph it was possible 
to find [Ab^ ] ; likewise, from the straight line part of the graph, 
it was possible to calculate the index of heterogeneity, a (= gradient). 
The intercept on the log[b] axis, obtained by extrapolating the straight 
line portion of the graph, is equal to log ([Ab^jK^^). can be
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FIG. 13. Typical plot of data from equilibrium dialysis of anti- 
DNP antibodies from two individual birds, using the ligand 
DNP-EACA.
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calculated from this value, since [Ab^] and a have already been 
determined. In practice, since a programmable calculator was 
available, it was found more convenient to calculate the intercept 
from two points lying on the linear portion of the graph, rather 
than extrapolating graphically. A programme was written for a 
Hewlett-Packard 9100B calculator which would compute and a when 
supplied with the value of [Ab^ ] (obtained from the plateau level) and 
the co-ordinates (x^, y^) and (x^, y^) of two points lying on the 
linear part of the graph. The calculation was as follows;
■ a = gradient
= (yg - y^ )^ / (xg - .
log [Ab^]K^^ = intercept 
= y^ - ax^  , 
therefore K = ( 10^1
o ( )
Figure 13 shows two typical graphs of log [b] plotted 
against log [c] from which data for the foregoing calculations could be 
obtained. These graphs were constructed from information contained in 
Table 3.
IT. FLUORESCENT ANTIBODY TECHNIQUE M D  DETECTION OF ANTIBODY-SECRETING 
CELLS IN TISSUE SECTIONS
The fluorescent antibody technique was used for the detection 
and enumeration of specific anti-HSA-producing plasma cells in the 
spleens of immune birds. The techniques employed are described below.
104
Preparation of fluorescein-con.jugated antibodies
Antiserum from rabbits immunised with HSA was labelled with 
fluorescein isothiocyanate ÇFITC ; obtained from British Drug Houses 
Ltd., Poole, England) using the procedure described by White, French 
and Stark (19T0)» which was itself based on the method of Coons,
Creech, Jones and Berliner (1942); the technique may be summarised 
as follows.
The globulins from 10 ml of rabbit anti-HSA antiserum were
precipitated by the slow addition of saturated ammonium sulphate,
previously cooled to 4°, such that the final mixture was 40^ saturated
in ammonium sulphate. The mixture was stirred mechanically for 30
minutes at 4° and the precipitate was then sedimented by centrifugation;
following this the precipitate was dissolved in PBS to the same volume
as the original volume of serum, and was re-precipitated as before by
addition of saturated ammonium sulphate. This final precipitate was
sedimented, dialysed exhaustively against PBS, and adjusted to a
“1protein concentration of between 10 and 12 rag ml . A volume of 8.5 ml 
of the resulting globulin solution (containing approximately 100 mg 
protein in toto) was labelled with fluorescein by adding 1.5 ml of 
fluorescein isothiocyanate solution (at 1 mg ml ^ in 0.5 M sodium 
carbonate/bicarbonate buffer, pH 9*0). The conjugation was carried out 
for 12-18 hours at 4^ with mechanical stirring. Labelled protein was 
separated from un-attached fluorochrome by gel filtration on a 30 cm x 
1 cm column of Sephadex 025 equilibrated with PBS. Protein molecules 
carrying an excess of fluorescein (and therefore, by virtue of their 
high net negative charge, having a tendency to be absorbed non-specifically
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onto tissue sections) were selectively removed by running the 
conjugate through a 20 cm x 1 cm column of diethylaminoethyl-cellulose 
(DEAE-cellulose, in the form of DE22 obtained from Whatman Biochemicals 
Ltd.9 Maidstone, Kent, England) and eluting the utilisable fluorescent 
antibody with PBS - unsuitable material remaining on the ion-exchanger.
Preparation and immunofluorescent staining of chicken tissues
Chickens were killed by an overdose of intravenous sodium 
pentobarbitone (as described on page 78 ), The spleens of birds were 
excised and cut into two or three pieces which were lodged on the 
walls of glass test tubes; these tubes were sealed with a rubber bung 
and rapidly frozen by immersion in an acetone/solid 00^ freezing 
mixture at -70^* Sections 5 ym thick were cut in a cryostat at -20^, 
placed on glass microscope slides, melted and dried in a stream of 
warm air and fixed in absolute methanol at 20° - 24° for 15 minutes. 
After being rapidly dried in a current of warm air, the sections were 
stained in the following manner.
Detection of plasma cells containing anti-HSA
The presence of antibody was shown using the "sandwich" 
technique of Coons, Leduc and Connolly (1955)* A solution of HSA 
(2 mg ml ^ in saline) was applied to the spleen sections which were 
then left for 30 minutes. Following this, the sections were washed 
thoroughly in three changes of PBS and then stained with fluorescein- 
labelled rabbit anti-HSA (l drop) for a further 30 minutes. Stained 
sections were finally washed in three changes of PBS and mounted in 
ia glycerol in PBS under cover-slips which were sealed with nail
106
varnish. This technique will also stain any antigen present in the 
section as well as antibody; however, by comparison of two adjacent 
sections, one stained by the "sandwich" technique and the other 
stained by the direct method (i.e. omitting the "sandwich" layer of 
antigen and therefore staining directly and exclusively for HSA in 
the sections) antibody can be differentiated from antigen by its 
presence only in the section stained by the two layers of the "sandwich" 
technique.
Fluorescence microscopy
The tissue sections stained either directly or by the 
"sandwich" technique were examined microscopically using a Wild M 20 
monocular microscope (Wild, Heerbrugge, Germany), fitted with dry and 
oil-immersion objectives and a bi-reflecting dark-ground condenser.
The light source for fluorescence microscopy was an Osram HBO 200 
high-pressure mercury arc contained within a Wild Universal Microscope 
Lamphouse. The exciter filters were BG12 (transmits ultraviolet and 
blue light) and BG38 (heat filter) (Schott and Genossen, Mainz,
Germany); the barrier filter was a Schott OGl (absorbs ultraviolet and 
blue light ; transmits red, orange, yellow and green), A conventional 
tungsten lamp, for white light observations, was built into the base of 
the microscope and could be brought into use by swinging out a mirror 
transmitting the light from the mercury arc to the condenser. Using 
the fluorescence arrangement, plasma cells containing antibody to HSA 
appeared as oval cells with an unstained eccentric nucleus and 
brightly fluorescent cytoplasm.
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The calculation of the number of specific anti-HSA plasma
cells per unit area of spleen section was done by counting the total
number of specific plasma cells, t , in a given number of different
viewing fields, n, of the splenic red pulp. When using the
oil-immersion objective lens in combination with a X6 eyepiece, the
diameter, d, of the viewing field (as judged as accurately as possible
from the gradations on a haemocytometer) was 0.30 mm. Therefore,
2the area of each viewing field is n(d/2) and the total area of tissue
2
section examined is TrCd/2) x n; accordingly, the number of specific 
plasma cells in a unit area of spleen section is equal to
TT(d/2 )^  X n tt(0.15)^  X n ™
It was considered that the number of specific plasma cells 
per unit area of a tissue section of uniform thickness was a more 
accurate way of expressing the results rather than as the number of
specific plasma cells per unit volume; since each section may be
assumed to be approximately 5 pm thick, and if a chicken plasma cell 
has a diameter of at least 8 pm (Lucas and Jamroz, I961), then the 
tissue section will contain no complete plasma cells - only parts of 
plasma cells. When calculating the number of plasma cells per unit 
volume however, these sectioned plasma cells could not reasonably be 
regarded as complete plasma cells, as this might inflate the final cell 
count. The measurement of plasma cell population density as the 
number of plasma cells per unit area of tissue section was therefore 
preferred.
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18. IMMUNODIFFUSION
Immunodiffusion was used for the qualitative assessment 
of sheep, rabbit and chicken antisera to protein antigens; the 
technique used was one of double radial diffusion as described by 
Ouchterlony and Nilsson (1973)j and is summarised below.
A 1.5% solution of agar (Special Agar-Noble, Difco 
Laboratories, Detroit, Michigan, U.S.A.) in barbitone buffer (0.05 M, 
pH 8.5) was melted and spread in an even layer 1 mm thick over the 
bottom of a plastic Petri dish (85 mm diameter x 15 mm). After the 
agar had set, up to six circular wells (diameter 1.2 mm) spaced 
equally on an imaginary circle (diameter 10 mm) around a central well 
were cut in the agar. The reference antigen solution was placed in 
the central well and the test solutions were placed in the surrounding 
wells. The gel was then left at room temperature in a damp chamber 
for 2k - 48 hours to allow diffusion and lines of precipitate to 
develop; an example is shown in Figure l4a*
For testing chicken antisera the barbitone buffer used 
contained Q% NaCl. This complied with the findings of Hersh and 
Benedict (1966) that precipitation of chicken IgG antibody by antigen 
at high salt concentration yields move precipitable chicken protein, 
especially in the zone of antigen excess, than precipitation at low 
salt concentration.
19. IMMUNOELECTROPHORESIS
Immunoelectrophoresis was used for the qualitative assessment
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of rabbit and chicken antisera to protein antigens, and for 
immunoglobulin class characterisation of chicken antibodies. A 
microtechnique, as described by Ouchterlony and Nilsson (1973) was 
employed.
A 1.5% solution of melted agar in barbitone buffer (O.O5 M, 
pH 8.5) was spread in an even layer (approximately 1 mm thick) over 
a clean glass plate, either 10 x 10 cm or 10 x 20 cm. After the 
agar had set, circular wells, and troughs parallel to the flow of 
current were cut alternately in the agar at 5 mm intervals. The 
wells were filled with test solution (e.g. serum, serum fractions or 
purified proteins) and the agar gel was connected by means of paper 
wicks to the cathode and anode reservoirs (containing barbitone 
buffer, 0.05 M, pH 8.5) on respective sides of an electrophoresis tank,
A potential difference of 200 V was applied, causing a current of 
about 17.5 mA to flow. A marker solution containing normal serum 
and a small amount of bromophenol blue was electrophoresed at the same 
time as the test solutions; bromophenol blue adheres to the albumin 
in the serum and therefore moves as a discrete blue spot towards the 
anode. , The time allowed for electrophoresis (usually about 2 hours) 
was judged from the position of the bromophenol blue ^albumin spot, 
albumin being the fastest moving serum component. After electrophoresis 
the troughs were filled with the appropriate reagents (e.g. unispecific 
or multispecific antisera) and diffusion of these against the electro­
phoresed fractions of the test solutions was allowed to proceed for 
24 - 48 hours at room temperature, in a moisturised environment. The 
specificity of antisera or the purity of serum fractions could be
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well a: sheep anti-HSA. 
well b: HSA ( 0 .5  mg ml  ^ )
FIG. Double diffusion of sheep anti-HSA antiserum.
well a: chicken 7S immunoglobulin. 
well b: chicken serum.
trough 1: sheep anti-chicken immunoglobulin, 
trough 2: rabbit anti-chicken u. chain.
FIG. 14. Immunoelectrophoresis of chicken immunoglobulins
Ill
inferred by inspection of the precipitate arcs which developed in 
the agar (e.g. as shown in Figure l4b).
Staining: of immunodiffusion and immunoelectrophoresis agar gels
Unprecipitated, material was removed from the agar by washing 
the gels in saline for 24 hours. The gel was then immersed for 2 
minutes in 0.5% amido black (naphthalene black) (G.T. Gurr Ltd.,
London, England) in methanol/glacial acetic acid (9:1 v/v). The-gel 
was washed several times in methanol/glacial acetic acid solvent, and 
then in saline and water respectively. Once the gel had been dried 
it could be kept as a permanent record of the test.
20. TANNING AND COATING OF RED BLOOD CELLS ; HAEMAGGLUTIHATION TESTS
Haemagglutination was used to measure anti-erythrocyte (human) 
antibody titres in the serum of chickens. Sheep red blood cells which 
had been tanned and coated with antigen (HSA) were also prepared and 
used for immunising chickens. The methods,for tanning and coating of 
red blood cells and for the haemagglutination tests followed the 
procedures recommended by Herbert (1973).
(Fanning of red blood cells for use in haemagglutination tests
Fresh human erythrocytes were obtained by allowing heparinised 
Venous blood mixed with ^/^ of its volume of dextran (6% in saline) 
to stand for 30 minutes, and then aspirating the supernatant leucocyte- 
rich plasma from the sedimented red blood cells. The erythrocytes 
were washed three times in saline and were packed down each time by 
centrifugation at 750 x for 10 minutes. Packed cells (0.6 ml) were
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pipetted into 1 oz screw—capped glass bottles and suspended in 10 ml
of saline; the erythrocytes were then sedimented by centrifugation
at 750 X for 10 minutes. The cells in each bottle were resuspended
“1
in 9*5 ml saline and to this 0.5 ml tannic acid solution (l mg ml 
in saline) was then added; the suspensions were incubated for 15 
minutes at 37° iu a water bath with mechanical shaker. The 
erythrocytes were again spun down and then resuspended in 10 ml saline 
containing 1% heat-inactivated normal chicken serum from which any 
natural anti-erythrocyte antibodies had previously been absorbed with 
the red blood cells to be used in the test. The tanned red blood 
cells were washed three times in saline containing 1% heat-inactivated 
absorbed normal chicken serum. The contents of each bottle were 
finally resuspended to a final volume of 50 ml in saline containing 1% 
heat-inactivated normal chicken serum - giving therefore a 1% suspension 
of erythrocytes (i.e. approximately 10^ erythrocytes ml ^ for human red 
blood cells).
Coating of sheep red blood cells with HSA
Sheep erythrocytes were obtained by dextran sedimentation from 
whole blood exactly as described for human erythrocytes in the 
preceding section. After three washes in saline, 6 ml of packed cells 
were pipetted into large screw-capped glass bottles and suspended in 
100 ml saline; the erythrocytes were then sedimented by centrifugation 
at 750 X g, for 10 minutes. The cells were resuspended in 95 ml saline 
and to this was then added 5 ml tannic acid solution (l mg ml ^ in 
saline); the suspensions were incubated for 15 minutes at 37° in a 
water bath with mechanical shaker. The SRBC were then washed twice in
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saline and resuspended each time in 50 ml saline. To each bottle 
containing 50 ml suspended SRBC, 50 ml of antigen (200 mg HSA in 
50 ml saline) were added and the bottles were incubated for 30 
minutes at 37° in a water bath with mechanical shaker. The coated 
SRBC were then washed three times with saline and the packed cells
were finally resuspended in about two volumes of saline (lO - 12 ml)
10 ”1 to give as nearly as possible 10 HSA-coated SRBC ml
Haemagglutination test
Starting at a 1/10 dilution of antiserum in saline, doubling 
dilutions (using Takatsy microdiluting loops) were made, again with 
saline, into consecutive wells of plastic microtitre haemagglutination 
plates (Flow Laboratories, Irvine, Scotland); this gave a final 
range of antiserum dilutions from 1/10 to 1/5120, each in a total 
volume of 25 yl. To each well a 25 yl volume of a 1% suspension of 
tanned human red blood cells was added, and the plate was left 
undisturbed overnight at 4°. The plates were examined the next day 
for agglutination of the red blood cells; for each antiserum the 
antibody titre was measured as the reciprocal of the highest serum 
dilution which gave an unequivocally positive agglutination reaction.
A negative control was always included, consisting of one well 
containing 25 yl of the tanned human red blood cells mixed with an 
equal volume of saline.
EXPERIMENTAL RESULTS
Il4
Antibody characteristics have been studied and treated 
as being a useful reflection of the available receptors and of the 
responsiveness of the cells bearing them - and hence of the process 
of cell selection. This is especially true in the chicken, where 
the relatively short half lives of immunoglobulins mean that cellular 
events (e.g. cessation of antibody biosynthesis) are followed 
closely by, and readily inferred from, serum antibody levels.
Primarily there are the events of cell selection and activation, 
which dictate the diversity of antibody specificities and the course 
of biosynthesis; secondary to these are various accessory 
mechanisms which modulate the magnitude and duration of the response 
once its specificity or specificities have been established.
The experimental work in this thesis explored certain 
aspects of the events leading to the biosynthesis of antibody as 
well as a number of factors which can regulate and modify the antibody 
response. Accordingly, the results have been categorised as 
follows :
Evidence on the mechanism of cell selection
I. The kinetics of antibody production in chickens in response to
immunisation with proteins and with hapten-protein conjugates.
II. The affinity of anti-hapten and the avidity of anti-protein
chicken antibodies.
Evidence for accessory control mechanisms
I. The effects of adjuvants upon antibody biosynthesis in
chickens.
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II. Antibody-mediated immunosuppression as an experimental 
model of negative feedback homeostasis in chickens.
Il6
EVIDENCE ON THE MECHANISM OF CELL SELECTION
I, The Kinetics of Antibody Production in Chickens in Response 
to Immunisation with Proteins and with Hapten-Protein 
Conjugates
Experiment 1. The Kinetics of Antibody Biosynthesis in Chickens 
in Response to Immunisation with a Single Intravenous 
Injection of HSA
This first experiment was carried out to investigate 
the kinetics of the anti-HSA antibody response in chickens following 
immunisation with a single intravenous injection of HSA.
If the characteristics of antibody biosynthesis are to 
be used as a marker of the selective pressures imposed upon receptor 
molecules, then obviously an overall impression of the kinetics of 
biosynthesis is necessary. The first few days of antibody
production are particularly interesting in this context, since they 
reflect the processes of cell recruitment, proliferation and 
differentiation - presumably relatively free of the complications of 
negative feedback mechanisms which might be expected to come into 
action at a later stage. An attempt was therefore made to determine 
and confirm the kinetics of anti-HSA biosynthesis in the chicken and 
to justify the pattern of kinetics in terms of receptor selection, 
followed by cellular activation and clonal expansion.
Experimental procedure A group of 12 chickens (lO weeks of age) 
were each immunised by a single intravenous injection of 250 yg HSA
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in 0.5 lül saline. The birds were bled (approximately 2 ml each)
3, 7, 12 and 21 days following primary immunisation. The serum 
from each blood sample was assayed for its antigen-binding capacity 
(ABG^q) by the Farr test using radio-iodinated HSA.
Results As can be seen from Table 4 and Figure 15, anti-HSA
was virtually undetectable in the serum 3 days after immunisation 
but thereafter there was a rapid rise in the antigen-binding 
capacity of the serum from each bird, reaching a maximum at about 
7 days after immunisation. Antibody levels fell sharply after this 
time with the result that 3 weeks after immunisation there was little 
or no anti-HSA antibody detected in the serum.
It might be assumed that the rate of reaction between 
antigen and an antibody-like receptor molecule on lymphoid precursor 
cells is similar to the rate observed for interaction between antigen 
and antibody molecules in vitro ; i.e. once the antigen has gained 
access to the antibody-forming precursor cells the association 
between antigen and receptor, whereby selection is accomplished, 
takes place relatively rapidly. On this presumption the rate-limiting 
step in antibody biosynthesis is therefore the subsequent events of 
cellular proliferation and differentiation. The chickens' response 
to a soluble protein antigen was compatible with a rapid recruitment 
of antibody-forming cells which did not however manifest itself, 
owing to the inertia of cellular development and clonal expansion, 
until 4 or 5 days after immunisation.
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TABLE 4. Serum anti-HSA antibody levels (ABC^^ in 
—1pg HSA ml ) in chickens following immunisation 
with 250 yg HSA iv.
BIRD
NUMBER
DAYS AFTER IMMUNISATION
3 7 12 21
399 0.61 7.31 2.53 1.40
401 0.46 11.11 3.88 1.50
425 1.00 9.54 2.58 1.80
431 0.89 11.43 3.71 2.24
407 1.23 9.21 3.70 3.68
402 0.83 8.49 2.98 1.66
4ll 0.97 12.20 6.38 2.36
4l6 0.68 8.83 3.18 2.89
4l8 1.13 3.86 2.04 1.28
419 1.47 7.45 3.60 1.61
421 0.89 8.10 4.72 2.88
429 0.63 10.43 3.38 1.96
MEAN (±SE) 0.92±0.08 9.00+0.65 3.5610.33 2.11+0.22
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-1ABCgQ (^g HSA ml )
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6 - -
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2
1 - -
0 -1----------- 1— :-------- 1—
10 15 20
Days after immunisation
25
FIG. 15. Mean values (± SE ) for serum anti-HSA antibody 
levels in chickens following immunisation with 250 jig HSA iv,
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Experiment 2. The Population Density in the Chicken Spleen
of Plasma Cells Secreting Specific Antibody Studied at 
Various Times after Immunisation with HSA
The results from the previous experiment suggested that 
following the administration of antigen to chickens there was a 
prompt selection and stimulation of precursor lymphoid cells with 
the subsequent production of specific antibody. The following 
experiment involved a closer examination of the cellular processes 
preceding the release of antibody molecules into the circulation, 
by studying the rise and fall of the plasma cell population, 
secreting anti-HSA, in the chicken spleen after primary immunisation.
Experimental procedure A group of 10 chickens (8 weeks of age)
were each immunised by a single intravenous injection of 10 mg HSA 
in 1 ml saline. Individual birds were killed at intervals of 1 to 
8 days following immunisation; their spleens were removed and frozen 
sections were prepared and then stained by the indirect "sandwich" 
fluorescent antibody technique to demonstrate cell-associated anti-HSA. 
The red pulp of each spleen section was scanned methodically under 
the microscope using ultra-violet illumination, and the number of 
positively stained (HSA-producing) plasma cells within a given number 
of microscope viewing fields (50 or 100) was counted.
Results The results were expressed as the number of positively
stained plasma cells per square millimetre of spleen section; these 
values are given in Table 5 and the mean value for each bird is 
represented graphically in Figure I6. The method for calculating the
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Average number ( ±SE ) of anti—HSA
2
plasma cells per mm of spleen section,
50 - -
40 - -
30 —
10
65 71 42 83
Days after immunisation
FIG. 16. Population density of plasma ce lls , expressed as
the number of specific anti-HSA plasma cells observed by
2
immunofluorescence per mm of spleen section ( approximate 
thickness 5 jim ), in the spleens of chickens at various times 
after immunisation with 10 mg HSA iv.
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population density of plasma cells was described on page 107»
Plasma cells secreting anti-HSA in response to 
immunisation with HSA were first detected in the red pulp of the 
chicken spleen as early as 3 days after immunisation (Table 
Figure l6). Maximum numbers of plasma cells were found h and 5 
days after immunisation (when the serum antibody levels were only 
just beginning to rise), and after 7 days (i.e. at the approximate 
peak of antibody levels in the circulation) the number of plasma 
cells had declined markedly.
The results from this experiment showed that there 
was a very rapid appearance and subsequent increase in the number 
of specific plasma cells which preceded a parallel sequence of 
events in serum antibody levels by approximately 2 days.
Experiment 3. The Kinetics of Antibody Biosynthesis in Chickens 
in Response to Immunisation with the DHP Hapten
The kinetics of antibody biosynthesis and the cellular 
events following immunisation with HSA have been established in the 
previous experiments, and the results were in agreement with the 
observations of other workers (e.g. White, French and Stark, 1970) 
who have also studied the antibody response to HSA in chickens. As 
the next step towards a satisfactory investigation of the affinity 
of anti-hapten antibodies, the kinetics of the anti-DNP response in 
chickens were examined. This was a preliminary study to assess the 
suitability of chickens as producers of anti-hapten antibody of high 
affinity; also to assess the importance of the physico-chemical
I2h
nature of the immunogen [e.g. the type of carrier, the epitope 
density) as well as the effect of carrier pre-immunisation and the 
importance of the age of the birds used for immunisation.
(a) The Effect of the Type of Carrier upon the Anti-Hapten 
Antibody Response in Chickens
It is well known that the carrier to which haptens are 
attached has a considerable influence upon the eventual antibody 
response to that hapten. In this experiment, the efficiency of 
different carriers, both particles and soluble proteins, for 
promoting biosynthesis of antibodies against the DNP group in 
chickens, was examined.
Experimental procedure Three groups of chickens (6 weeks of
age) were each immunised as follows.
Group 1 : DNP-cellulose ; a suspension of 10 mg ml , 0.5 ml iv.
• ™3-Group 2 : DNP-haemocyanin; 2 mg ml , 0.-5 ml iv.
Group 3 : DNP-HuRBC’s; 2 x 10^ cells ml 0.5 nil iv.
The methods of preparing the antigens used for immunising birds in 
Groups 1, 2 and 3 were described on pages 62, 55 and 6l respectively. 
For all three antigens used in this experiment it was not possible 
to determine the degree of hapten substitution. After immunisation, 
blood samples were collected at regular intervals and the serum from 
each was assayed for its hapten-binding capacity by the Farr test 
using radio-iodinated DNP-CSA.
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Results The results were expressed as the hapten-hinding
capacity for each serum sample and are given in Table 6. In 
addition, the anti-HuRBC agglutination titre of antiserum obtained 
from each bird 7 days after immunisation is included.
An anti-hapten antibody response, as measured by a 
modified Farr test using radio-labelled DNP-CSA (see page 80), 
was not detected when using chromatographic cellulose as a carrier 
for the DNP group; this was inferred from the failure of serum 
samples taken 7 days after immunisation to bind significantly more 
hapten than serum taken after only 3 days. By the same criterion, 
the DNP hapten conjugated either to human erythrocytes or to snail 
haemocyanin did elicit an antibody response, albeit slight, by at 
least 7 days after primary immunisation (Table 6). Thus, although 
the human erythrocytes and snail haemocyanin were shown in a 
limited manner to be better carriers than cellulose, the amount of 
anti-DNP antibody detected was small. This could be attributed to 
an unsuitable method of immunisation or to an inherent inability of 
the birds to respond to the hapten-carrier combinations used. No 
attempt was made to measure antibodies to either of the carrier 
molecules used for immunising birds in Groups 1 and 2, but the serum 
from each bird was tested 7 days after immunisation for antibodies to 
human erythrocytes using the haemagglutination test described on 
page 113; this showed that birds in Group 3 (immunised with DNP-HuRBC) 
had all formed antibodies to the carrier erythrocytes, whereas the 
birds in Groups 1 and 2 (with one apparent exception) had no 
antibodies to human erythrocytes in their serum. It is worth noting
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that diiring the course of the experiment many of the birds were 
suffering from coccidiosis, which was apparent from post-mortem 
findings; i.e. dead birds had the characteristic haemorrhagic 
caeca, and smears of caecal contents, stained with Giemsa, 
contained numerous merozoites. There is therefore the possibility 
of antigenic competition acting to lessen the anti-DKP response 
under these circumstances,
Cb) The Effect of Epitope Density upon the Antibody Response in 
Chickens to a Hapten-Protein Con.jugate
The epitope density has been shown to influence the 
heterogeneity of specificity and the amount of antibody produced in 
a mammalian species (barraide and Janof, 1972), as well as the 
induction of tolerance (Feldmann, 1972b), In the present experiment 
therefore, the effect of the degree of hapten substitution upon 
anti-hapten antibody production in chickens was examined, to try and 
find the optimum hapten density for eliciting biosynthesis of 
detectable amounts of anti-DNP antibodies.
Experimental procedure Four groups of chickens (6 weeks of age)
were each immunised as follows.
Group 1 ; 8 mg DNP^^-HSA in 1 ml FCA im.
Group 2 : 10 mg DNP^-HSA in 1 ml FCA im.
Group 3 : 100 pg DNP^^~HSA in 1 ml FCA im.
Group  ^ : 100 pg DNP^-HSA in 1 ml FCA im.
Epitope densities [DNP;protein molar ratios) were measured spectro- 
photometrically as described on page ^6. Blood was taken at
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TABLE 7* The effect of epitope density upon the antibody response 
of chickens to the carrier (HSA) following immunisation 
with a hapten-protein conjugate (DNP-HSA). The antibody
response to the carrier moiety is expressed as the 
antigen-binding capacity (ABC^q in pg HSA ml ^) for each 
serum sample.
BIRD
NUMBER
IMMUNISATION ABC^q (pg HSA ml"^) 
AT 7 days
MEAN 
(± SE)
909 GROUP 1 : 1.3
910 8 mg 0.8
911 DNP^^-HSA 4.2 1.9
912 in FCA im 1.2 (± 0.6)
913 3.4
91H 0.8
134 GROUP 2 : ■ 8.1
135 10 mg 9.9
136 DNPg-HSA 16.0 9.6
137 in FCA im 11.7 (± 1.6)
138 4,1
139 7.8
903 GROUP 3 : 0.3
904 100 pg 0.3
905 DNPj^g-HSA 0.1 0.4
906 in FCA im 0.1 (± 0.2)
907 0.3
908 1.2
150 GROUP 4 : 3.6
151 100 pg 0.4
152 DNPg-HSA 5.7 4.9
153 in FCA im 0.2 (± 1.8)
154 8.1
156 11.6
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-1ABC^q (^g HSA ml )
12
10
8
2
0
Large dose (8 or 10 mg) 
conjugated protein.
Small dose ( 100 ^ g  ) 
conjugated protein.
DNPg-HSA D N P ^ g - H S A  
Hapten : Protein molar ratio
FIG, 17, The effect of epitope density upon the antibody 
response of chickens to the carrier ( HSA ) following 
immunisation with a DNP-HSA conjugate. The antibody 
response to the carrier moiety is expressed as the mean
ABC ( t  SE ) for each group of birds.
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intervals after immunisation and each serum sample was assayed 
both for hapten-hinding capacity and for carrier (HSA)-hinding 
capacity hy separate Farr tests.
Results No apparent antibody to the hapten was detected in any
of the experimental groups, so that no conclusions concerning the 
effect of epitope density upon the antibody response to the hapten 
moiety could be reached. Again, this could be attributed to 
deficiencies in the assay system or to a genuine failure of the 
birds to respond to the type and amount of immunogen used.
Antibodies to the carrier (HSA) were detected however 
(Table 7) and at a given dose of antigen the antibody response to 
the carrier (i.e. the anti-HSA response) was inversely related to 
the epitope density (Figure IT)* The simplest explanation for this 
is that at high epitope density the hapten groups were so numerous 
that they interfered sterically with the native determinants of the 
HSA molecule and prevented recognition of these; thus the densely 
substituted molecule provoked only a small anti-HSA antibody response.
(c) The Effect of Carrier Pre-Immunisation upon the Subsequent 
Production of Antibody in Chickens to a Hapten-Protein Conjugate
It has been shown in both mammals and birds that pre­
immunisation with carrier protein alone has an enhancing effect upon 
the subsequent anti-hapten response when that animal is later 
challenged with hapten coupled to the same protein (e.g. Sarvas ét al,, 
197^)* In this experiment, the potential of carrier (HSA) pre­
immunisation to enhance the subsequent production of anti-DNP anti­
bodies by chickens was studied.
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Experimental procedure Four groups of chickens (8 weeks of
age) were each immunised hy intravenous injection of antigens 
according to the following schedule.
Group 1 : Carrier pre-immunisation with 500 yg HSA iv, T days
before immunisation with 10 mg DNP -HSA iv. (on day O).
1 1
Group 2 : Immunisation with 10 mg DNP^^-HSA iv.
Group 3 : Carrier pre-immunisation with 500 yg HSA iv, 7 days
before immunisation with 100 yg DNP^^-HSA iv. (on day 0).
Group k ; Immunisation with 100 yg DNP^^-HSA iv.
The birds were bled 7 days after pre-immunisation (just before 
immunisation with DNP-HSA) and at invervals thereafter. Each 
serum sample was assayed both for hapten-binding capacity and for 
carrier (HSA)-binding capacity by separate Farr tests using radio- 
iodinated DNP-CSA and HSA respectively.
Results The results were expressed as the respective binding
capacities for DNP and HSA and are given in Table 8. There was 
no evidence that pre-immunisation of birds with a small (500 yg) 
priming dose of the carrier protein caused an enhanced anti-hapten 
response when these birds were immunised 7 days later with DNP-HSA. 
Here again, only a very slight response to the DNP hapten was 
detected 7 days after immunisation with conjugate and the magnitude 
of the response was similar both in birds which were pre-immunised 
and in those which were not - indicating that pre-immunisâtion with 
500 yg of the carrier had no discernible effect upon the subsequent 
response to a hapten when conjugated to the same protein and 
administered 7 days later.
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TABLE 8. The effect of carrier pre-immunisation upon the
biosynthesis of anti-hapten antibodies in chickens.
Results are expressed as (a) anti-HSA antibody levels
in terms of the antigen-binding capacity (ABC^q in
yg HSA ml and (b) anti-DNP antibody levels in terms
of the hapten-binding capacity (HBC in ng DNP- 
-1
lysine ml ).
BIRD
NUMBER
IMMUNISATION ANTI-HSA LEVELS (ABC , 
yg HSA ml AT VARIOUS 
TIMES RELATIVE TO IMMUN­
ISATION WITH DNP-HSA.
-30 MINS + h DAYS + 7 DAYS
ANTI-DNP LEVELS 
(HBC3Q, ng DNP- 
lysine ml"I) 7 
DAYS AFTER IMMUN­
ISATION WITH DNP-HSi
976 Carrier pre­ 23.3 18.6 24.5 710
977 immunised ; 38.1 15.8 30.2 190
978 10 mg DNP-HSA 33.3 10.1 14.3 520
979 iv. 7 days later 28.8 14.7 24.4 710
984 10 mg DNP-HSA - 2.0 27.0 340
966 iv. - 0.8 38.8 790
980 Carrier pre­ 12.7 9.3 13.5 60
981 immunised; 20.6 l4.6 6.4
982 100 yg DNP-HSA 22.2 20.2 * i6.6 30
983 iv. 7 days later 22.0 20,8 10.3
985 100 yg DNP-HSA - 3.2 19.4 30
987 iv. — 0.7 11.9 50
- not detectable
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(d) The Effect of Ap.e and Development of Chickens upon their 
Ability to Synthesise Anti-Hapten Antibodies
It has been suggested that certain of the immunological 
faculties of the chicken are not fully developed until about 5 or 6 
weeks of age (Wolfe and Dilks, 1948). So far, experiments have been 
conducted to discover the most satisfactory conditions for 
elicitation of a good anti-hapten antibody response in chickens; 
namely by studying the advantages of different carriers and epitope 
densities and of carrier pre-immunisation. Finally therefore, the 
effect of age (and by inference, the effect of immunological 
maturity) upon the capability of chickens to biosynthesise anti­
hapten antibodies was examined.
Experimental procedure A group of 6 adult hens (15 weeks of age)
were each immunised by a single intravenous injection of 5 mg 
DWP^j^-HSA in 1 ml saline; an additional bird (no. 89I) was immunised 
by a single intravenous injection of 5 mg unsubstituted HSA. For 
comparative purposes, the antibody responses observed in this group 
of adult birds were compared with the antibody responses of the 
young 8-week old birds immunised with 10 mg DHP^^-HSA in 1 ml saline 
iv, which were used in the previous experiment and were of the same 
breed as the 6 adult birds used here. All the adult birds were bled 
at intervals up to 3 weeks following immunisation and the serum 
antibody levels of anti-DNP and anti-HSA antibodies were determined 
by separate Farr tests.
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TABLE 9. The anti-HSA and anti-DNP antibody responses in 15"^eek 
old birds following immunisation with 5 mg DNP^^^-HSA. 
Results are expressed as (a) anti-HSA antibody levels in 
terms of the antigen-binding capacity (ABC^^ in yg HSA 
ml and (b) anti-DNP antibody levels in terms of the 
hapten-binding capacity (HBC^q in ng DNP-lysine ml ).
BIRD
NUMBER
3 5
DAYS AFTER IMMUNISATION 
7 9 12 14 21
IMKlUJij*"
ISATION SERUM ANTI-HSA ANTIBODY LEVELS (ABC30» Vg HSA ral”^)
882 5 mg DNP-HSA iv. <0.1 24.4 18.4 7.8 2.0 0.7 0.3
883 ti II <0.1 21.1 10.3 5.9 1,2 0.4 0.2
884 II II <0.1 53.1 53.9 24.4 8.9 3.9 1.9
885 II II <0.1 27.2 13.3 6.4 2.9 1.4 0.5
886 It It <0.1 63.3 66.6 39.0 17.1 8.1 1.8
887 II II <0.1 27.7 18.8 6.3 1.7 0.5 0.1
891 5 mg HSA iv. nd 7.5 58.8 53.6 nd nd 5.8
DAYS AFTER IMMUNISATION
BIRD
NUMBER
IMMUN­ 3 5 7 9 12 14 21
ISATION SERUM ANTI-DNP ANTIBODY LEVELS (HBC. ng DNP-lys ml ^
882 5 mg DNP-HSA iv. 42.6 957.2 1313.6 436.7 430.2 468.2 139.0
883 II II 48.7 493.1 810.0 331.6 158.6 317.8 163.2
884 II II 33.9 866.8 1512.5 1426.6 1091.9 492.2 215.4
885 II II 45.4 631.2 595.3 471.1 398.3 255.5 100.8
886 II It 53.8 581.0 782.8 1110.1 574.6 375.2 157.1
887 II II 33.7 666.3 441.1 1013.5 657.9 315.8 93.8
891 5 mg HSA iv. nd 28.3 26.6 17.3 nd nd
nd
not detectable 
not determined
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-1ABC^q (^g HSA ml )
70 T
60 --
50 --
40 --
20 - ■
6 10 12842
Days after immunisation.
FIG. 18. The anti-HSA antibody response in a group of six  
15-week old birds following immunisation with 5 mg DNP^^-HSA.
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HBC^q ( ng DNP-lysine ml  ^ )
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1400
1200
1000
600
400
200
4 6 8 102 12
Days after immunisation.
FIG, 19. The anti-DNP antibody response in a group of six
15-week old birds following immunisation with 5 mg DNP^^-HSA.
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Results The results were expressed as the binding capacities
of each serum sample for HSA and DNP; these values are given 
in Table 9 and the anti-HSA and anti-DNP responses are shown 
respectively in Figures 18 and 19. Just as with the young 8-week 
old birds used in the previous experiment (3c) (Table 8), adult 
birds readily produced antibodies specific for the HSA carrier.
However, the older birds were much more capable of synthesising 
detectable amounts of anti-DNP antibodies (Figure 19) than the 
8-week old birds. Thus, despite previous unsuccessful attempts 
to elicit good anti-DNP responses in chickens, a quantitative 
response was observed in adult birds using the immunisation regimen 
described. The specificity of anti-DNP biosynthesis and of the 
assay system used for its detection was confirmed by the failure 
to demonstrate DNP-binding activity in serum samples from bird 
no. 891 - which received only unsubstituted HSA (Table 9)* These 
results therefore suggest that birds develop the capacity to 
respond to haptens as they become older; in this instance, the 
critical age was apparently greater than 6 weeks and less than 15 
weeks.
Experiment k. The Effect of Immunising Chickens with a Hapten-Carrier 
Con.jugate (DNP-HSA) and Challenging Either with Carrier 
Alone (HSA) or with the Hapten on a Different Carrier
The results of the previous experiment implied that the 
age of the birds was an important consideration in successfully 
immunising chickens to the DNP hapten. So as not to lose sight of one 
of the original objectives (i.e. to elicit biosynthesis of detectable
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amounts of reasonably high affinity antibody and to discover how 
different immunisation procedures affected this), the facility of 
adult birds for secondary stimulation was studied.
Experimental procedure The same group of 6 adult hens used in
the previous experiment (Experiment 3d; immunisation with 5 mg 
DNP^I^-HSA iv.) was divided into two groups of 3, and each group 
was challenged, 1^0 days after priming, as follows:
Group 1 : secondary immunisation with 5 mg HSA in 1 ml saline iv.
Group 2 : secondary immunisation with 2 mg DNP-HCN in 1 ml saline iv.
The birds were bled at intervals following secondary immunisation, 
and serum samples were assayed for both DNP- and HSA-binding activity.
Results The results were expressed as'the binding capacities
of each serum sample for HSA and DNP; these values are given in 
Table 10 and the anti-DNP and anti-HSA responses are shown 
respectively in Figures 20 and 21.
In birds in Group 1 which were primed with DNP-HSA and 
re-immunised with unsubstituted HSA, the secondary antibody response 
to the carrier was greater than in the primary response (Table 10; 
Figure 21) but no anti-hapten activity was found. Chickens in 
Group 2, which had been primed with DNP-HSA and then re-immunised 
with DNP conjugated to a different carrier (haemocyanin), showed a 
rapid (i.e. detectable after 3 days) secondary antibody response to 
the hapten (Table 10; Figure 20) - but no antibody to the original 
carrier, HSA, was found.
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Anti-DNP antibody levels; 
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Days after primary immunisation.
FIG. 20. The effect of immunising chickens with a hapten-carrier 
conjugate ( DNP-HSA ) and challenging 40 days later with the same 
hapten on a different carrier ( i.e . DNP-HCN) upon the anti-DNP 
antibody response.
lUl
Anti-HSA antibody levels; 
ABCgQ (jigHSA m l”  ^ ).
200-r
180--
, (day 40) 
5 mg HSADNP-HSA
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Days after primary immunisation.
FIG. 21. The effect of immunising chickens with a hapten-carrier 
conjugate ( DNP-HSA ) and challenging 40 days later with the 
carrier alone upon the anti-HSA antibody response.
l k2
Secondary immunisation therefore caused production of 
antibodies specific only for those antigenic determinants used in 
the secondary stimulus. Indeed, the DNP hapten presented a second 
time on a heterologous carrier, caused very rapid anti-DNP 
biosynthesis and increased amounts of antibody -were produced; the 
kinetics of the response (e.g. rapid onset of biosynthesis) and its 
magnitude suggested that the response was anamnestic - in which case, 
there was no apparent requirement of the immunological memory for 
carrier specificity. Alternatively, the pattern of the so-called 
secondary response reflected the greater efficiency of haemocyanin 
as a carrier compared with HSA, in a situation where no memory had 
been imparted.
When the levels of anti-HSA antibody in the serum at
the y-day peak of the primary antibody response of birds in Group 1
were compared with the secondary responses at day Uy» a close 
correlation between them was evident (i.e. correlation coefficient 
= 0.998; the probability of obtaining so high a value by chance was 
P » 0.02). The primary and secondary anti-DNP levels of birds in 
Group 2 were too similar to each other at y days and at kj days to 
allow any meaningful comparison to be made.
II. The Affinity of Anti-Hapten and the Avidity of Anti-Protein
Chicken Antibodies
Experiment 5. The Effect of Antigen Dose upon the Affinity of Chicken 
Antibodies for DNP-EACA
If it is assumed that a process of cell selection does
Ik3
take place and involves the interaction of antibody-like receptors 
with antigen, then it would be expected that the affinity of serum 
antibody for antigen would depend on the valency and dose of the 
antigen to which the individual is responding. In mammalian species, 
the average affinity of antibodies has generally been shown to 
correlate with the dose and type (e.g. structure and valency) of 
the antigen, as well as with the method of immunisation and the 
duration of a response.
In this experiment an attempt was made to relate the 
average affinity of chicken anti-hapten antibodies to the dose of 
immunogen.
Experimental procedure Two groups of chickens (lO weeks of age)
were each immunised as follows.
Group 1 : 10 mg DNP^^-HSA in 1 ml saline iv.
Group 2 : 100 pg DNP2|^ "HSA in 1 ml saline iv.
Blood samples (20 ml) were taken by cardiac puncture from each bird 
7 days after primary immunisation. A globulin fraction was 
prepared from each serum sample, and these globulin fractions were 
assayed by equilibrium dialysis for their affinity for the ligand 
DNP-EACA.
The values for free and bound hapten concentrations, [c] 
and [b] , were obtained from the equilibrium dialysis data (as described 
on page 100). Next, a plot of log^^ [b] against log^^ [c] was 
constructed for each serum sample, and from this graph the values for 
the heterogeneity index and for the mean intrinsic association
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constant were derived (_as described on pages 100 and 103).
Results The results were expressed in terms of the geometric
mean intrinsic association constant , litres mole ^), the
heterogeneity index (a) and the hapten-binding capacity of the
”1serum ng DNP-lys ml }; these values are given in Table 11.
Average affinities of serum antibodies following immunisation with
either 10 mg or 100 yg of DNP-HSA were very low, in the range
2 ^ • “1 . .S5 10 to 10 litres mole . The mean value for the affinity
at 7 days in the group immunised with 10 mg of DNP-HSA was
unejxpectedly higher than that in the group immunised with 100 yg DNP-
HSA; this observation was contrary to the prediction based on a cell
selection theory, that lesser amounts of antigen would have stimulated
only those clonotypes of high affinity. However, on statistical
testing it appeared that the difference between the two groups might
conceivably have arisen by chance - the probability of this
happening Cas judged by the two-tailed t-test) gave P = 0.059.
In both experimental groups the index of heterogeneity 
was invariably 1.0, which implied that there was an homogeneous 
population of antibodies. There was no correlation between the 
absolute amount and the affinity of serum antibodies.
One important q.uestion which is posed by these results 
concerns the very low affinities which were obtained. If the 
receptor sites on the lymphocytes had the same low affinity for 
hapten as antibodies in the serum had, then it is difficult to see 
how any number of lymphocytes could have been stimulated at all.
Ik6
Experiment 6. The Effect of Repeated Immunisation upon the Amount 
and the Avidity of Anti-HSA Antibodies Produced hy Chickens
The results of the previous experiment indicated that 
immunisation of chickens with a hapten-protein conjugate evoked the 
biosynthesis of antibodies of very low average affinity for the hapten. 
The simplest explanation for this is that the birds were incapable of 
biosynthe si sing detectable amounts of medium or high affinity anti-DNP 
antibodies when immunised with the antigen at the doses and according 
to the procedures employed in the previous experiment.
An alternative approach to studying the effects of cell 
selection upon the quality of antibody produced was therefore tried; 
this was to measure the avidity of chicken antibodies for protein 
antigens, and in particular in the situation where antigen was 
repeatedly administered to the bird.
Experimental procedure Four chickens (12 weeks of age) were
each immunised by an initial intravenous injection of 100 yg HSA 
(in 1 ml saline). Thereafter each bird was given repeated doses of 
100 yg HSA at weekly intervals for U weeks. Each week the birds 
were bled just before injection of HSA, as well as on the day 
preceding and on the day following injection. The values for the 
avidity, K^, and the total antigen-binding capacity, [AbJ , were 
derived from a least squares linear plot of 1/[b] (reciprocal of the 
bound HSA concentration) against 1/[c] (reciprocal of the free HSA 
concentration) - using both the IBM 370/155 computer and a Hewlett 
Packard 9100 B calculator, as described on pages 89 and 91*
lUr
Results The results were expressed in terms of and [AhJ ,
and these values are given in Table 12. The values for avidity 
showed little variation during the initial three weeks following 
the first injection of antigen, but there was a significant 
increase in avidity during the fourth week (i.e. the mean value of 
for day 20 tested against the mean value of for day 27 gave 
P = 0.017 by the two-tailed t-test; likewise the mean value of 
for day 21 tested in the same way against the mean value of for 
day 28 gave P = 0.03^). This pattern of a significant increase 
in the mean avidity occurring during the fourth week after the 
first injection of antigen was reflected.in the pattern of antigen- 
binding capacities, which also rose markedly during the fourth 
week. Some increase in the antigen-binding capacity did however 
occur during the third week, and it was interesting that this 
presaged the increase in avidity (which was only detected at the end 
of the fourth week) ; on the basis of a cell selection theory, a 
plausible explanation would be that the greater amounts of antibody 
present in the serum during the third week were appropriating more 
of the injected antigen, and therefore only cells bearing high 
avidity receptors were being triggered to respond in the fourth week.
The antigen-binding capacities at the end of the second 
week after the first injection of antigen (i.e. after 13, iH and 15 
days) were lower in all experimental birds when compared with the 
serum antigen-binding capacity in the same individual 7 days 
previously (i.e. at the end of the first week). This refractory 
phase suggested that efficient homeostasis was in operation, preventing 
further stimulation of antibody biosynthesis following the second
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injection of antigen. However, this homeostatic effect was 
overcome during the third and fourth weeks, as evidenced by the 
significant increases in the antigen-hinding capacity found in 
serum samples from each bird at this time,
EVIDENCE FOR ACCESSORY CONTROL MECHANISMS
The experimental work described so far has been 
concerned with the effect of structure and amount(s) of antigen(s) 
injected upon those parameters (i.e. the antigen-binding capacity, 
affinity, avidity and heterogeneity) which have been taken as 
markers of antibody biosynthesis and thus of cell selection.
However, there are other regulatory factors which are capable of 
modifying the course of antibody biosynthesis - either at cell 
selection or at a later stage. For example, the use of adjuvants 
to enhance a response, and the immunosuppression achieved by passive 
antibody (and the naturally occurring equivalent of this, namely 
negative feedback inhibition) can be counted as regulators of 
antibody biosynthesis, although the level at which they operate is 
a matter for discussion.
I. The Effects of Adjuvants upon Antibody Biosynthesis in Chickens
Experiment 7• The Effect of Freund's Complete Adjuvant upon the 
Kinetics of Anti-HSA Antibody Biosynthesis in Chickens
The inclusion of antigen in a water-in-oil emulsion 
which also contains mycobacteria and which is injected into the 
breast muscle of a chicken might be expected to modify the antibody
150
response to that antigen as compared to the response observed 
following immunisation by straightforward intravenous injection of 
antigen in solution; such modification might be expected for two reasons 
at least. First of all, the antigen solution is restricted to the 
dispersed aqueous phase of the water-in-oil emulsion which is 
injected into the muscle of the bird; in view of this it would be 
predicted that removal of antigen from the site of injection in 
the tissue and its encounter with the cells of the immune system is 
a protracted albeit continuous process, although the actual kinetics 
of antigen removal have not been confirmed by experiment. The 
second point to consider is the presence of mycobacteria in the 
adjuvant mixture; mycobacteria are classically associated with the 
chronic granulomatous type of cell reaction, in which circulating 
cells migrate from the bloodstream and accumulate to form a solid 
granuloma. The development of lymphoid nodules in the later stages 
of granuloma formation (White, Coons and Connolly, 1955) and also 
the extraction of considerable amounts of specific antibody from 
adjuvant granuloma tissue in chickens (French, Stark and White, 1970) 
suggest that, in the chicken at least, the granuloma which develops 
following immunisation with antigen in FCA is the site of at least 
some, if not most, of the production of specific antibody.
The present experiment was carried out to examine the 
effects of FCA upon the kinetics of antibody biosynthesis following 
immunisation with either 5 mg or 100 yg HSA in FCA. The intention 
was to compare the kinetics of this response (including the relation­
ship between antibody levels in the serum and in the granuloma tissue
151
of each bird) with the pattern of antibody production following 
immunisation of chickens with antigen in saline in the absence of 
adjuvant, i.e. to study how the gradual release of antigen 
together with the inclusion of mycobacteria in the adjuvant 
influenced the kinetics of biosynthesis; from this it was hoped 
to form some conclusions as to how these two properties of the 
adjuvant were effective at the cellular level.
Experimental procedure Two groups of birds (8 weeks of age) were 
used; the first group of 6 birds were each immunised by a single 
intramuscular injection of 5 mg HSA in FCA and the second group of 
6 birds were each immunised by a single intramuscular injection of 
100 jig HSA in FCA. In each case, 0.5 ml of adjuvant (containing 
5 mg M. avium in the oil phase and with the antigen included in the 
aqueous phase) was injected into the left breast muscle. The 
birds were bled at regular intervals up until 7 weeks following 
immunisation and serum anti-HSA antibody levels were determined by 
the Farr test. After the final bleeding at 48 days the birds were 
killed to enable quantitation of the antibody in the granuloma which 
had developed at the site of injection in individual birds.
Results The results were expressed as the antigen-binding
capacity of each serum sample at various times after immunisation, 
(and of the antibody-containing extract prepared from the granuloma 
tissue of each bird 48 days after immunisation) and these values are 
given in Table 13, whilst mean values of serum antibody levels at 
the two doses of antigen used are shown in Figure 22.
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FIG. 22. The effect of Freund's complete adjuvant upon the 
kinetics of anti-HSA antibody biosynthesis in chickens.
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The kinetics of antibody biosynthesis following 
immunisation with either 5 mg or 100 yg of HSA in FCA indicated 
that in the majority of birds (i.e. 4/5 and 3/6 respectively for the 
two antigen concentrations) there was a biphasic antibody response.
These birds showed an initial phase of biosynthesis, the kinetics 
of this phase being very similar to the pattern observed following 
intravenous administration of antigen in saline (e.g. as shown in 
Figure 15, page 119 ); thus, once peak levels of antibody had been 
attained after about J days there was at least some decline 
observed in those birds which had been immunised with 5 mg HSA, 
whereas chickens which had been given 100 yg HSA showed a levelling 
off rather than any diminution of antibody levels (Figure 22). It 
was noticeable that the few birds immunised with HSA in FCA and 
which failed to show a definite biphasic pattern of antibody 
production, were coincidentally the same birds which showed a poor 
response at T days after immunisation. However, a second phase of 
antibody biosynthesis was observed in most of the experimental birds, 
and this was first detected between 3 and 4 weeks after immunisation.
The levels of antibody in the serum rose steadily and there was no 
indication of a decline before 48 days. This pattern of antibody 
biosynthesis is in agreement with that described by French, Stark 
and White (l9T0) who reported a similar biphasic response in chickens 
immunised with 40 yg HSA in FCA.
These results would suggest that either the feedback 
homeostasis which normally operates from about T days after immunisation 
becomes ineffective with the passage of time and therefore a second 
phase of antibody biosynthesis is stimulated by the antigen which is
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still present at the site of injection, or else that homeostasis 
has been actively alleviated, for example by the disruptive action 
of mycobacteria upon germinal centres containing segregated B cells 
Cthe mechanism proposed by White, 1973), again giving the chance for 
antigen still in the tissues to provoke a second phase of antibody 
biosynthesis. In both cases the presence of mycobacteria might 
well cause potentiation of the secondary response.
The kinetics of the second phase of the antibody response 
observed in birds following immunisation with antigen in complete 
adjuvant were dissimilar to the pattern seen after a second intra­
venous injection of antigen in solution (e.g. 40 days after a first 
injection), as shown in Figure 21 on page lUl . In a genuine 
secondary response there was good evidence that feedback homeostasis 
was just as effective (i.e. a rapid decline in serum antibody levels 
was observed once the peak had been reached 5 to 7 days after 
secondary injection) as in the primary response. This rapid decline, 
as evidence of efficient homeostasis, was not seen in the adjuvant- 
assisted antibody response; in fact the duration of the second phase 
of biosynthesis, which began between 20 and 30 days after immunisation 
and showed no signs of diminishing by 48 days, suggested that 
homeostasis was not in operation and this, with the slow release of 
antigen from the tissues at the site of injection, was contributing 
towards such a protracted second phase.
There was a significant correlation of antigen-binding 
capacity of serum with antigen-binding capacity of granuloma extract 
when samples obtained 48 days after immunisation of chickens with HSA
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FIG, 23. Correlation of antigen-binding capacity of serum with 
antigen-binding capacity of granuloma extract for samples 
obtained 48 days after immunisation of chickens with either 
5 mg (•)  or .100 ug (o) HSA in FCA.
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in FCA were compared (see Figure 23)i for birds immunised with 5 mg 
HSA the correlation coefficient was 0.788 and for chickens immunised 
with 100 yg the correlation coefficient was O.989 (the significance 
probability“values of these two correlations being P = 0.057 and 
P = 0.0057 respectively). The most likely explanation for these 
significant correlations is that most of the antibody biosynthesis 
in the second phase of the adjuvant-assisted response was taking 
place within the granuloma rather than in the spleen or elsewhere, 
which would concur with the findings of French, Stark and White (1970). 
The fact that the correlation between the antigen-binding capacity in 
the serum and that in the granuloma extract was not as good for 
chickens immunised with 5 mg HSA in FCA as for those birds given 
100 yg HSA in FCA could be attributed to the relatively large amounts 
of antigen still present in the tissues of birds in the first group 
combining with the antibody produced within the granuloma, effectively 
lowering the antigen-binding capacity of the tissue and increasing 
the error in its measurement,
Experiment 8. The Effects of Freund*s Complete and Incomplete
Adjuvants upon the Avidity of Anti-HSA Antibodies in Chickens
The results of the previous experiment showed that the 
anti-HSA response in chickens immunised with antigen in FCA, had two 
distinct phases of biosynthesis. In order to explain this phenomenon 
White (1973) has suggested that the adjuvant actively causes feedback 
homeostasis to be relaxed, and that antigen still present in the 
adjuvant depot in the muscle then elicits a second antibody response. 
Another possibility is that feedback is ablated spontaneously, and
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that residual antigen then provokes a. subsequent response - 
potentiated perhaps by the inclusion of mycobacteria. A third 
alternative is that the later phase of antibody biosynthesis depends 
on a population of, say, T cells, which take a long time to 
proliferate or on an entirely different population of B cells. In 
any case, it would appear that adjuvant regulates the response at 
some stage subsequent to the initial selection and triggering of 
antibody-producing cells, as well as affecting these processes directly,
The quality of antibody might be expected to reflect the 
way in which adjuvant affects an established antibody response; if 
it is supposed that a similar spectrum of antibody-producing cell 
clones which were active in the first phase is restimulated in the 
second phase, then overall increases in avidity between first and 
second phases (increases determined by the passage of time and by the 
exponentially diminishing amounts of antigen released by the adjuvant 
depot) might be predicted. On the other hand, if a different 
population of uninitiated antibody-producing cells is involved in the 
second phase of antibody biosynthesis, then an equal or lower avidity 
in the second phase would be anticipated.
The present experiment was carried out to study the 
avidity of antiboc^ from the first and second phases of the adjuvant- 
mediated antibody responses, and to compare these values with the 
avidities of antibody obtained from a primary antibody response in 
chickens immunised with antigen without adjuvant.
Experimental procedure Three groups of birds (12 weeks of age) 
were each immunised by a single intramuscular injection of 40 yg of
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HSA as follows.
Group 1 : 40 yg HSA in FCA, 0,5 ml, im.
Group 2 ; 40 yg HSA in FIA, 0,5 ml, im.
Group 3 : 40 yg HSA in saline, 0.5 ml, im.
The birds were bled at intervals following immunisation and antibody
avidities were quantitated.
Results The results were expressed as the relative association
constant for each serum sample, and these values are given in
Table l4. Between 5 and 12 days after immunisation with HSA in FCA
there was a significant increase (P = 0.012) in avidity - which was 
reconcilable with a process of cell selection whereby avidity would be 
expected to increase when the antigen concentration decreased as a 
function of time after immunisation. Thereafter the avidity appeared 
to decline, but this decline was of very doubtful statistical 
significance (P = 0.075 by two-tailed t-test).
Birds in Group 1 (immunised with HSA in FCA) showed a 
mean avidity after 12 days which appeared greater than the corresponding 
mean values for birds in both Groups 2 and 3, but this was not
■T
confirmed by subsequent statistical testing (P = 0.22 and P = 0.06 
respectively). As well as this, the overall changes in avidity for 
birds in each of Groups 1, 2 and 3 between 5 and 29 days (i.e. between 
the first and second phases of antibody biosynthesis for chickens in Groups 
l and 2 immunised with HSA in FCA and FIA) were not significant 
(P > 0.05), neither were the changes observed between 5 and 12, and 
between 12 and 29 days significant for birds in Groups 2 and 3.
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Experiment 9• The Effect of Freund's Complete Adjuvant upon the
Relative Amounts of 19S and 75 anti-HSA Antibodies in Chickens. 
Comparison of this Proportion with that Found in Primary and 
Secondary Antisera from Birds Immunised Without Adjuvant.
The previous experiment showed that there was no 
significant change in avidity between the early (5 or 12 day) and 
late (29 day) phases of the adjuvant-assisted antibody response in 
chickens; this in turn suggested that there was no shift in the 
average avidity of the clones selected by antigen to biosynthesise 
antibody as might be expected were the second phase produced by a 
different» or a more selected set of cells.
Another way of looking at this particular problem was to 
characterise the first and second phases of the adjuvant-assisted 
antibody response in terms of the ratio of TS to 198 antibody, and 
to see if the difference in this ratio between the first and 
second phases resembled the difference between a primary and a 
secondary response following administration of antigen without adjuvant.
Experimental procedure Four birds (12 weeks of age) were each
immunised by a single intramuscular injection of 5 mg HSA in Freund’s 
complete adjuvant into the left breast muscle. The birds were bled 
at intervals following immunisation, and the antisera obtained from 
all the birds at each bleeding were pooled together. A sample from 
each antiserum pool was diluted 1 :50, and 1 ml volumes were layered 
onto k ml sucrose density gradients which were then centrifuged 
overnight (as described on pages 72 and 73). After centrifugation, 
the polyallomer tubes were pierced and fractions were collected drop-wise
162
from the bottom of each tube ; the amount of anti-HSA antibody in 
each fraction was quantitated and characterised (as described on 
page 73 et seg,). From this, the total amounts of 7S and of 198 
anti-HSA antibody in 1 ml of undiluted antiserum were calculated; 
the relative proportions of JS and 198 antibodies from both phases 
of the adjuvant response were compared with the proportions of 78 
and 198 antibodies found in primary and secondary antibody responses 
elicited in a group of 3 birds immunised with 5 mg HSA in saline 
Civ) and challenged days later with 2 mg HSA in saline (iv).
Results The results were ultimately expressed as the total
amounts of 78 and 198 antibodies in 1 ml of undiluted (pooled) 
antiserum, and these values are given in Table 15 (a and b). The 
separations of 78 and 198 antibodies for each antiserum pool are 
shown graphically in Figure 2^.
For those birds immunised with 5 mg HSA in Freund's 
complete adjuvant, the proportion of 198 antibody estimated in pooled 
antiserum 7 days after immunisation was 3 7 this compared with a 
figure of 28,7% for the 198 contribution in pooled antiserum from birds 
7 days after immunisation with 5 mg HSA in saline, injected intra­
venously. During the second phase of the adjuvant-assisted response, 
e.g. 28 and 34 days after immunisation, the proportion of 19S 
antibody was 19.5% and l6.6% respectively; this latter value 
corresponded to the approximate peak of the second phase of the response 
elicited by immunisation with antigen in Freund's complete adjuvant 
and was comparable to the proportion of 198 antibody (19.8%) found at 
the 7"day peak of a genuine anamnestic secondary response, provoked
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TABLE 15a. The effect of Freund's complete adjuvant upon the 
relative amounts of 198 and 78 anti-HSA antibodies 
produced by chickens during the course of biosynthesis. 
Results are expressed as the total amounts (yg) of 
HSA bound by both 198 and 78 antibodies in 1 ml of 
undiluted pooled antiserum, and thence as the 
percentage total antibody represented by each class.
CLASS OF 
MTIBODY
DAYS AFTER IMMUNISATION WITH 5 mg HSA in FCA im. 
7 28 34
TOTAL AMOUNT (yg) HSA BOUND BY EACH ANTIBODY CLASS IN 1 ml SERUM
7S 23.6 (62.6%) 60.9 (60.5%) 61.7 (83.4%)
198 14.1 (37.4%) 9.8 (19.5%) 12.2 (16.6%)
TABLE 15b. A comparison of the relative amounts of 198 and 
78 anti-HSA antibodies produced by chickens at the 
respective 7“day peaks of a primary and a secondary 
antibody response. Results are expressed as above, 
in Table 15a.
CLASS OF 
ANTIBODY
7 DAYS AFTER PRIMARY 7 DAYS AFTER SECONDARY 
IMMUNISATION WITH IMMUNISATION WITH 
5 mg HSA iv. 2 mg HSA iv.
TOTAL AMOUNT (yg) HSA BOUND BY EACH ANTIBODY CLASS IN 1 ml SERUM
TS ■ 38.8 (71.3 )^ 47.8 (80.2%)
198 15.5 (28.7 )^ 11.8 (19.8#)
l6k
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FIG. 24. Separation by sucrose density gradient ultra­
centrifugation of chicken 7S and 19S anti-HSA antibodies in 
pooled antiserum taken 7 and 34 days after immunisation with 
5 mg HSA in FCA im, also 7 days after immunisation with 
5 mg HSA in saline iv and 7 days after secondary immun­
isation with 2 mg HSA in saline iv.
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by a second injection of antigen (2 rag) given 40 days after primary 
immunisation.
In terms of the distribution of TS and 198 antibodies 
therefore, the drop in the proportion of 198 antibody between the 
early and late phases of antibody production stimulated with antigen 
in FCA was similar to the decline in the proportion of 198 antibody 
between a primary and a secondary anamnestic antibody response.
This was taken as evidence that specific immunological memory was 
imparted during the first phase of the adjuvant-assisted response, 
which was reflected by an increase in the TS:198 antibody ratio in 
the second phase.
Experiment 10. The Effect of Bacterial Lipopolysaccharide upon the 
Biosynthesis of Antibodies Following Immunisation of Chickens 
with HSA Adsorbed onto Sheep Erythrocytes.
The biphasic antibody response observed in chickens 
immunised with antigen in Freund’s complete adjuvant has been studied 
in the preceding experiments. By comparing the avidities and the 
respective proportions of TS and 198 antibodies in the first and 
second phases it was suggested that the second phase represented in 
effect a secondary anamnestic response elicited by residual antigen 
from the water-in-oil depot at the site of injection and which perhaps 
followed the alleviation of feedback inhibition by the action of the 
adjuvant, as postulated by White (l9T3). A further empirical finding 
reported by Nielsen (19T^) and by White and Nielsen (l9T5) was that 
immunisation of chickens by simultaneous injection of sheep red blood 
cells and Salmonella adelaide brought about a cyclical pattern of
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anti-SRBC macroglobulin antibody biosynthesis; again it was 
postulated that the oscillating levels of antibody in the serum 
reflected repeated activation and relaxation of a negative feedback 
mechanism resulting in a regular series of ever-diminishing waves 
of antibody biosynthesis.
The original idea in the present experiment was to 
measure antibody avidity at the crest of each wave of biosynthesis 
throughout a cyclical antibody response, to discover whether or not 
there was a progressive rise in avidity. In preference to measuring 
avidity for such an extremely heterogeneous entity as the sheep 
erythrocyte, an attempt was made to elicit cyclical antibody 
biosynthesis to HSA; it was hoped that this could be achieved by 
adsorbing HSA onto the surface of sheep erythrocytes and then 
immunising chickens with these modified erythrocytes (HSA-SRBC) 
injected together with a thymus-independent antigen, bacterial 
lipopolysaccharide. If the production of a cyclical response to HSA
was feasible, the pattern of antibody avidities from successive 
antibody peaks would permit further elucidation of the mechanisms of 
homeostasis.
Experimental procedure Two different batches of lipopolysaccharide,
prepared from Escherichia coli, were kindly provided by the Department 
of Microbiology, Glasgow University. Three groups of chickens (12 
weeks of age) were each immunised with HSA-coated tanned sheep red 
blood cells, prepared as described on page 112, as follows,
10
Group 1 C3 birds) : 10 HSA-SRBC + 250 yg LPS (l) injected iv.
Group 2 (3 birds) : 10^^ HSA-SRBC + 250 yg LPS (2) injected iv.
Group 3 (2 birds) : 10^^ HSA-SRBC injected iv.
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The birds were bled at intervals following immunisation, 
and anti-HSA antibodies in the serum samples were quantitated by the 
Farr test.
Results The results were expressed as the antigen-binding
capacities for individual serum samples and these values are given in 
Table l6.
Although there was a good anti-HSA response in each case 
to immunisation with HSA-coated sheep erythrocytes, there was no 
evidence of cyclical anti-HSA biosynthesis - at least up until 37 days 
following immunisation. However, it was apparent that all the birds 
showed prolonged production of anti-HSA antibodies (Table l6). This 
result was found in all three groups showing that the effect was not 
dependent upon the inclusion of lipopolysaccharide with the antigen 
but resulted from the presentation of HSA coated onto sheep 
erythrocytes. Thus there were significant amounts of anti-HSA 
antibody detected up to 37 days after primary immunisation; also, 
the rate of decline of the ABC^^ values of sera, from 3 weeks 
following immunisation onwards, was very slow (a virtual plateau in 
some cases) and was more reminiscent of the mammalian primary antibody 
response than the typical avian response.
There was also an apparent distinction, in terms of the
absolute amounts of antibody present in the serum, between male and
female birds of the same strain and age. Thus, 6 days after
immunisation the average ABC^Q for all the female birds in the
"I
experiment was l6.1 (±5*l) Pg HSA ml , whereas for all the male birds 
the average ABC^^ was 71*3 (±6.4) yg HSA ml This finding lends
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weight to the argument that immune responsiveness is subject to 
genetic control, and is maybe different for birds of different strain, 
sex or age.
II. Antibody-Mediated Immunosuppression as an Experimental Model 
of Negative Feedback Homeostasis in Chickens.
Experiment 11. The Effect of Passive Antibody and the Time of its 
Administration upon the Primary Antibody Response to HSA in 
Chickens.
Immunosuppression mediated by passive antibody has two 
possible modes of action; either the antibody binds to the antigen 
and prevents it from interacting with lymphocytes, or else the 
antibody and antigen act together to tolerise or incapacitate clones 
of antigen-sensitive cells.
In many ways the action of passively administered anti­
body is considered to be analogous to the homeostasis effected by 
antibody-mediated feedback inhibition. Therefore, the effects of 
passive anti-HSA upon the primary antibody response to HSA in the 
chicken were investigated, to find out to what extent the striking 
negative feedback homeostasis seen in chickens can be explained in 
terms of antibody-mediated feedback.
Experimental procedure Three groups of chickens (9 weeks of
age) were each immunised as follows.
Group 1 : 1 ml of passive anti-HSA 2k hours before injection of
250 ug HSA iv.
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Group 2 : 1 ml of passive anti-HSA 48 hours after injection of
250 pg HSA iy.
Group 3 : no passive immunisation; 250 yg HSA injected iv.
Passive antibody was prepared from pooled antiserum collected 7 days 
after immunisation of six 8 to 12-week old birds each with a single 
intravenous injection of 10 mg HSA in saline. Antibody-containing 
globulin was fractionated from the pooled antiserum according to 
the method described on pages 71 and 72. The ABC for the anti-HSA 
globulin was 126 yg HSA ml
The experimental birds were bled at intervals following 
active immunisation and individual serum samples were assayed for 
anti-HSA antibodies by the Farr test.
Results The results were expressed as the antigen-binding
capacity for each serum sample and these values are given in Table 17.
The kinetics of anti-HSA antibody levels in the serum of each bird
are shown in Figure 25.
All the birds in Group 1 (i.e. those given passive 
antibody 2k hours before active immunisation) showed depressed levels 
of anti-HSA in the serum relative to the values obtained for birds
receiving no passive antibody (i.e. those birds in Group 3). The
effectiveness of passive antibody administered 48 hours after active 
immunisation was eq.uivocal, as the high levels of anti-HSA in the 
serum of these birds (e.g. 7 days after active immunisation) could 
be attributed partly to residual passive antibody and partly to 
antibody synthesised de novo. If it is assumed that the last portion
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TABLE 17* The effect of passive anti-HSA antibody and the time of 
its administration upon the primary antibody response to 
HSA in chickens. Results are expressed as the antigen- 
binding capacity (ABC^q , yg HSA ml of individual serum 
samples.
BIRD
HUMBER
DAYS
4
AFTER ACTIVE IMMUNISATION 
7 8 10
IMMUNISATION SERUM ANTI-HSA;
“ S o
(yg HSA ml
01 GROUP 1 ; 0.5 0.7 0.6 0.2
02 Passive anti- 1.1 0.9 0.6 0.3
03 HSA 24 hours 0.4 1.1 1.0 0.4
o4 before injecting 0.8 0.8 0.5 0.2
05 250 yg HSA' iv. 0.6 0.7 0,6 0.2
06 GROUP 2 : 
Passive anti-
6.8 3.6 2.3 0.7
07 HSA 48 hours 
after injecting 
250 yg HSA iv.
4.6 3.4 1.4
08 GROUP 3 : 0.02 1.5 1.1 0.4
09 250 yg HSA iv. 0.1 3.5 1.9 0.8
10 0.08 4.5 2.8 0.8
11 0.1 3.0 1.6 0.5
1T2
-1HSA ml )
1.96 days
1.0 - -
A No passive Ab.
■ Passive Ab +48 hrs.
o Passive Ab - 24 hrs.
0.05
65 74 8 109
Days after administration of antigen.
FIG. 25. The effect of passive antibody and the time of its 
administration upon the primary antibody response to HSA 
in chickens.
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of the graphs in Figure 25, i.e. from day 8 to day 10, represents 
ejcponential decay of antibody without fresh synthesis, as stated by 
White (1973), then the half life of the antibody in the birds used 
in the experiment can be estimated. Visual inspection indicated a 
mean half life very close to 1.4 days. This would imply that in 
the two chickens from Group 2, which had a mean ABC^^ of about 7.2 yg 
HSA ml ^ on day 4 (presumably all or almost all of this being 
passive antibody), then one would expect that by day 7 the passive 
antibody would have declined to an ABC^^ of 1.6 yg HSA ml Thus
the serum level of actively synthesised antibody can be estimated 
by subtracting this from the mean of the observed ABC^Q values for 
day 7: which was 4.1 yg HSA ml ^ for the birds in Group 2. This
gave a mean ABC^^ of 4.1 ~ 1.6 = 2.5 yg HSA ml ^ which could be
attributed to actively synthesised antibody. Although this is 
below the mean ABC^^ (3.13 yg HSA ml for the control group
(Group 3), it is not significantly lower (P = 0.513), making any
conclusion that immunosuppression has occured in birds from Group 2 
a q.uestionable one.
Thus, passive antibody was immunosuppressive if given 
1 day before antigen, but its effect was not clearly demonstrable 
when administered 2 days after antigen.
Experiment 12. The Effect of the Dose of Passive Antibody upon its 
Ability to Suppress Primary Antibody Biosynthesis in Chickens.
The results from the previous experiment established that 
passive antibody, administered in large amounts, was certainly capable
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of immunosuppression if given before active immunisation with antigen.
The quantity of antibody used in each bird to achieve this suppression
of antibody biosynthesis (i.e. 1 ml of anti-HSA globulin, ABC^^ =
“1126 yg ml ) was sufficient to neutralise much of the immunising 
dose of antigen (250 yg HSA), and it could be that the passive 
antibody is doing no more than lowering the effective dose of antigen. 
In an attempt to explore the mechanisms of antibody-mediated immuno­
suppression a stage further, the effect of the amount of passive 
antibody upon its ability to suppress antibody biosynthesis was 
investigated. Thus, if immunosuppression was achieved only by using 
large doses of passive antibody, this would indicate that the passive 
antibody was acting solely by neutralising the antigenic stimulus 
rather than having a direct effect upon the cells involved in 
biosynthesis.
Experimental procedure Five groups of chickens (8 weeks of age)
were used in this experiment; four groups were immunised passively 
with chicken anti-HSA globulin and then 24 hours later the birds in 
all five groups were each immunised actively with 250 yg HSA. The 
precise details of passive immunisations, prior to the administration 
of antigen, are given below.
Group 1 ; 1 ml passive antibody, undiluted, iv.
Group 2 : 1 ml passive antibody, diluted 1/4, iv.
Group 3 : 1 ml passive antibody, diluted 1/16, iv.
Group 4 : 1 ml passive antibody, diluted 1/64, iv.
Group 5 : no passive antibody.
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The passive antibody was prepared from pooled 
antisernm collected 7 days after immunisation of four 15 week old 
birds each with a single intravenous injection of 10 mg HSA in saline. 
Antibody-containing globulin was fractionated as before. The ABC, 
for the anti-HSA globulin was 202 yg HSA ml
'30 
-1
The experimental birds were bled at intervals following 
passive and active immunisations and individual serum samples were 
assayed for anti-HSA antibodies by the Farr test.
Results The results were expressed as the antigen-binding
capacity for each serum sample and these values are given in Table l8; 
the relationship between the dose of passive antibody given and serum 
antibody levels 7 and 10 days after active immunisation is illustrated 
in Figure 26.
At 7 days after active immunisation the mean ABC valuesju
for birds in Group 1 and for birds in Group k were significantly lower 
(P = 0,096 and P = 0.061 respectively, by the two-tailed unpaired 
t-test) than the mean ABC^^ for birds in the control group, Group 5. 
These findings suggested that, in this experiment, immunosuppression 
could be effected at two different dosage levels of passive antibody. 
In view of this, undiluted passive antibody might be expected to act 
by neutralising antigen in the circulation - effectively nullifying 
the antigenic stimulus. In contrast, such a mechanism cannot be 
proposed for immunosuppression achieved by passive antibody diluted 
1/64, and this could reflect a direct inhibitory influence of antigen- 
antibody complexes (in considerable antigen excess) upon antigen- 
sensitive cells.
176
TABLE 18. The effect of the dose of passive antibody administered 
24 hours before active immunisation upon its ability to 
suppress primary antibody biosynthesis to. HSA in chickens. 
Serum antibody levels are expressed as the antigen-binding 
capacity (ABC^^, yg HSA ml"!) for each serum sample.
BIRD
NUMBER
DOSE OF PASSIVE 
Ab PRIOR TO 
250 yg HSA iv.
DAYS BEFORE/AFTER ACTIVE IMMUNISATION 
-1 +3 +7 ' +10
SERUM ANTI-HSA; ABCgo (yg HSA ml"l)
25 GROUP 1 : 1 ml 19.8 0.2 1.2 1.7
26 undiluted Ab iv. 13.4 0.1 0.3 0.3
27 l4.1 0.2 0.4 0.4
Mean (±SE) I5.8C+2.O) 0.2(±0.03) 0.6(±0.3) 0.8(±0.5)
28 GROUP 2 : 1 ml 4.4 1.0 0.5 0.2
29 Ab diluted 2.5 0.03 5.7 1.4
30 1:4 iv. 3.1 0.01 5.4 3.6
34 1.9 0.01 0.9 0.4
Mean C±SE) 3.0(±0.6] 0.3(±0.3) 3.i (±i .4) 1.4(±0.8)
31 GROUP 3 : 1 ml 1.2 0.01 3.9 1.7
32 Ab diluted 1.2 0.02 20.7 9.4
33 l:l6 iv. 1.5 0.01 1.7 0.7
Mean (+8E) 1.3(±0.1) O.l(iO.Ol) 8.8(±6.0) 3.9(±2.8)
36 GROUP 4 : 1 ml 0.3 <0.01 0.4 0.3
37 Ab diluted 0.2 <0.01 1.9 1.2
38 1:64 iv. 0.3 <0.01 1.2 0.6
39
-
0.4 . 1.3 0.6
Mean (±SE) 0.3(±0.05) nd 1.2(±0.3) 0.7(±0.2)
4o GROUP 5 : nd <0.01 8.4 3.9
4l No Ab. nd <0.01 1.4 0.9
42 nd <0,01 2.5 1.9
43 nd <0.01 8.0 3.3
Mean ( SE) nd nd 5.i (±1.8) 2.5(10,7)
nd - not determined
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FIG. 26. The effect of the dose of passive antibody ( given 
24 hours before antigen ) upon its ability to suppress primary 
antibody biosynthesis to HSA in chickens.
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Experiment 13. Comparison of the Immunosuppressive Potency of 
Chicken Antibody Obtained either from Serum T Days after 
Primary Immunisation or Extracted from Freund^s Adjuvant 
Grannlomata 48 Days after Immunisation.
It has been found in tmamnals that the degree of immuno­
suppression achieved -by equivalent amounts of passive antibody was 
directly related to the affinity of the antibody (e.g. Walker 
and Siskind, I968). An attempt was therefore made to correlate
the immunosuppressive potency with the avidity of passive antibody in
chickens.
The respective sources of low and high avidity chicken 
anti-HSA antibodies were the serum obtained at the y-day peak of the 
primary antibody response, and the extract from granulomata obtained 
at the 48-day peak of the second phase of the adjuvant-assisted response 
in chickens. The granuloma extract was used as a source of high 
avidity anti-HSA since French, Stark and White (19T0) demonstrated 
that antibody from the second phase of the antibody response in 
chickens following immunisation with antigen in Freund’s complete 
adjuvant was more avid than that from the initial phase.
The present experiment was therefore conducted to test 
the hypothesis that high avidity antibody is more immunosuppressive 
than an equivalent amount of low avidity antibody. Thus the immuno­
suppressive capabilities of antibody from the peak of the primary 
antibody response in chickens were compared with those of antibody 
contained in granuloma extract.
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Experimental procedure Two groups of chickens (6 weeks of age)
were each given an intravenous injection of one of the passive 
antibody preparations followed 24 hours later by immunisation with 
HSA. A third experimental group of birds received no passive 
antibody but were immunised with HSA. The schedule for immunisation 
was as follows.
Group 1 : 1 ml passive anti-HSA (peak primary response) iv. 24
hours before injection of 250 yg HSA iv.
Group 2 : 1 ml passive anti-HSA (granuloma extract) iv. 24 hours
before injection of 250 yg HSA iv.
Group 3 : no passive antibody; active immunisation with 250 yg
HSA iv.
Passive anti-HSA globulin was obtained from two sources ; (l) from 
pooled antiserum collected J days after immunisation of three 12-week 
old birds each with a single intravenous injection of 2 mg HSA in 
saline. The ABC^^ was 10.3 yg HSA ml (2) from granuloma extract
obtained 48 days after immunisation of four 8-week old chickens with 
5 mg HSA in EGA. The ABC^^ was 11.4 yg HSA ml“ .^
The experimental birds were bled at intervals following 
passive and active immunisations and individual serum samples were 
assayed for anti-HSA by the Earr test.
Results The results were expressed as the antigen-binding capacity
for each serum sample and these values are given in Table 19. There 
was no apparent difference in the amount or kinetics of antibody 
biosynthesis between any of the 3 experimental groups of birds.
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TABLE 19» Comparison of the ijnmunosuppressive potency of
chicken antibody obtained either from serum 7 days 
after primary immunisation or extracted from 
Freund's adjuvant granulomata 48 days after 
immunisation. Serum antibody levels are expressed 
as the antigen-binding capacity (ABG^^, yg HSA ml ^).
BIRD
NUMBER
IMMUN­
ISATION
DAYS AFTER ACTIVE 
3 7
IMMUNISATION 
12 21
SERUM ANTI-HSA; ABC^Q (yg HSA ml"^)
399
4oi
425
431
GROUP 1 :
1 ml Ab (lO, 
day 7 ) 24 hours 
before 250 yg 
HSA iv.
0.6 7.3 
0,5 11.1 
1.0 9.5 
0.9 11.4
2.5 1.4 
3.9 1.5
2.6 1.8 
3.7 2.2
MEAN (±SE) 0.8(±0.1) 9.8(±0.9) 3.2(10.3) 1.7(10.2)
407
402
4ll
4l6
GROUP 2 :
1 ml Ab 
(granuloma 
extract) 24 
hours before 
250 yg HSA iv.
1.2 9.2 
0.8 8.5 
1.0 12.2 . 
0.9 8.8
3.7 3.7
3.0 1.7 
6.4 2.4 
3.2 2.9
MEAN (±SE) 1.0(±0.1) 9.7(±0.8) 4.1(10.8) 2.7(10.4)
4l8 GROUP 3 : 1.1 3.9 2.0 1.3
419 No Ab; 250 yg 1.5 7.5 3.6 1.6
421 HSA iv. 0.9 8.1 4.7 2.9
429 0.6 10.4 3.4 2.0
MEAN (±SE) l.OC+0.2) 7.5(11.4) 3.4(10.5) 2.0(±0.3)
l8l
including the control group. This obviously reflected a failure 
to achieve inmunosuppression by antibody prepared either from 
primary immune serum or from granuloma extract. The quantity of 
antibody in these preparations was too small to have much neutralising 
effect on antigen in vivo, nor was there any evidence of immuno­
suppression having been achieved by mechanisms other than straight­
forward neutralisation, as was found, for example, in Experiment 12.
Experiment l4. The Effect of Passive Anti-Carrier and Anti-Hapten 
Antibodies upon the Primary Antibody Response of Chickens to a 
Hapten-Protein Conjugate.
The experimental investigation of antibody-mediated 
immunosuppression in chickens has so far been concerned with the level 
at which passive antibody operates, whether it is by neutralising 
antigenic determinants or else by inhibiting the cells responsible 
for the biosynthesis of antibody, or both.
Another clue to this puzzle comes from the determinant 
specificity of antibody-mediated immunosuppression. As mentioned on 
pages 42 and 43, it has been found in certain instances that immuno­
suppression was absolutely determinant specific (i.e. that antibody to 
one determinant suppressed the response to that determinant only) 
whilst in other cases the specificity overlapped to include unrelated 
determinants on the same antigen. The present experiment was to 
examine the effects of either anti-carrier or anti-hapten antibodies, 
given passively, upon the antibody response of chickens to the hapten 
and to the carrier components of a hapten-protein conjugate.
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Experimental procedure Three groups of chickens (15 weeks of
age) were each immunised as follows.
Group 1 : 1.3 ml of anti-HSA globulin iv. 12 hours before injection 
of 500 yg DNP^g-HSA iv.
Group 2 : 1.3 ml of anti-DNP globulin iv. 12 hours before injection 
of 500 yg DNP^2“HSA iv.
Group 3 : no passive antibody before injection of 500 yg DNP^^-HSA iv.
Passive antibody was obtained from 2 separate pools of antiserum,
each collected 7 days after immunisation of 2 groups of three chickens
(15 weeks old) immunised with a single intravenous injection of 5 mg
HSA or 2 mg DNP-HGN in saline respectively. The ABG^q for anti-HSA
“1
globulin was 150 yg HSA ml ; HBC^^ for anti-DNP globulin was 6240 ng
* « ft
DNP-lysine ml , The experimental birds were bled at intervals 
following passive and active immunisations and individual serum samples 
were quantitated for anti-HSA and anti-DNP antibodies by separate Farr 
tests.
Results The results were expressed as the DNP- and HSA-binding
capacities of each serum sample and these values are given in Table 20. 
There was no evidence of immunosuppression mediated by passive antibody, 
in that birds belonging to Groups 1 and 2, immunised passively with 
anti-HSA and anti-DNP respectively, produced antibodies to DNP-HSA in 
comparable amounts to those produced by the control birds in Group 3, 
which received no passive antibody. The moderate differences which 
did occur were no larger than might be expected to arise by chance, as 
judged by Student's t-test.
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TABLE 20. The effect'of passive anti-carrier and anti-hapten antibodies 
upon the primary antibody response of chickens to a hapten- 
protein conjugate (DNP-HSA). Results are expressed as (a) 
anti-HSA levels in terms of the antigen-binding capacity (ABC , 
yg HSA ml”^) and (b) anti-DNP antibody levels in terms of the 
hapten-binding capacity (HBC , ng DNP-lysine ml“i).
BIRD
NUMBER IMMUNISATION 30*
TIME AFTER IMMUNISATION WITH DNP-HSA 
5 days 7 days 10 days
ANTI-HSA LEVELS ; ABCgq (yg HSA ml ^)
1201 GROUP 1: anti- 0.9 0.1 1.8 1.1
1202 HSA 12 hours 0.8 2.5 36.1 8.9
1203 before 500 yg 
DNP-HSA iv.
1.0 1.8 8.5 3.6
Mean (±SE) ' 0.9(10.06) 1.5(±0.T) 15.5(110.5) 4.5(12.3)
1204 GROUP 2 : anti- 0.06 2.2 7.0 2.5
1205 DNP 12 hours 0.08 25.4 54.4 24.5
1206 before 500 yg 
DNP-HSA iv.
0.06 4.8 15.3 7.3
Mean (±SE) 0.07(10.01) 10.8(±7.3) 25.6(±i4.6) i i .4(±6.7)
1207 GROUP 3: nd 8.1 26.7 9.9
1208 500 yg DNP-HSA nd 3.4 4,0 1.2
1209 iv. nd 42.5 52.4 l4.8
Mean (±SE) nd 18.0(±12.3) 27.7(114.0) 8.6(±3.9)
BIRD
NUMBER IMMUNISATION
30*
TIME AFTER IMMUNISATION WITH DNP-HSA 
5 days 7 days 10 days
ANTI-DNP LEVELS; HBCgo(ng DNP-lys ml“^)
1201 GROUP 1; anti- 12.6 24.6 44.1 32.1
1202 HSA 12 hours 23.4 101.6 161.7 78.8
1203 before 500 yg 24.8 40.5 96.4 51.1
DNP-HSA iv.
Mean (±SE) 20.3(13.9) 55.6(123.5) 100.7(134.0) 54.0(113.6)
1204 GROUP 2: anti- 99.7 84.3 117.5 64.8
1205 DNP 12 hours 194.0 196.1 275.5 105.1
1206 before 500 yg 137.0 169.9 203.6 90.9
DNP-HSA iv.
Mean (±SE) 143.6(±27.4) 150.1(133.8) 198.9(145.6) 86.9(111.8)
1207 GROUP 3: nd 123.6 216.5 81.8
1208 500 yg DNP- nd 52.7 49.6 25.4
1209 HSA iv. nd 96.3 87.2 43.1
Mean (±SE) nd 90.9(120.7) 117.8(150.5) 50,1(116.6)
nd - not determined
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In this experiment there was enough anti-HSA administered 
to birds in Group 1 to bind about 40% of the HSA injected 
subsequently; and there was enough anti-DNP administered to bind 
about 20^ of the DNP, i.e. about 2 DNP groups per molecule of 
conjugate. The results show that this was insufficient to produce 
a demonstrable immunosuppressive effect. This tends somewhat to 
support the hypothesis that antibody-mediated immunosuppression in 
chickens depends on neutralisation of the antigenic stimulus, rather 
than suppression of lymphocytes by complexes in antigen excess.
•Experiment 15. The Effect of the Repeated Injection of Antigen 
upon the Magnitude and Duration of Serum Antibody Levels in 
the Chicken. An Attempt to Delay Feedback Inhibition.
The prompt switching off of antibody biosynthesis in the 
chicken at about J days after immunisation has been attributed to 
efficient feedback regulation by circulating antibody (White, 1973) ~
tt
and Uhr and Moller (1968) have emphasised the analogy between 
antibody-mediated immunosuppression and homeostasis by feedback 
inhibition.
In the present experiment a further attempt was made to 
distinguish between the possible mechanisms of antibody-mediated 
immunosuppression. If the mechanism is solely the neutralisation of 
the antigenic stimulus, it would be expected that the negative feedback 
could -be prevented or at least delayed by administering more and more 
antigen during the first four days of antibody biosynthesis. On the 
other hand, if the immunosuppressive agent is an antigen-antibody 
complex formed in antigen excess, then its action should not be so
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easily inhibited by repeated administration of antigen.
Experimental procedure Three groups of chickens (20 weeks old)
were each immunised as follows.
Group 1 : Primary immunisation with 5 mg DNP^g-HSA iv. This was
followed by further injections of 1 mg HSA iv. 3, 4, 5»
6 and 7 days later.
Group 2 : Primary immunisation with 5 mg DNP^g-HSA iv. This was
followed by further injections of 40 yg of the divalent
DNP hapten 1 ,6-bis-(2,4-dinitrophenylamino)hexane iv. 3,
4, 5)6 and 7 days later.
Group 3 : Primary immunisation with 5 mg DNP^^-HSA iv. only.
The birds were all bled at intervals following primary 
immuni sat ion with DNP-HSA; on those days when both bleeding and 
administration of antigen supplements had to be done, the blood samples 
were taken first. Individual serum samples were assayed for anti-HSA 
and anti-DNP antibodies by Farr tests.
Results The results were expressed as the separate DNP-binding and
HSA-binding capacities of each serum sample, and these values are given 
in Table 21.
Supplementary injections of HSA, given for 5 consecutive 
days beginning 3 days after the initial immunisation with DNP-HSA, 
caused an increase in the levels of anti-HSA detected and also caused 
a few days delay in the attainment of peak levels of anti-HSA in the
serum of 3 out of 4 birds in the group, as shown in Figure 27. This
procedure however had no effect upon the amount or time of synthesis 
of anti-DNP antibody in comparison to the control group of birds. In
contrast, supplementary injections of a divalent hapten (DNP^-
186
TABLE 21. The effect of priming chickens with DNP-HSA (5 mg iv.) and 
then repeatedly boosting on days 3, 4, 5, 6 7 with either
HSA or with divalent DNP hapten. Results are expressed as 
(a) anti-HSA antibody levels in terms of the antigen-binding 
capacity (ABC^o, yg HSA ml“^) and (b) anti-DNP antibody levels 
in terms of the hapten-binding capacity (HBC , ng DNP-lysine 
ml-l). 30
BIRD
NUMBER SEX IMMUNISATION
DAYS
... 5
AFTER FIRST IMMUNISATION 
7 10 14
ANTI-HSA LEVELS; ABC30 (yg HSA ml*"^ )
1210 F GROUP 1: 5 mg 39.8 290.4 93.4 24.5
1211 F DNP-HSA iv, 0.2 67.2 164.7 50.5
1212 F then 1 mg HSA 8.6 247.2 355.5 75.5
1216 M iv. 3)4,5,6 & 0.1 1.0 41.6 T.2
7 days later
Mean (±SE) 12.2(19.4) 151.5(±69.7) 163.8(±63.7) 39.4(114.9)
1213 F GROUP 2; 5 mg 50.2 126.1 22.7 6.3
1214 F DNP-HSA iv, 31.8 59.1 ■ 19.7 7.1
1215 F then 40 yg 110.9 TT.9 24.9 9.2
1219 M divalent DNP 0.7 0.7 1.5 0.3
iv. 3,4,5)6 &
7 days later
Mean (±SE) 48.4(123.2) 65.5(125.9) 17.2(15.3) 5.7(11.9)
1216 F GROUP 3: 5.0 21.6 6.5 2.6
1217 F 5 mg DNP-HSA 11.3 30.5 5.7 *
1220 M IV. 0.3 1.8 0.9 0.5
Mean (±SE) 5.5(±3.2) 18.0(18.5) 4.4(11.7) 1.6(11.1)
- ANTI-DNP LEVELS; HBC30 (ng DNP-lys ml”^
1210 F GROUP 1: 5 mg 69.6 66.5 51.9 23.0
1211 F DNP-HSA iv. 184.1 375.3 134.7 57.3
1212 F then 1 mg HSA 224.6 269.7 151.6 64.0
1216 M iv. 3,4,5)6 & 97.9 145.8 94.8 110.4
7 days later
Mean (±SE) 144.1(±36.2) 214.3(±68.0) 108.3(±22.2) 63.7(118.0)
1213 F GROUP 2; 5 mg 173.3 273.1 103.8 48.3
1214 F DNP-HSA iv. 169.8 348.4 123.8 59.0
1215 F then 40 yg 275.2 235.3 95.1 50.6
1219 M divalent DNP 37.5 36.5 19.3 21.3
iv. 3)4,5,6 &
7 days later
Mean (±SE) 151.5(±40.0) 223.3(±62.5) 85.5(122.8) 44.8(18.2)
1216 F GROUP 3: 266.9 510.8 204.9 97.2
1217 F 5 mg DNP-HSA 107.0 182.9 42.2 *
1220 M IV. 87.3 243.9 209.5 192.1
Mean C±SE) 153.7(±57.0) 159.5(156.8) 152.2(±55.l) 1A4.7(147.6)
M - male bird; F - female bird; * - bird died
-1ABCgQ (jig HSA ml )
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FIG. 27. The effect of repeated injection of antigen ( either 
HSA or divalent DNP hapten ) upon the magnitude and duration 
of anti-HSA antibody levels in chickens primed with DNP-HSA,
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diaminohexane) had no effect either on the amount of anti-DNP produced, 
or upon the time at which peak levels of anti-DNP were detected in 
the serum relative to the control group of birds (i.e. day T),
Although there was evidence that supplementary injections
of HSA, as well as eliciting increased amounts of antibody, caused
an apparent delay in the arrival at peak levels of anti-HSA in the
serum (until day 10 for 3 out of 4 birds in the group, = 3.9^;
P = 0.026), this result must be interpreted with caution. In this
experiment the antigen-binding capacities do not reflect merely the
synthesis of antibody, but are also affected by its neutralisation
and removal by the repeated injections of antigen. It was however
possible to make some approximate calculations as to what .extent the
repeated injection of antigen affected the ABC^^ value. For example,
if a 20-week old bird has a body weight of about 2 kg and therefore a
total blood volume of 200 ml, then by day 7 birds in Group 1 would each
have received a total of 4 mg HSA in addition to the original injection
of 5 nig DNP-HSA; that is the ABC^^ values recorded at day 7 would
-1have been effectively lowered by as much as 20 pg ml due to repeated 
injection of antigen. Even making this allowance, 3 out of 4 birds 
in Group 1 still had a higher serum ABC^^ value at 10 days than at 7 
days, suggesting that biosynthesis had not been completely switched off,
The production of antibody by individual birds was again 
found to depend on the sex of the bird; in this case the sera of 
female birds contained much greater amounts of anti-HSA and slightly 
increased amounts of anti-DNP antibodies compared with serum samples 
from male birds. This observation contrasts with that reported on 
page 167s where male birds produced appreciably more antibody than 
female birds.
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Experiment l6. Screening of Chicken Anti-HSA Antisera for 
Evidence of Anti-Idiotype Autoantibodies.
The antibody contributing to the negative feedback of a 
response to a given antigen has usually been thought to be specific 
for that antigen, but there has been recent evidence (Fitch, 19T4) 
that it may in fact be an autoantibody specific for an immunoglobulin
idiotype which in turn is specific for the antigen. If this were
true in chickens, it would be expected that serum obtained early in an 
immune response, containing the first idiotypes formed, would react 
with serum obtained from the same individual later in the response 
when anti-idiotype antibody may have been formed. The aim of this 
experiment was to search for evidence of such reactions.
Experimental procedure Six birds (15 weeks of age) were each
immunised with 10 mg HSA in saline, a single intravenous injection.
The birds were bled 5> 6, 7» 9, 10, 11 and ih days after immunisation.
The sera obtained from individual birds at various times 
after immunisation were then tested in a double diffusion gel for 
evidence of autoantibody activity. Each antiserum from an individual 
was tested in turn against the other six antiserum samples from the 
same individual, by placing about 2 yl of the antiserum in a central well 
with- the remaining antisera in six equally-spaced wells surrounding 
(and 10 mm from) this central well. All tests were done at two different 
salt concentrations; i.e. in agar gel containing 0.8% (0.137 M) NaCl 
as well as in agar gel containing 8% (1.37 M) NaCl. This was done to 
exclude the possibility of chicken antibodies failing to precipitate
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at physiological salt concentrations, as has been reported by Hersh 
and Benedict (1966).
The double diffusion gels were left at room temperature 
for 48 hours and then examined for evidence of autoantibody activity, 
in the form of precipitin lines, between antisera taken early during 
the antibody response and antisera collected at later stages in the 
response.
Results Precipitin lines were seen in the gel only for tests
involving antiserum samples from one individual bird. In this case, 
antiserum taken 5 days after immunisation appeared to react with 
antiserum from the same bird taken 7» 9 and 10 days after immunisation. 
However, this reaction reflected the presence of residual amounts of 
HSA in the serum of the bird 5 days after immunisation, which reacted 
in the gel with the anti-HSA antibodies present 7» 9 and 10 days after 
immunisation, rather than demonstrating the presence of anti-idiotype 
autoantibodies.
The bird in question had the highest ABC^^ value at day 7 
of the group of six, and in fact serum (representing days 7, 9 and 10) 
from this bird reacted similarly (i.e. formed weak precipitin lines) 
when tested in a double diffusion gel with day 5 antisera from all the 
other birds in the group (at both high and low salt concentrations).
There was therefore no evidence of anti-idiotype auto­
antibodies being produced and acting to regulate continued biosynthesis 
of specific antibody by the individual.
DISCUSSION
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Among the several factors which control or can influence 
an immune response, the nature of the antigenic stimulus (for 
example, the type and dose of antigen) is one of the most important 
considerations, and affects antibody biosynthesis from its inception. 
In addition there are other factors which may modify or regulate 
an immune response, including for instance the use of adjuvants and 
the operation of homeostatic mechanisms.
The physical and chemical characteristics of an antibody 
response are useful indicators of how that response is being 
controlled. These indications include not only the kinetics of 
biosynthesis but also certain attributes of the antibody molecules 
themselves - their specificity, affinity, avidity, as well as their 
class and the heterogeneity of affinities within a population; all 
of these parameters show considerable variability under experimental 
conditions, thus affording a means of studying the cellular and 
molecular events which constitute an immune response and the 
mechanisms by which it is controlled.
CONTROL RELATED TO IMMUNOGENICITY
The selection of lymphoid precursor cells by antigen was 
studied by following the kinetics of antibody biosynthesis and then 
interpreting experimental results in terms of the induction and 
subsequent regulation of the biosynthesis of specific antibody.
The kinetics of antibody biosynthesis in chickens 
immunised with a single intravenous injection of HSA in saline showed
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that there was a rapid rise in serum antibody levels between h and 
7 days following immunisation, and after the peak level had been 
reached (about the seventh day) there was a steady exponential 
decline in the amount of antibody detected in the serum; these 
findings are apparent from Table 4 (page 118) and are shown in 
Figure 15 (page 119) and were in agreement with the results of White, 
French and Stark (1970). Since chicken IgG has a relatively short 
half-life, for example a value of 1.93 days has been cited by White 
(1973), this means that the rise and fall of serum antibody levels 
quickly reflect the preceding events at the cellular level with 
reasonable accuracy. The early pattern of antibody production can 
therefore be reconciled with an initial recruitment of lymphoid 
precursor cells as a result of antigen molecules interacting with 
cell-bound receptors of complementary specificity, followed by 
differentiation and proliferation of these triggered cells. If 
the interaction between antigen and cell-associated receptors is at 
all analogous to the interaction between antigen and antibody 
in vitro, then clearly this would not be a rate-limiting step in the 
production of antibody. The interval of approximately 4 days between 
the administration of antigen and the detection of free antibody in 
the circulation must be determined by the rate at which activated 
cells differentiate, proliferate and start secreting antibody 
molecules in detectable amounts; it is possible that attributing a 
time lag of 4 days to the processes of differentiation and 
proliferation is an exaggeration - due to the fact that the first 
antibody molecules to be produced by plasma cells will associate with 
antigen in the circulation and will therefore evade detection by an 
antigen-binding assay.
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More direct evidence for the sequence and timing of 
events in the induction phase came from studying the population 
kinetics of specific plasma cells in the splenic red pulp of chickens 
immunised with 10 mg HSA, as reflected by the number of immuno- 
fluorescent antibody-containing cells per unit area at various times 
after immunisation. Plasma cells secreting anti-HSA antibodies 
were first detected in the red pulp of the spleen 3 days after 
immunisation, their number rising sharply to a maximum at 4 days 
and subsequently diminishing so as to be virtually absent 8 days 
after immunisation (Table 5, page 121; Figure l6, page 122); the 
kinetics of the plasma cell population followed the same pattern as 
the kinetics of antibody levels in the serum (Figure 15, page 119) 
but there were temporal discrepancies, for example between the time 
at which specific anti-HSA plasma cells were first detected (3 days) 
and the apparent onset of antibody biosynthesis (4 days), or between 
the time at which the density of specific plasma cells in the spleen 
was at its greatest (4 to 5 days) and the attainment of peak antigen- 
binding capacities in the serum (about 7 days). Perhaps the first 
mentioned of these discrepancies could be explained by the limitations 
of an antigen-binding assay for representing actual biosynthesis of 
antibody at a time when the vast majority of the specific antibody 
molecules secreted by plasma cells are being neutralised by 
combination with antigen in the body, as was suggested previously.
In support of this. White, French and Stark (1970) have shown that 
in chickens immunised with HSA, circulating HSA:anti-HSA complexes were 
detectable at least 1 day before any antigen-binding by the serum was 
evident, and that as much as 10% of a 10 mg dose of HSA injected
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intravenously was still in the circulation 4 days after immunisation. 
Although White, French and Stark (1970) have also reported that the 
maximum number of antibody-containing cells in the red pulp was not 
reached until 6 days after immunisation, it must be pointed out that 
in their experiments peak antibody levels in the chickens were not 
attained until 9 days after immunisation.
The response of chickens to the DNP hapten was studied 
for two reasons; firstly, to find out what features the kinetics of 
the anti-DNP antibody response had in common with the kinetics of the 
anti-HSA response, and secondly, depending upon the capability of 
chickens to biosynthesise anti-DNP antibodies, to measure the affinity 
of anti-DNP antibodies produced under various experimental conditions.
Although the production of anti-hapten antibodies by 
chickens has been reported in the past (Gold and Benedict, 1962;
Orlans, Saunders and Rose, 1968; Gallagher and Voss, 1969 ; Voss and 
Eisen, 1972; Sarvas et al., 1974; Yamaga and Benedict, 1975a), 
there has been no quantitative examination of the kinetics of anti­
hapten antibody biosynthesis in chickens. Orlans, Saunders and Rose 
(1968) have in fact emphasised how surprisingly difficult it was to 
elicit an antibody response in chickens to a haptenated protein (DNP- 
BGG), to the extent that they resorted to intra-splenic administration 
of the antigen in trying to elicit biosynthesis of anti-DNP antibodies. 
Furthermore, Yamaga and Benedict (1975a) have reported that chickens 
given a single intravenous injection of 2 mg DNP-BGG did not produce 
enough antibody for equilibrium dialysis measurements, even though 
both 7s and macroglobulin anti-DNP antibodies were detected by radio- 
immunoelectrophoresis.
195
The importance of the antigen, especially the nature of 
the carrier to which haptens are attached, in controlling the course 
of "biosynthesis was explained in the Introduction (page 39)* The 
early theories, such as postulated by Singer (1964), that the carrier 
did no more than provide a suitably immunogenic local environment 
for each haptenic determinant have largely been superseded, and it 
is now considered more likely that the carrier is recognised by 
specific "helper" cells (probably T lymphocytes) and that this 
recognition somehow facilitates the activation of hapten-specific 
antibody-producing cells (Mitchison, 1969; Rajewsky, 19Tl)*
From the early work of Landsteiner and Simms (1923), 
reinforced by more recent investigations (e.g. Siskind, Paul and 
Benacerraf, I966), it was concluded that to elicit biosynthesis of 
antibodies specific for a haptenic determinant, the carrier to which 
that hapten was attached had itself to be immunogenic. This prompted 
the trial of three different carriers for their suitability to 
promote antibody responses in chickens to the DNP which was conjugated 
to each carrier: the carriers investigated were (l) A large protein
molecule, haemocyanin (MW about T x 10^ daltons) from Helix pomatia.
(2) A particulate carrier in the form of human erythrocytes. (3) A 
structural polysaccharide of regularly repeating units, which in this 
instance was chromatographic cellulose. From the small but 
significant increase in anti-DNP levels detected in serum samples 
between 3 and T days after immunisation of chickens with DNP groups 
coupled to either haemocyanin or human erythrocytes (Table 6, page 126), 
it was apparent that these two entities had some proficiency as
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carriers for the hapten, although the amount of anti-DNP antibody 
produced in either case vas small. DNP coupled to chromatographic 
cellulose elicited no antibody formation (Table 6, page 126); 
although the exact cause for this vas not apparent, perhaps the lack 
of intrinsic immunogenicity invalidated this particular molecule as 
a suitable carrier.
Another aspect of the chemical nature of the antigen vhich 
in other animal models has been found to influence production of 
anti-hapten antibodies, is the degree of substitution of haptenic 
determinants on the carrier. If co-operation betveen carrier- 
specific "helper” T cells and hapten-specific antibody-producing B 
cells can be envisaged as a means for effectively concentrating antigen 
sufficiently for triggering the hapten-specific B cells, as suggested 
by Mitchison (1969), then a high degree of hapten substitution on 
the carrier might be expected to increase the local concentration of 
hapten even more and improve the chances of successful activation.
It has in fact been shovn in mammals by Kontiainen (l9Tl)» Larralde 
and Janof (19T2) and by Davie and Paul (l9T2a) that multi-substituted 
antigens vere more effective than oligo-substituted antigens for 
elicitation of high titre anti-hapten antibodies. On this evidence 
there appeared to be a direct but non-linear relationship betveen the 
degree of hapten substitution (alloving for the increase in the 
absolute concentration of hapten) and the amount of anti-DNP vhich vas 
produced by the animal. This relationship is illustrated in Figure 28 
vhich is based on the observations of Larralde and Janof (l9T2) and the 
same authors also demonstrated that antibody affinity vas inversely 
related to the number of hapten groups per carrier molecule.
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FIG. 28. The effect of the hapten-carrier molar ratio 
upon the quantity and the affinity of anti-hapten antibody 
produced, ( after Larralde and Janof, 1972 ).
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Attempts to relate, by experiment, the amount of anti-DNP 
produced by chickens to the degree of haptenic substitution of the 
immunogen, furnished inconclusive results. Thus neither densely 
(DNP|^ 2~HSA) nor sparsely (DNP^-HSA) haptenated carrier protein 
provoked biosynthesis of anti-DNP antibodies. However it was 
interesting to note that levels of anti-HSA (i.e. antibodies directed 
against the carrier) were inversely related to the epitope density 
(Table J, page 128; Figure 1%, page 129). The simplest 
explanation for this is that at high degrees of substitution the 
haptenic groups were being superimposed upon native determinants of 
the carrier and were thereby diminishing the immunogenicity of the 
carrier. A similar situation has been reported by Parish (1971), 
who described how monomeric flagellin which had been heavily 
acetoacetylated was shown to be apparently non-immunogenic when 
injected into rats. The difference in the response of the chicken 
to lightly and heavily haptenated HSA could therefore reflect a 
paradoxical situation: a sparsely substituted carrier carried
insufficient hapten to promote a response but was itself recognised 
well enough, whereas at high levels of substitution the carrier was 
encumbered by hapten groups, became increasingly non-immunogenic, and 
was not recognised by "helper" T cells.
It has been shown in mammals (Rajewsky et al. , 1968; Katz 
et al., 1970) and more recently in birds (Sarvas et al., 197^) that 
pre-immunisation witli a small quantity of the carrier alone caused an 
enhancement of the primary anti-hapten antibody response upon 
subsequent immunisation with hapten conjugated to the homologous 
carrier. The rationale for this observation was that pre-immunisation
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with a small amount of the carrier stimulated the appropriate 
population of "helper" T cells into a state of preparation and 
proliferation prior to subsequent challenge with haptenated carrier. 
However, chickens pre-immunised with 500 yg HSA 7 days before 
immunisation with either 100 yg or 10 mg HSA failed to produce 
significantly greater amounts of anti-DNP antibodies than birds which 
had not been pre-immunised. In fact, any critical assessment of 
carrier pre-immunisation was impeded by the finding that only those 
birds immunised with a large dose (lO mg) of DNP-HSA produced 
detectable amounts of anti-DNP and indeed in these birds there was 
no apparent enhancement of anti-DNP production as a result of pre­
immunisation (Table 8, page 132). All the birds responded well to 
the carrier and chickens which were pre-immunised with HSA produced , 
correspondingly greater amounts of anti-HSA antibodies. It has 
recently been reported by Sarvas et al. (l97^) that a large pre­
immunising dose (e.g. 200 to 2000 yg BSA or HGG) of carrier actually 
caused specific inhibition of the subsequent antibody response to the 
hapten - perhaps because anti-carrier antibody was inhibiting cell 
co-operation. Thus in the experiment described on page 130, in 
which experimental birds were pre-immunised with a 500 yg dose of 
HSA and challenged with DNP-HSA 7 days later (which would have 
coincided with the attainment of maximum levels of anti-HSA in the 
circulation of these pre-immunised birds), the amount of anti-HSA 
present 7 days after pre-immunisation might well have negated any 
advantage of alerting the carrier-specific "helper" cell population.
Different ways of presenting the DNP hapten (e.g. using
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varions types of carrier, different epitope densities and pre- 
immunisation with carrier alone) seemed to have little effect upon 
the facility of chickens to produce anti-DNP antibodies, and the 
poor anti-DNP responses made it difficult to evaluate these 
variations in the antigenic stimulus. A number of years ago it was 
reported by Wolfe and Dilks (ip48) that older birds produced more 
antibody than did younger birds and they suggested that some of the 
immunological faculties of chickens were not fully developed until 
about 5 weeks of age. .In addition, certain characteristics of the 
antibody response in chickens immunised with HSA in PGA have also 
been shown to be age-dependent (Henderson, 1975)* In foetal and 
neonatal mice the heterogeneity of anti-hapten antibody affinities 
was apparently much less than in adult mice (Goidl and Siskind, 1974) - 
again suggesting that certain parameters of the antibody response 
were age-dependent. In the experiments in which the effects of
epitope density, choice of carrier and pre-immunisation were 
investigated, the birds used were never older than 8 weeks - both because 
of the availability of young birds and because chickens aged 6 to 8 
weeks were known to respond consistently well to immunisation with a 
protein antigen (e.g. HSA), there was no precedent for excluding 
them. However, it was found that immunisation of 15-week old adult 
birds with 5 mg DNP-HSA injected intravenously elicited not only a 
significant anti-DNP response (Table 9, page 134; Figure 19, page 136) 
where a similar immunisation schedule in younger birds had proved 
unproductive, but a strong anti-HSA response was also detected (Table 9, 
page 134; Figure 18, page 135)- Certainly, most previous reports 
of anti-hapten antibody biosynthesis have involved immunisation of
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adult birds (e.g. Orlans, 1968; Yamaga and Benedict, 1975%), although 
young inbred birds {k - 10 weeks) have been used for producing anti- 
NIP (4-hydroxy—3-iodo-5-nitrophenylacetyl) antibodies (Sarvas et al., 
1974). The results reported here therefore strongly suggested that 
the age of the birds was important in determining their responsiveness 
to dinitrophenylated antigens.
The kinetics of the anti-DNP response in 15-week old 
chickens are given in Table 9 (page 134) and shown in Figure 19 (page 
136), and the pattern of this response may be compared with that of 
■the anti-HSA response in the same birds (Table 9; Figure I8, page 135)» 
There was virtually no anti-DNP activity detected in serum samples 
3 days after immunisation, but from then onwards there was a steady 
increase in serum antibody levels. These antibody levels reached 
maximum values about 7 days after immunisation and subsequently 
decreased - although the decline of anti-DNP antibody levels was not 
as patently exponential as the decline of anti-HSA antibody levels.
The pattern of the kinetics of anti-DNP biosynthesis was therefore 
broadly similar to that for anti-HSA production, implying that the 
previous discussion about the sequence and timing of events prior to 
and during secretion of anti-HSA antibody molecules was also tenable 
for the anti-DNP response. It is worth noting that the specificity 
of the assay system for anti-DNP was confirmed by the fact that serum
from bird number 89I, which had been immunised simply with native HSA,
failed to bind the radio-labelled DNP-CSA. A comparison of the
anti-HSA and anti-DNP responses just described showed no apparent
correlation between the two; this supported the proposal that the 
carrier was indeed playing a secondary role (e.g. facilitating cell
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co-operation) rather than merely providing suitably immunogenic 
locations for hapten groups. If this latter suggestion were correct, 
then a positive correlation between the antibody response to the 
carrier and to the hapten moieties might have been expected.
The importance of the nature of the antigen and how it is 
presented and the relevance of these factors when considering 
extrinsic control of antibody biosynthesis, have already been 
emphasised. Immunological memory is an intrinsic control mechanism 
which usually results in enhanced antibody biosynthesis when an animal 
is re-immunised with the same antigen as used for primary immunisation. 
To explain this phenomenon it has been suggested by Sercarz and Coons 
(1962) that three different cell types, representing different phases 
in the differentiation of the immunocompetent cell, may be recognised 
and they have been annotated as follows; x ; virgin lymphocytes 
which have had no contact with antigen, y ; memory cells, z : 
antibody-forming cells derived from x or y as a result of antigenic 
stimulation. One attractive possibility is that x ->• y,y ->■ z and x z 
transitions all proceed via a common activated blast cell intermediate. 
The operation of immunological memory is therefore manifest in a 
secondary response; in the primary response a relatively small number 
of X cells specific for the antigen are induced to differentiate and 
proliferate, but some time (a time of k days after injection in the 
case of chickens was arrived at - see page 115) must elapse before the 
number of antibody-forming cells has expanded sufficiently to produce 
detectable serum antibody. By contrast, in the secondary response 
the individual starts with an expanded population of y cells whose
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proliferative response to antigen is more immediately reflected by 
an increase in serum antibody which subsequently reaches a higher 
level relative to the primary response because of the greater 
number of committed cells produced. When the DNP group, attached 
to a different carrier, was used for a second immunisation in adult 
birds, an anti-DNP response with the apparent characteristics of an 
anamnestic response (i.e. a more rapid and intense response) was 
observed. Thus, re-immunisation with 2 mg DNP-HCN of birds primed 
with 5 mg DNP-HSA resulted in high anti-DNP levels in all the birds 
(Table 10, page 139i Figure 20, page l4o), the peak value of which 
was up to ten times the corresponding value recorded at the peak of 
the primary response. If these secondary responses were genuinely 
anamnestic (with respect to the hapten), then there was no evidence 
of the "carrier effect"; i.e. there was no apparent requirement 
that the hapten be coupled to the same carrier both times for it to 
elicit a response having the characteristic kinetics of an anamnestic 
anti-DNP response. This might suggest that carrier-specific 
"helper" T cells were not involved in promoting the anti-hapten 
response, the DNP conjugates (DNP-HSA and DNP-HCN respectively) 
behaving effectively as T-independent antigens. On the other hand, 
it could be that haemocyanin is a more efficient carrier anyway, and 
that the supposed anamnestic response was in fact a more intense 
primary response. There was certainly no indication of tolerance to 
the DNP hapten in the secondary response, making tolerance an unlikely 
reason for the unresponsiveness to DNP found in young birds. Some 
of the birds which were primed with DNP-HSA were challenged with 
native HSA alone; here again there was a marked increase in anti-HSA
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levels in the secondary response compared to those seen in the 
primary response (Table 10, page 139; Figure 21, page l4l) and 
it was evident that those birds which responded well in the primary 
response also responded well to a second injection of antigen (i.e. 
if for these chickens the obtained 7 days after primary immun­
isation is compared with the ABC^Q obtained in the same bird 7 days 
after secondary immunisation, then the correlation coefficient was
0.998 and the probability of obtaining so high a value by chance was 
P = 0.02). This positive correlation would be consistent with the 
idea that antibody-forming cells and memory cells were derived from 
a common activated blast cell intermediate, and that consequently the 
numbers of antibody-forming cells and of memory cells were both 
dependent upon the number of precursor cells which were activated by 
antigen.
Whilst a certain amount of information concerning the 
control of antibody biosynthesis may be inferred from the kinetics of 
antibody biosynthesis alone, the average affinity and the overall 
distribution of affinities, and the variation of these parameters under 
different experimental conditions, provide more detailed evidence about 
the cell selection process inasmuch as the characteristics of secreted 
antibody are very probably analogous to those of receptor molecules. 
Another reason for investigating the immunogenicity of dinitrophenylated 
antigens in chickens was therefore to establish an experimental system 
for accurately measuring antibody affinity in chickens.
An equilibrium dialysis system was devised for measuring 
the affinity of chicken anti-DNP antibodies for the ligand DNP-e-
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ajninocaproic acid which incorporated the following features;
”3(l) A wide range of hapten concentrations (a range from 10 to 
10 ^ M DNP-EACA) was used, comparable for example to the range 
employed by Werblin and Siskind (l9T2a) who were dealing with free
~6 —% 3
hapten concentrations at equilibrium ranging from 10 to 10 M.
This effectively ensured that each antibody subpopulation would, at 
some of the hapten concentrations used, be partly and only partly 
saturated with hapten. Unless this condition is attained for every 
antibody subpopulation, the affinity measured might not be 
characteristic of the whole population of antibody molecules. In 
other words, the antibody population effectively studied might be 
artificially selected if a narrower range of hapten concentrations 
was used; this might have happened for example in the experiments of 
Eisen and Siskind (1964) and Little and Counts (1969)» who used free 
hapten concentrations with less than a one hundred-fold difference 
between the highest and lowest hapten concentrations. (2) Only 
whole serum or else a crude globulin fraction was dialysed, thus 
avoiding possible selective loss of high affinity antibody during 
purification, as has been shown to occur by Lopatin and Voss (1974b).
(3) For calculating the geometric mean intrinsic association constant 
(i.e. the average affinity) a graph of log [bound hapten] against log 
[free hapten] was plotted; in theory, the concentration of free 
hapten required to saturate all antibody combining sites could then 
be read directly from the plateau of the graph (as described on page 97) 
such that no independent measurement of antibody concentration was 
required. Once the concentration of combining sites, [Ab^], had 
been found, values for the average affinity (K^) and the heterogeneity
206
index (a) could then be determined using the relationships 
(derivation shown on page 95 et seq.) that; (i) the intercept on
the log [b] axis is equal to log [Ab^]. and (ii) the slope of
the straight line portion of the graph is equal to a.
The logarithmic scale used for the concentrations of both free and
bound hapten prevented clustering of the experimental points at one 
end of the graph. (4) Single containers (300 ml capacity poly­
ethylene bottles) were used for each different hapten concentration, 
each containing a large volume (200 ml) of hapten solution;
Werblin, Kim, Smith and Siskind (1973) have recommended using large 
volumes of hapten solution in order to minimise errors due to 
radioactive contaminants and impurities in the hapten solution.
The equilibrium dialysis data is represented typically by 
the graphs shown in Figure 13 (page 102). These graphs are
different from conventional graphs of such data, examples of which 
are shown in Figure 29; for instance, Eisen and Siskind (1964) and 
Little and Counts (1969) plotted log r/(n-r) against log c (where 
r = moles of hapten bound per mole of antibody, n = maximum number 
of moles of hapten that can be bound per mole of antibody and c - 
concentration of free hapten). From the straight line drawn through 
various values of log r/(n~r) and log c, the parameters a (index of 
heterogeneity) and K^ (geometric mean intrinsic association constant) 
were determined using the relationship log r/(n-r) = a log c + a log K^ 
which is the Sipsian adsorption isotherm. A graph of this sort 
is shown in Figure 29(A). Another method sometimes used is to 
construct binding curves as Scatchard plots of r/c against r (where
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FIG. 29. Representative graphs of equilibrium dialysis data. 
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r represents moles of ligand boimd per mole of antibody at free 
ligand molar concentration c), as done for example by Lopatin and 
Voss (l9T^a) and Hoffmeister and Voss (l97^) using the relationship 
r/c = nK - rK (as before, n is the limiting value for r at infinite 
c and K is the equilibrium constant), A third method, such as 
used by Werblin and Siskind (1972a), was to plot l/R against l/C 
according to the equation l/R = l/KW.l/C + l/N (where K is the 
equilibrium constant, R is the concentration of bound antibody sites, 
N is the total concentration of antibody sites in the reaction 
system and C is the equilibrium concentration of free hapten). 
Experimental data plotted according to both these methods are also 
shown in Figure 29(B & C), For all three methods the equations 
used are all essentially equivalent and were derived from the law 
of mass action.
The equilibrium dialysis system and the methods for 
plotting data and thence determining the affinity and heterogeneity 
index were given in detail on page 97 et seq,, and Figure 13 (page 
102) shows two typical plots; the salient features of these two 
graphs, which serve as an appraisal of the method, were as follows, 
(l) The portion of the log [b] against log [c] graph at low values 
of [c] was consistently a good straight line. Values of the 
heterogeneity index, calculated from the straight line portion using 
the relationship log [b] = a log [c] + log ([Ab^].K^^), were usually 
equal to, or just less than 1.0, indicating marked homogeneity of 
the antibody population. A similar finding has been reported for 
rat anti-DNP antibodies by Larralde and Faber (l97l)* (2) From
the equations derived for calculating antibody affinity, it was
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predicted that a definite, flattened plateau should be obtained 
at high concentrations of free hapten ; in practice (see Figure 13) 
this was seldom achieved and the concentration of free hapten at 
which all antibody combining sites were occupied by hapten was 
indeterminate - often there was no real flattening of the graph
— Ij. - g
(even at free hapten concentrations of 10 and 10 M), and in
instances where saturation of antibody combining sites with hapten
was evident the considerable scatter of experimental points at
high values of [c] introduced significant errors in the exact
positioning of the "plateau”. This predicament was aggravated
by the proportionally small amounts of radioactive hapten which
could be used at the high concentrations of free hapten, and thus
the amount which could bind to antibody was correspondingly small,
(3) The values for antibody affinity which were calculated from
graphs such as those shown in Figure 13, were consistently low
(e.g, between 10^ and 10^ litres mole ^), and the question arises
whether this sort of affinity can justifiably represent specific
binding by antibody; if so, it is difficult to see how antigen
would interact with receptors of such low affinity in the first
place. Werblin, Kim, Quagliata and Siskind (1973) have operationally
defined as specific antibody those combining sites occupied by
-6hapten at a free hapten concentration of 5 x 10 M or less. There 
was therefore an apparent lack of high affinity anti-DNP antibody 
produced in chickens immunised with a single intravenous injection 
of either 10 mg or 100 yg DNPg^-HSA (Table 11, page lUH), and a 
similar finding has been reported by Yamaga and Benedict (1975&) “ 
a maximum range in -AG^ from 8.28 to 9*19 kcal mole ^ (equivalent to
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5 6 . ” 1K = 8.6 X 10 to 3.9 X 10 litres mole ) for birds given two 
o
injections of DNP-BGG at a variety of doses (e.g. from 20 yg to
20 mg DNP-BGG with an interval between the two injections of 1, 3
or 8 weeks). At the same time, Yamaga and Benedict (l975b) have
found that-immunisâtion of chickens with antigen in FCA gave rise
to production of higher affinity antibodies, and Hoffmeister and
7 “ 1Voss (197^) have given a value of 1.6 x 10 litres mole for 
anti-DNP antibodies from chickens which had received three injections 
of 9 Bg DNP-BGG in FCA. In conclusion, it was found that chickens 
produced anti-DNP antibodies of very low affinity but of considerable 
homogeneity following an intravenous injection of either 10 mg or 
100 yg DNP-HSA. On the evidence of restricted precipitin arcs seen 
in radio-immunoelectrophoresis, Hoffmeister and Voss (l97^) have 
previously suggested that chicken anti-DNP antibodies seemed to be 
less heterogeneous than, say, rabbit anti-DNP antibodies. In the 
light of the findings that adult birds responded well to an immunogen 
such as DNP-HSA whereas young birds did not, then perhaps in this 
case the age of the birds (10 weeks) was critical. Alternatively, 
Mond, Kim and Siskind (l97^), iu order to explain why rabbits 
immunised with a single intravenous injection of 15 mg DNP-HCN 
failed to produce high affinity antibodies, have suggested that at 
higher antigen doses only low affinity antibody-producing cells were 
triggered whilst cells of high affinity were tolerised.
Affinity has been used to describe the quality of 
antibody in terms of its interaction with a simple molecule such as 
a hapten; since the interaction between antibody and a complex 
antigen (e.g. HSA) cannot be characterised or defined in quite the same
211
way (because each antigen is made up of a number of different 
determinants, probably each of which serves as a target for 
antibody molecules with specificity for that determinant), certain 
assumptions have to be made before the law of mass action can be 
applied to the interaction between antiserum and a complex antigen. 
For this reason, the quality of binding between antiserum and a 
complex antigen is described as the avidity of that antiserum - 
and because of the conditions which have to be made before an 
avidity value can be calculated, it is only a relative value and 
cannot be regarded as an accurate thermodynamic expression of 
binding in the same way as affinity can. Nevertheless, methods 
for determining antibody avidity have been described, for example 
Steward and Petty (1972) have reported avidities for mouse anti-HSA 
antibodies, and a similar method was used here for finding the 
avidity of chicken anti-HSA antibodies (procedures described in 
detail on page 86 et seq.).
The effect of a second encounter‘with antigen upon the 
antibody response of an individual has already been mentioned and 
its implications for a selection theory regulated by the operation 
of immunological memory have been discussed. The same sort of 
mechanisms might be expected to operate when an individual is given 
several injections of the same antigen (i.e. primed with antigen and 
then boosted) - thus the first immunisation would trigger some 
antigen-sensitive precursor cells to differentiate into antibody- 
forming cells, others into memory cells; antigen injected 
subsequently would utilise these memory cells, resulting in a 
relatively larger number of cells being activated to producing
212
antibody - and yet more memory cells would be initiated so that a 
further antigenic stimulus would again result in enhanced antibody 
production. On the basis of a cell selection theory it might be 
predicted that repeated injections of the same antigen would cause 
an animal to produce antibody of progressively higher avidity;
i.e. as more antibody was produced in response to successive 
antigenic challenges, the greater would be the competition between 
the combining sites on secreted antibody molecules and those on 
cell surface receptor sites - resulting in selective stimulation of 
those cell receptors of high avidity. When chickens were 
immunised with successive 40 yg doses of HSA injected intravenously 
at weekly intervals (i.e. challenge was made at the presumed peak 
of antibody biosynthesis resulting from the preceding injection), 
a consistent pattern in both the antigen-binding capacity and the 
avidity of antibody was observed (Table 12, page 1^8). In terms of 
the absolute amounts of antibody present, there was always a 
considerable drop in antigen-binding capacities in serum samples 
taken the day after injection of antigen - indicating that systemic 
interaction between antigen and antibody had occurred or else that 
free antigen present in the serum was competing with, and therefore 
inhibiting, binding of the radio-labelled antigen used in the avidity 
assay system. However, at least some of each booster injection had 
obviously reached and stimulated precursor cells, as was evident 
from the increased levels of circulating antibody observed 6 and 7 
days after each challenge (with the noteable exception of those 
values observed at the end of the second week). The avidity of 
antibody from each bird in this experiment was significantly higher
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at 27 days than it was at 20 days after the initial injection of 
antigen (e.g. the average avidity at day 20 compared with that at 
day 27 by a two-tailed t-test gave P = 0.017)* There was no 
discernible pattern of avidity changes for the serum samples taken 
on 3 days consecutively (i.e. before and after boosting with antigen) 
in any one week. This observation was consistent with the idea that 
maturation of antibody affinity or avidity with time after immunisation 
is a result of selection of antibody-forming precursor cells of 
progressively higher affinity as antigen concentration becomes less, 
rather than being due to selective removal of antibody of high 
affinity (or avidity) from the circulation at the start of the 
response when antigen is present in copious amounts. The significant 
increase in avidity at the end of the fourth week could well have 
been due to the increased amounts of antibody present at the end of 
three weeks (Table 12, page l48) competing with the antigen-sensitive 
cell receptors and resulting in cells of high avidity being 
selectively stimulated to differentiate into antibody-producing cells.
So far, the control of antibody biosynthesis has been 
related to the immunogenicity of the antigen. However, an antibody 
response is usually governed by additional factors which may for 
example modify the immunogenicity of the antigen and influence 
biosynthesis in this way or else may regulate antibody production 
once active biosynthesis has started.
THE EFFECTS OF ADJUVANT UPON THE IMMUNOGENICITY OF THE ANTIGEN AND 
UPON THE BIOSYNTHESIS OF ANTIBODIES
It has been recognised for many years that certain
2lh
substances, when administered to an animal in accompaniment with 
antigen, will cause a potentiation (i.e. will provoke an increase 
in the amount and/or duration) of antibody biosynthesis to that 
antigen. For this reason such substances have been termed 
adjuvants, and their effect upon the control of antibody biosynthesis 
is obviously of great interest. The theories which have been 
postulated in the past concerning the mode of action of adjuvants are 
numerous and each of the different properties of an adjuvant have 
been implicated at some time or other: thus, adjuvanticity has been
attributed, wholly or in part, to a variety of factors, including 
the depot effect, enhanced activity at cell surfaces, labilisation of 
lysosomes and increased phagocytosis of the antigen.
A study of the kinetics of antibody biosynthesis in 
chickens which had been immunised with HSA in FCA enabled certain 
conclusions to be reached as to how adjuvants may cause modification 
of antibody biosynthesis. The general pattern (Table 13, page 152; 
Figure 22, page 153) of the kinetics of anti-HSA antibody production 
showed that there was an initial phase of biosynthesis analogous to 
a primary antibody response, and from about 7 days onwards there was 
a definite decline in antigen-binding capacities for birds immunised 
with 5 mg HSA, and at least a stabilisation of antibody levels in 
birds immunised with 100 yg HSA. However, between 3 and 4 weeks 
following primary immunisation of chickens with either 5 mg or 100 yg 
HSA in FCA a second phase of antibody production was observed in most 
of the birds, which persisted for at least 3 weeks. These findings 
are in agreement with those of French, Stark and White (1970)> who
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reported similar biphasic responses for birds immunised with yg 
HSA in FCA. Although antibody levels in the second phase of 
biosynthesis (that is in birds showing the biphasic response) were 
somewhat higher than the levels in the same individuals during the 
initial phase, these increases were certainly not as great as some 
of those reported by French, Stark and White (19T0)* However, the 
second phase certainly lasted much longer than the first phase, and 
mean ABC^^ values showed no sign of diminishing up to I48 days after 
immunisation. The question of how adjuvants affect the control of 
biosynthesis may be discussed from at least two points of view.
The first consideration is that antigen is probably released only 
slowly from the site of injection, so that small amounts will be 
present in the circulation and tissues for a considerable time - in 
contrast to the fate of antigen when it is administered as a single 
intravenous injection; for example, White, French and Stark (19TO) 
have shown that in chickens a 10 mg dose of HSA was virtually cleared 
from the circulation by the fifth day after 'injection. The second 
factor to bear in mind is the inclusion of mycobacteria in the oil 
phase of the water-in-oil emulsion. It has been argued by White 
C1973) that the mycobacteria were responsible for structural 
disorganisation of germinal centres, and that this in turn disrupted 
the homeostatic processes whereby specific clones of lymphocytes were 
segregated into germinal centres: the end result of this being that
the homeostasis which regulated the biosynthesis of specific antibody 
was alleviated. The kinetics of antibody biosynthesis seen here 
(Figure 22, page 153) were consistent with an initial phase of 
antibody production, which was regulated to some extent by homeostasis
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(e.g. in birds immunised with 100 pg HSA in FCA the mean ABC^^ 
levelled off after about the seventh day, rather than showing any 
tendency to decline whilst in birds immunised with 5 mg HSA in FCA 
there were more definite signs of homeostasis). Subsequently there 
was a failure of the homeostatic mechanism, either as a direct 
result of the action of mycobacteria or else because homeostasis 
only endures for a finite period of time anyway, and a second 
prolonged phase of antibody biosynthesis was elicited by small amounts 
of antigen leaking from the water-in-oil emulsion in the muscle.
In some ways the kinetics of the antibody response following 
immunisation with HSA in FCA, as shown in Figure 22 (page 153), 
were similar to the kinetics observed in chickens given repeated 
intravenous injections of HSA at weekly intervals (Table 12, page 1^8); 
in the latter experiment, after a refractory phase in the second 
week, there were marked increases in antibody levels during the third 
and fourth weeks after the initial injection - suggesting that the 
homeostasis which regulated the primary response to antigen was no 
longer effective after this length of time or with repeated antigenic 
stimulation. Perhaps the same sort of process was happening in 
birds immunised with antigen in adjuvant. In any case, the duration 
of the second phase of biosynthesis showed that there had been no 
repetition of the sharp negative feedback seen in the first phase or 
in the secondary response provoked by a second intravenous injection 
of antigen.
There was a significant correlation between the antigen- 
binding capacity of serum and that of granuloma extract when compared
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in samples taken ^8 days after immunisation, for birds immunised 
with 100 yg HSA in FCA (correlation coefficient = 0,989; P = 0,0057) 
and a fair correlation for birds given 5 mg HSA in FCA (correlation 
coefficient = 0,788; P = 0.057)> and this is shown in Figure 23 
(page 156). One plausible explanation for such good correlation 
is that most, if not all, of the antibody produced at later stages 
of the second phase in fact comes from the granuloma. This would 
agree with the findings of French, Stark and White (1970) who reported 
that there were no genuine anti-HSA-producing plasma cells in the 
spleen in the second phase of the response in birds immunised with 
HSA in FCA but that the antibody content of the granuloma at this 
time (e.g. days) was between four and thirty times greater than 
that found in any other tissues (including the spleen), and 
histological examination of the granuloma showed an intense 
infiltration of plasma cells around the periphery.
Changes in the quality of antibody during the first and 
second phases of the response following immunisation with antigen in 
FCA were monitored by the changes in avidity; measurement of avidity 
of antibody to a protein antigen (HSA) was preferred to measuring 
affinity of anti-hapten antibodies because of the very low affinity 
values obtained for anti-DNP antibodies in chickens. It has already 
been argued that the second phase of the adjuvant-assisted response in 
chickens could be considered as a secondary response stimulated by 
antigen still present in an immunogenic form. There remains the 
question of whether this persistent antigen, which is slowly and 
continuously released from the antigen depot, stimulates the same 
clones (in the form of specific memory cells for example) of antibody-
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producing cells which accomplished the initial phase of the response 
or whether it stimulates a different population of cells once the 
homeostatic regulation has been actively alleviated or has relaxed 
spontaneously. In the first instance (i.e. stimulation in the 
second phase of antibody-forming cell precursors analogous to those 
triggered in the primary phase) an overall increase in antibody 
avidity between first and second phases (the increase determined by 
the passage of time and by the exponentially decreasing amounts of 
antigen released from the water-in-oil emulsion) might be expected. 
Conversely, if a different and dissimilar population of antibody- 
producing cells was involved in the second phase of antibody 
biosynthesis, then an equal or lower avidity in the second phase 
might be predicted since the higher affinity clones might have been 
selectively stimulated in the first phase, leaving only the lower 
affinity clones to respond in the second phase. Such a comparison 
of avidity for antibody from the first and second phases respectively 
gave equivocal results (Table lU, page l6l). In all cases the 
avidity of antibody measured at 29 days after immunisation with 
antigen in either FCA or FIA was higher than the corresponding value 
after 5 days, and this tendency for the avidity to increase has 
previously been reported by French, Stark and White (19T0). Although 
it seemed that immunisation of chickens with antigen in Freund's 
complete or incomplete adjuvant appeared to cause an increase in 
anti-HSA avidity in the second phase (e.g, at day 29) relative to 
the first phase of the response (e.g, at day 5), these increases 
were not statistically significant (P = 0.13 and P = 0.29 respectively) 
when compared using a two-tailed t-test. However, these increases.
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although not satisfying the statistical criterion P < 0.05, did 
provide some indication, especially when considered along with 
previous results of French, Stark and White (1970), that time- 
dependent and dose-dependent increases in avidity had occurred, 
evidence that a similar cell population (memory cells programmed 
during the initial phase perhaps) to that which participated in 
the first phase of the adjuvant-assisted response was also 
responsible for production of antibodies in the second phase.
Several properties of antibody molecules which help in 
elucidating control mechanisms have already been mentioned (e.g. the 
specificity, affinity and heterogeneity of the molecules); another 
characteristic which has proved useful in this respect is the isotypic 
heterogeneity of antibody molecules - the immunoglobulin class to 
which they belong. For example, the proportion of 198 to 78 
antibody has been found to vary with the type of antigen (e.g. large 
antigen molecules made up of regularly repeating subunits tend to 
elicit production of IgM antibodies predominantly), with the dose of 
antigen and with time after immunisation (e.g. a general pattern is 
for early IgM biosynthesis which is subsequently replaced by IgG 
production). Accordingly, it has been shown by Nielsen (197^) that 
following immunisation of chickens with SRBC there was an early IgM 
response which rapidly gave way to biosynthesis of IgG antibody.
On page 20 it was argued that this sort of pattern could be explained 
by preferential stimulation of'IgM-producing cells early on by 
multivalent antigen (because of the advantages of IgM itself being 
multivalent and therefore having a high net affinity for such antigen)
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followed later by activation of IgG-producing cells by partially
ft II
degraded (oligovalent) antigen - as suggested by Makela et al. (1967). 
On the one hand this scheme is confounded by reports that both IgM- 
and IgG-producing cells carry monomeric IgM receptors (Vitetta, Baur 
and Uhr, 1971)» but on the other hand it is compatible with the 
idea that IgG antibody specifically inhibits production of IgM 
antibody (e.g. as reported by Finkelstein and Uhr, 1964).
A comparison of the relative amounts of 198 and 78 
anti-HSA antibody in the primary, secondary and adjuvant-assisted 
antibody responses in chickens was made (see Table 15 a & b , page 
163, and Figure 24, page l64). In the primary response following 
immunisation with 5 mg HSA injected intravenously, 78 antibody 
constituted 71% of the total anti-HSA after 7 days, whereas at the 
7-day peak of a secondary response following challenge with 2 mg 
HSA injected intravenously just over 80% of the total was 78. There 
is a considerable discrepancy between these values and those reported 
by Pierce, Chubb and Long (1966); these authors found that antibody 
obtained from chickens 7 days after immunisation with BSA (100 mg per 
kg body weight injected intraperitoneally) consisted of only 33% IgG 
(67% IgM) as measured by passive haemagglutination with antibody 
fractions separated by sucrose density gradient ultracentrifugation. 
Furthermore, Pierce, Chubb and Long (1966) also reported that 
antiserum obtained from these same birds 7 days after secondary 
immunisation with 10 mg BSA injected ip contained 45% IgG (55% IgM) 
anti-BSA. More recently, Yamaga and Benedict Cl975u) have shown
that anti-DNP antisera which were obtained after two injections of
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DNP-BGG (2 mg iv) and then fractionated by gel filtration, consisted 
of between 37% and 68% IgM when the two injections were given one 
week apart, and between 29% and 35% IgM when injections were given 
three weeks apart; for antigen doses other than 2 mg (e.g. 20 yg,
200 yg or 20 mg DNP-BGG) the antibody response was made up entirely 
of IgG antibodies. The distribution of antibody classes in antiserum 
samples obtained from birds immunised with 5 mg HSA in FCA (given in 
Table 15a, page l6s) was 63% 7S anti-HSA (37% 19S) in the first phase 
(day 7) rising to between 60.5^ (day 28) and 83% (day 34) in the 
second phase. Thus the proportion of 7S to 198 anti-HSA in the 
second phase of the adjuvant-assisted response was very similar to 
that seen in a genuine anamnestic response. This would fit in with 
the idea that in the secondary response (and by analogy, in the 
second phase of the adjuvant-assisted response), memory cells 
sensitized during the first encounter with antigen were promoting 
biosynthesis but with the omission of much of the preliminary IgM 
production seen in the primary response. Perhaps the switch from IgM to 
IgG antibody production which occurred in the primary response had been 
maintained in the memory cells.
The modifications in antibody biosynthesis in chickens 
resulting from administration of adjuvants may therefore be partly 
attributed to two important properties of the adjuvant mixture: 
firstly the dispersal of antigen in the aq.ueous phase of a water-in- 
oil emulsion and secondly, the presence of mycobacteria - which 
appears to inhibit homeostasis in chickens (White, 1973) and might 
anyway be expected to exert some non-specific stimulatory effect ( at
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least on macrophages and possibly on lymphocytes as well). The 
operation (and break-down) of homeostatic regulation has been 
investigated in a different experimental system by Nielsen (19T4)
and White and Nielsen (1975) who demonstrated that coneommittant
10 9 immunisation of chickens each with 10 sheep erythrocytes and 10
heat-killed Salmonella adelaide cells gave rise to an oscillatory
pattern of anti-SRBC antibody biosynthesis which was predominantly
198 antibody and showed at least three successive peaks, 7 to 9,
15 to 17 and 25 to 29 days after injection. It could be argued that
the oscillation was due to incomplete homeostasis - which in turn might
have been brought about by the S. adelaide or could be attributed to
a lack of 78 antibody production allied to the fact that 198 antibody
had only a limited capacity for inhibiting further biosynthesis.
As with the biphasic response observed in chickens immunised with
antigen in FCA, comparison of antibody avidities at successive peaks
of biosynthesis should provide some indications of the cellular
events involved in the oscillation. With this aim in mind, an
attempt was made to elicit cyclical production of antibody to HSA
(a T-dependent antigen) by immunising chickens with HSA adsorbed onto
SRBC (10^^ HSA-SRBC per bird) injected together with 250 yg lipo-
polysaccharide from E. coli. In fact there was no evidence of
cyclical biosynthesis of anti-HSA (Table l6, page l68); however,
there was an appreciable anti-HSA response -.which at least indicated
that HSA adsorbed onto SRBC (aided perhaps by the adjuvant action of
the lipopolysaccharide) was a potent immunogen. Although the exact
quantity of HSA adsorbed onto the sheep erythrocytes was not known,
Wolberg, Liu and Adler (1969) have estimated that the maximum amount
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of BSA which could he adsorbed onto 6 x 10 tanned sheep 
erythrocytes was 4 yg; on this basis it would be expected that 10^^ 
sheep erythrocytes (i.e. the number of SRBC injected into each bird) 
would be coated with a total amount of HSA equivalent to not more 
than 67 yg. It was interesting to note that the decline of anti-HSA 
antibody levels once the peak had been reached about 7 days after 
immunisation was much slower than in birds immunised with HSA in 
saline, and this effect was apparently independent of the inclusion 
of bacterial lipopolysaccharide. From the experimental results 
given in Table I6 (page 168) it was noted that the sex of a bird 
had a direct bearing upon the amount of anti-HSA antibody present in 
the serum of that bird (e.g. typified by comparing peak ABC^g values 
6 days after immunisation). The male birds responded significantly 
better than the female birds of the same age and strain - e.g. ABC
30
at 6 days ranged from 58.7 to 84.1 yg HSA ml ^ for male birds and
from 7.9 to 26.8 yg HSA ml ^ for females, and comparing these values 
by a two-tailed t-test gave P < 0.001. Although the female birds 
were.slightly smaller in size than the males, it was unlikely that 
this made much difference to the dosage of antigen (in terms of mg 
per kg body weight). There remains the possibility that the genes 
controlling the antibody response are sex-linked or that certain 
aspects of biosynthesis are subject to some sort of hormonal 
regulation.
REGULATION OF ANTIBODY BIOSYNTHESIS
The homeostatic regulation of antibody biosynthesis has 
already been referred to several times; for example, by studying the
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kinetics of production of anti-HSA antibody (Figure 15, page 119) 
and of anti-DNP antibody (Figure 19, page 136) it was obvious that 
serum antibody levels started to fall about 7 days after immunisation - 
which could have been due either to the removal of antigen and lack 
of further stimulation, or else to active inhibition of biosynthesis.
The latter hypothesis, i.e. active inhibition,is strongly supported 
by the observation of a refractory phase in birds given a second 
injection of antigen 7 days after primary immunisation (Table 12, 
page l48) and in chickens immunised with antigen in Freund’s complete 
adjuvant (Table 13, page 152). These findings suggested that 
antibody biosynthesis was being actively regulated and it has been 
proposed that this takes the form of negative feedback inhibition by 
circulating antibody. A similar mechanism has been implied for
II
regulation of antibody responses in mammals (Uhr and Moller, I968).
To investigate this proposed mechanism in chickens it was considered 
justifiable to use passive immunisation with specific antibody as a 
means of trying to simulate this homeostatic regulation in vivo.
Passive anti-HSA antibody administered 24 hours before 
active immunisation was found to cause an appreciable degree of 
immunosuppression (Table 17» page I7I; Figure 25, page 172). By 
comparison, the direct effect of passive antibody injected 48 hours 
after active immunisation was difficult to assess because antibody in 
the circulation (e.g. at J days) could be attributed partly to active 
synthesis and partly to survival of the passively administered antibody, 
It was possible to calculate from the observed rate of antibody decay 
(between 7 and 10 days) how much passive antibody was likely to survive 
for 7 days, and to derive by subtraction an adjusted mean ABC^^ at 7
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days which represented the amount of antibody synthesised by the 
birds themselves (e.g. adjusted mean = 2.5 yg HSA ml ^).
There was, however, no significant difference between this value and 
the mean ABC^Q at T days for the control group of chickens (which 
received no passive antibody). On the evidence of this rough 
calculation passive anti-HSA given 48 hours after active 
immunisation appeared to be relatively ineffective. Probably it 
was given too late to have any significant effect on the course of 
biosynthesis. The timing of events which follow administration of 
antigen and precede the appearance of large amounts of antibody in 
the serum has already been discussed. Thus, after 48 hours it might 
be expected that receptors on progenitor cells had already been 
triggered and activation of these cells had been induced but that the 
processes of cellular differentiation and proliferation prior to 
secretion of specific antibody on a large scale were not fully 
completed. In this situation passive antibody given 48 hours after 
antigen might be too late to have much influence on the clonal 
expansion of activated cells. This argument is reinforced by the 
work of White, Henderson, Eslami and Nielsen (1975) who have 
described the localisation of a protein antigen in the chicken spleen: 
one of the first events was the departure of antigen, complexed with 
antibody, from the blood into the white pulp of the spleen - and 
this process took place from about 30 hours after immunisation, 
indicating that some antibody at least had been produced by this time.
The amount of passive antibody required to achieve inhibition 
is another important consideration in elucidating the mechanisms of
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antibody-mediated immunosuppression and of negative feedback 
inhibition. From the kinetics of antibody biosynthesis it was 
noticeable that antibody levels invariably declined once a peak 
had been reached at about 7 days after immunisation with a single 
intravenous injection of antigen, and this was independent of the 
amount of antibody in the serum (e.g. Table 4, page 118). Presumably 
the amount of passive antibody required for successful immunosuppression 
is indicative of whether antigen is simply being masked by antibody 
molecules or whether receptor-bearing cells are actually being 
incapacitated. Such a proposal would require that large amounts 
of passive antibody were necessary to physically neutralise the 
antigen, whilst much smaller amounts might suffice for suppression 
of antibody-producing cells. The effect of diluting passive antibody 
upon its ability to suppress the antibody response to a given amount 
of antigen showed that the degree of immunosuppression was not 
related in any simple manner to the dose of passive antibody, and 
significant immunosuppression was achieved with undiluted antibody as 
well as with antibody diluted 1/64 (Table l8, page 176; Figure 26, 
page 177). In fact, marked immunosuppression was seen both at low
and high concentrations of passive antibody, whereas at an intermediate 
dose (e.g. passive antibody diluted I/I6) there was little evidence of 
immunosuppression (Figure 26, page 177). In terms of the tripartite 
model proposed by Chan and Sinclair (1971) it could be argued that an 
intermediate amount of passive antibody was insufficient to mask all 
the antigenic determinants, but conversely, failed to leave enough 
free determinants on antigen-antibody complexes for recognition by 
antibody-like receptors on B cells - thereby preventing inhibition via
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the Fc portions of antibody molecules in the immune complex from 
taking place.
It has been shown by Walker and Siskind (1968) that the
degree of antibody-mediated immunosuppression was directly related
to the affinity of the passive antibody given to an animal. It has
already been postulated and shown (Table l4, page 161) that antibody
taken from the second phase of the anti-HSA response in chickens
immunised with HSA in FCA was probably more avid than antibody from
the first phase; French, Stark and White (1970) have reported a
similar result. Considering these two hypotheses together, it might
be predicted that antibody from the second (high avidity) phase of
the FCA-mediated response (e.g. antibody extracted from the adjuvant
granuloma) to be more immunosuppressive than an equivalent amount of
serum antibody obtained at the peak of a primary response. This
idea was tested by passively immunising two groups of chickens with
one or other of either granuloma extract or serum antibody from the
peak of a primary response. However, there was no evidence of
antibody-mediated immunosuppression with either preparation (Table 19,
page 180); perhaps this was due to the amount of passive antibody
used, i.e. birds received 1 ml of either primary response antibody
(ABC^q = 10.3 yg HSA ml ^) or granuloma extract (ABC^^ = 11.4 yg HSA 
-1
ml ). These amounts of antibody were considerably less than the 
quantities used in the investigation into the timing of passive 
immunisation - where birds received 1 ml of passive anti-HSA (ABC^q = 
126 yg HSA ml ^ ), and would not have neutralised the antigen (250 yg 
HSA) to any great extent.
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The homeostatic regulation which restricts antibody 
biosynthesis in chickens is an antigen-specific mechanism; similar 
specificity has been demonstrated for immunosuppression mediated by 
passive antibody, although there have been conflicting reports on 
whether passive antibody directed against a certain determinant is 
capable of inhibiting the antibody response to the whole antigen or 
just to the determinant in question. If antibody is inhibiting 
biosynthesis by suppressing the antibody-forming cells it would be 
logical to postulate that antibody directed against one determinant 
specificity (say for example against a hapten) might also suppress 
production of antibody to neighbouring determinants (e.g. to the 
carrier for that hapten). On the other hand, a simple masking 
effect by passive antibody might be expected to block only those 
determinants whose specificity was complementary to that of the 
antibody. The precise specificity of passive antibody, whether it 
suppresses the response to its own complementary determinant alone or 
else to the entire antigen of which that determinant is part, can 
therefore be considered to reflect the mechanism by which the passive 
antibody is acting. The effect of anti-hapten and anti-carrier 
antibodies upon the antibody response in chickens to a hapten-carrier 
conjugate was studied to investigate this proposal. The results for 
this study (Table 20, page I83) were equivocal insofar as there was 
too much variation within the experimental groups to enable any 
meaningful comparison,of groups as a whole; none of the differences 
which did occur were any larger than might be expected to arise by 
chance, as judged by a two-tailed t-test. In similar experiments 
carried out in mammals, Brody, Walker and Siskind (1967) found that
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when two haptens were coupled to the same carrier, and this antigen 
was used for immunisation, then antibody to one hapten suppressed 
the response only to that hapten. Conversely, Henney and Ishizaha 
(1970) have demonstrated that both anti-hapten and anti-carrier 
responses could be inhibited by passive antibody to either the 
hapten or to the carrier alone.
For the antibody response elicited in chickens by a single 
intravenous injection of antigen, whether that antigen is soluble 
protein, hapten linked to a carrier or else particulate matter, the 
kinetics of biosynthesis have shown that the decline of the primary 
response invariably started between 6 and 9 days after immunisation. 
This in itself contradicted the idea that removal of antigen presaged 
the decline in antibody biosynthesis since it might be expected 
that different types of antigen were catabolised at different rates; 
rather it suggested that the same homeostatic mechanism was 
operational in the case of each different antigen, and this was 
independent of the type of antigen but dependent upon the presence of 
antibody (or antigen-antibody complexes). Accordingly, removal of 
specific antibody from the circulation would be expected to postpone 
the onset of homeostasis, and this has been demonstrated by plasma­
pheresis of immune rabbits (Graf and Uhr, 19^9; Bystryn, Graf and Uhr, 
1970)* Another way of achieving the same objective was attempted in 
chickens, namely to give repeated injections of antigen during the 
course of primary antibody biosynthesis which would ensure that all 
the antibody produced by the birds was immediately complexed with 
antigen. This would at least help to decide whether the feedback is
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mediated by free antibody or by immune complexes. In the case of 
the anti-HSA response it was found that supplementary injections of 
HSA, given for five consecutive days beginning three days after the 
initial immunisation, caused both an increase in the levels of anti- 
HSA detected and apparently caused a few days' delay in the 
attainment of peak antibody levels in the serum (Table 21, page l86; 
Figure 2J, page 18?). However, even allowing for the amount of 
antibody removed from the circulation by the supplementary injections 
of antigen, it was still true that peak antibody levels were not 
reached before the tenth day in three out of four birds. It would 
therefore appear that the supplementary HSA injections were able to 
delay the action of the homeostatic process. This rather weighs 
against the proposal of Chan and Sinclair (l9Tl) that inhibition is 
mediated by antigen-antibody complexes in antigen excess.
In contrast, supplementary injections of DNP as a divalent 
hapten had no demonstrable effect on the homeostasis of either the 
anti-DNP or the anti-HSA response. White (1973) has proposed that 
homeostasis is achieved by the localisation of antigen-antibody 
complexes onto the surfaces of dendritic cells which leads subsequently 
to the segregation into germinal centres of antibody-forming precursor 
cells which are circulating in the white pulp of the spleen. This 
implies that homeostasis could only be postponed until all the 
antibody-producing B cells capable of responding have been segregated 
into germinal centres. Once this happens, the bird becomes refractory 
to further antigenic stimulation (as was noticed, for example, in 
chickens which were immunised at weekly intervals and which showed 
evidence of a refractory phase during the second week after primary
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injection - see Table 12, page l48).
Although feedback homeostasis in chickens has been 
attributed to antigen-specific antibody, it was recently shown by 
Pitch (19T4) that anti-idiotype autoantibody was produced during the 
later stages of an antibody response in rabbits which was specifically 
reactive to those idiotypes produced during the early stages, and it 
was suggested that this autoantibody may regulate the response. To 
test for a similar phenomenon in chickens, chicken anti-HSA antisera 
taken at various times during the course of an antibody response were 
screened for anti-idiotype activity by testing each antiserum against 
the others from the same individual in a double diffusion system.
This admittedly simple test gave no indication of the presence of 
anti-idiotype activity in any of the antisera. This further supports 
the concept that homeostasis in the chicken is brought about by 
antibody specific for the antigen.
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